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1.1. CLASSIFICATION OF THE SSDNA VIRUSES 
 
A broad range of viruses with a single stranded DNA (ssDNA) genome has been 
identified so far. These viruses have been found in vertebrates as well as in plants and 
bacteria. An overview of the ssDNA viruses is presented in Figure 1. Two families of 
ssDNA viruses have been found in vertebrates: the parvoviridae and the circoviridae. 
The parvoviridae are a long-known family of viruses that has members infecting many 
species. The family of circoviridae was more recently discovered and new members of 
this family are being identified until today. This family contains 3 different genuses: 
the circoviruses, the gyroviruses and the anelloviruses. The classification of new 
members of the circoviridae in these genuses is made based on their size and genomic 
organisation. Only one gyrovirus has been characterized, the chicken anaemia virus 
(CAV) isolated for the first time by Yuasa et al. (1979). Recently viruses with similar 
characteristics as CAV (Hino, 2002) have been isolated from humans and classified in 
the genus of the anelloviruses. The first isolation of a human anellovirus was made 
from a patient (initials T.T.) with post-transfusional hepatitis (Nishizawa et al., 1997) 
and was named TT-virus. Two more human anelloviruses were characterized in 2000: 
TT-like mini virus (Takahashi et al., 2000) and SEN virus (Primi et al., 2000).  
The genus with the highest number of members is the genus of the circoviruses. 
Members of this genus were isolated from several avian and mammalian species. 
Porcine circovirus type 1 (PCV1) was the first circovirus to be identified (Tischer et 
al., 1982) followed by the psittacine beak and feather disease virus (Pass et al., 1984). 
In 1998, a second type of the circovirus was found in association with the postweaning 
multisystemic wasting syndrome, a new emerging disease in pigs at that time (Ellis et 
al., 1998). This virus was named porcine circovirus type 2 (PCV2). Many circoviruses 
have only recently been characterized such as the bovine circovirus (Nayar et al., 
1999), goose circovirus (Soike et al., 1999), Columbid circovirus (Woods et al., 1993) 
and duck circovirus (Soike et al., 2004). 
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1.2. MORPHOLOGY AND GENOMIC ORGANISATION OF THE CIRCOVIRUSES 
 
In 1982, Tischer et al. detected the first porcine circovirus (PCV1) as a 
contaminant of the porcine kidney cell line PK-15 (ATCC-CCL13). This new virus 
was very small in size (17 nm) and did not have an envelope. It was found to contain 
one single-stranded circular DNA molecule of approximately 1760 bases. In 1998, a 
new porcine circovirus was identified that showed 76% DNA homology with PCV1. 
This new virus was named PCV2 (Morozov et al., 1998). Morphology and genomic 
organisation were shown to be identical for both porcine circoviruses.  
Analysis of the DNA molecule showed that it was ambisense and contained 11 
possible open reading frames (ORF’s). Until now, proteins from only two of these 
ORFs have actually been detected in infected cells. These two ORFs (ORF1 and 
ORF2) code for three different proteins. It is uncertain if these proteins are the only 
ones that are expressed by the virus since more viral mRNAs have been detected in 
PK-15 cells infected with the virus (Bratanich and Blanchetot, 2002; Cheung, 2003). 
ORF2 situated on the viral strand of the genome, codes for the capsid protein 
(Nawagitgul et al., 2000). The capsid of the virus is built only out of this protein 
(Crowther et al., 2003). When expressed in baculovirus systems, recombinant ORF2 
proteins spontaneously form virion-like particles (VLPs) (Kim et al., 2002), indicating 
that the assembly of the virion capsid is very efficient. ORF 2 is the region in the 
genome that shows the highest variation between PCV1 and PCV2 with an amino acid 
homology of 65% (Morozov et al., 1998). The other characterized viral proteins are the 
non-structural Rep proteins. These proteins are associated with replication of the viral 
genome. The genetic information for these proteins is located in ORF1, situated on the 
complementary viral DNA strand. Through a frame shift, this single ORF is able to 
code for two different proteins, assigned Rep and Rep’ (Mankertz et al., 1998; 
Mankertz et al., 2001). Rep and Rep’ proteins join and form a complex that is involved 
in replication of the viral genome (Steinfeldt et al., 2001). The DNA sequence of 
ORF1 is highly conserved between PCV1 and PCV2 (amino acid homology of 86%) 
(Morozov et al., 1998). This is an indication for the importance of the Rep protein 
complex for survival of the viruses. The morphology and genomic organisation of 
PCV2 is shown in Figure 2.  
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In PK-15 cells it was observed that viral antigens appeared in the infected cells 
starting from 18 hours post inoculation (hpi). The PCV2 capsid protein was found 
mainly in the nucleus of the infected cells indicating that assembly of the virus 
occurred at that site. Starting from 30 hpi, the production of progeny virus could be 
demonstrated (Cheung and Bolin, 2002). 
 
 
 
Figure 2. Morphology and genomic organisation of PCV2. A. The PCV2-virion 
consists of a capsid without envelope. B. The genome of PCV2 is a single stranded 
circular DNA molecule with a stem loop structure. C. A highly conserved 
nonanucleotide sequence is located on the top of the stem loop structure. Close to the 
stem loop structure the ORF2 starts on the viral strand coding for the capsid protein, in 
the other direction, on the complementary strand, starts ORF1 that codes for the Rep 
protein. 
 
 
All members of the circoviridae share the property that they are not able to 
express a broad variety of viral proteins due to the limited genetic information they 
carry. Many of them are very wide spread in the population of their natural host 
(Sanchez et al., 2000; Rahaus et al., 2003; Ali et al., 2002; De Herdt et al., 2001) and 
many of these viruses are able to cause persistent infections (Bolin et al., 2001; Maggi 
et al., 2001; Imai et al., 1999). This indicates that disregarded their relatively simple 
structure, circoviridae are very successful in maintaining themselves in the population 
of their host.  
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1.3. REPLICATION CYCLE OF THE PORCINE CIRCOVIRUSES 
 
The mechanism involved in attachment and internalization of porcine circoviruses 
into their host’s cells is unknown. The cellular receptors that bind porcine circoviruses 
and by doing so initiate the replication cycle of the virus, remain to be discovered. 
Replication of the circovirus genome once it is inside the cell is believed to occur 
through a mechanism known as the rolling cycle replication (Meehan et al., 1997). The 
Rep/Rep’ complex binds to the starting-point of the DNA-replication and initiates the 
DNA replication cycle. However, with the Rep/Rep’ complex, no DNA-polymerase 
activity could be observed. The actual synthesis of new viral DNA is believed to be 
carried out by a cellular DNA-polymerase. This accounts for the fact that PCV1 
requires replicating cells to complete its infectious cycle (Tischer et al., 1987). This 
rolling cycle replication has already been described in phages and plasmids (Novic, 
1998) but also in plant viruses with a circular ssDNA genome: the nanoviridae 
(Groneborn, 2004) and geminiviridae (Laufs et al., 1995). Vertebrate circoviruses 
seem to have a high homology with these plant viruses. They have similar sizes, 
structures and genetic organisations and some sequences in their genomes are almost 
identical. One of these nearly identical sequences is the nonanucleotide sequence 
localized on the top of the stem loop structure. This highly conserved domain was 
proven to be the starting point of the rolling cycle replication (Meehan et al., 1997; 
Niagro et al., 1998). The nonanucleotide sequences of different vertebrate and plant 
viruses are presented in Table 1. The similarities between circoviruses that infect 
vertebrates and nanoviruses that infect plant are so striking that it is believed that the 
circoviridae are actually derived from these nanoviridae. Through a kingdom shift, a 
nanoviruse is thought to have infected a vertebrate host and to have recombined with a 
vertebrate virus (possibly a calicivirus) present in that host at that time. This way, a 
completely new virus was created. Luckily such a kingdom shift is a very rare event 
during evolution (Gibbs and Weiller, 1999). 
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Table 1. Alignment of the nonanucleotide sequence of different vertebrate and plant 
viruses. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.4. PATHOGENESIS OF A PORCINE CIRCOVIRUS TYPE 2 INFECTION 
 
Experimental PCV2-infection of pigs has been achieved by various inoculation 
routes. The main natural infection route of PCV2 is generally believed to be the 
oronasal route. In the events following the primary infection, many questions remain to 
be answered. Until today, it is still unknown where the primary replication of PCV2 
takes place. As a result it is unknown which physical barrier between the inner body 
and the outside environment is important in the prevention of PCV2-infection. 
Consequently it is also unclear what kind of local immune response would be able to 
interfere with (re-)infection of the host. Starting from 7 days post experimental 
inoculation (dpi), a mainly cell-associated viremia could be detected (Pensaert et al., 
2004) resulting in the spread of the virus to all organs in the body. A quite interesting 
characteristic of PCV2 is that at later stages of the infection, the virus can be isolated 
from a high variety of organs (Ellis et al., 2000; Magar et al., 2000; Sanchez et al., 
2001). This indicates that PCV2 is able to replicate in many different cell types or that 
it replicates in cells that are commonly present in different organs.  
Hamel and Nayar 
2004AAGTATTACbovine circovirus
Kloet and Kloet, 2004TAGTATTACpsittacine beak and feather disease virus
Mankertz et al., 2000TAGTATTACcolumbid circovirus
Lazarowitz et al., 1987
Boevink et al., 1995
Rohde et al., 1995
Harding et al., 1993
Meehan et al., 1998
Cheung, 2003
Reference
TAATATTACgeminivirus
TAGTATTACsubterranean cloves stunt virus
TAGTATTACcoconut foliar decay virus
TATTATTACbanana bunchy top virus
Plant viruses
AAGTATTACporcine circovirus type 2
TAGTATTACporcine circovirus type 1
Vertebrate 
viruses
Nonanucleotide 
sequenceVirus
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The identification of the target cell for PCV2-replication has been the subject of 
many studies. Based on morphological identification, PCV2-antigens were detected 
mainly in monocytes/macrophages but also to a lesser extent in hepatocytes, different 
types of epithelial cells, endothelial cells, lymphocytes, muscle cells, fibroblasts and 
neurons (Rosell et al., 1999; Kennedy et al., 2000; Stevenson et al., 2001). In 2003, 
Sanchez et al. performed a series of studies in porcine foetuses and newborn piglets. In 
these studies, porcine foetuses were inoculated in utero with PCV2 at different 
gestational ages (57, 75, 92 and 104 days of gestation). Following the same inoculation 
protocol, 1-day-old gnotobiotic piglets were inoculated with the same infectious dose 
of PCV2. The population of PCV2-positive cells was determined both in foetuses and 
in newborn pigs and compared. They observed considerable differences in PCV2-
infected cells between pre- and postnatally inoculated animals. In foetuses, the main 
target cells were found to be cardiomyocytes and macrophages in the heart, the main 
target organ in PCV2-infected foetuses, and hepatocytes and macrophages in the liver. 
In postnatal piglets, hearts were almost negative for PCV2 and if present, antigens 
were only detected in macrophages. In lungs and lymphoid organs, the majority of 
positive cells were of the monocyte/macrophage lineage. In the postnatally inoculated 
piglets, two patterns in PCV2-positive cells were observed (Sanchez et al., 2004). In 
most of the piglets, only macrophages were shown to contain PCV2 proteins (both 
structural and non-structural PCV2-proteins were detected). Infectious PCV2-titres in 
the organs of these piglets were low. In a minority of piglets, high PCV2-titres were 
detected. In these piglets, besides infected macrophages, also a population of CD4+ T-
cells, CD8+ T-cells and B-cells were infected. This study was the first study to 
emphasize the difference in degree of PCV2-replication and to correlate this with 
differences in the infected cell populations. This observation was of major importance 
for this thesis. Sanchez and co-workers did not discriminate dendritic cells (DCs) from 
other cells of the monocyte/macrophage lineage. The interaction of PCV2 with DCs is 
currently under investigation by another research group. It was observed that DCs are 
infected by PCV2 but no progeny virus could be detected (Vincent et al., 2004). The 
authors hypothesize that DCs would play an important role in the dissemination of 
PCV2 throughout the body. It is not clear whether PCV2 alters the immunological 
functions of the DCs it infects. Although many cell types have been claimed to contain 
PCV2 antigens in vivo, there is no known type of primary porcine cells that can be 
used to produce high titres of PCV2 in vitro.  
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Starting from 14 days after experimental inoculation, the number of PCV2 DNA 
copies decreased in most of the inoculated pigs. The start of the decrease in PCV2 
replication coincided with the first detection of antibodies against PCV2 (Ladekjær-
Mikkelsen et al., 2002). Other studies report the first detectable anti-PCV2 antibodies 
starting between 14 and 21 days post inoculation (dpi) (Progranichnyy et al., 2000; 
Bolin et al., 2001; Harms et al., 2001). Only one study reports the existence of PCV2-
neutralizing antibodies. These antibodies were detected starting from 28 dpi 
(Prognanichnyy et al., 2000). Since PCV2 is endemically present in most of the farms 
(Sanchez et al., 2000), most of the piglets under field conditions will receive 
maternally derived antibodies (MDA) against the virus. In the absence of infection, the 
MDA will decrease below the detection limit of standard serology assays between the 
age of 7 to 8 weeks (Labarque et al., 2000). Under field conditions the seroconversion 
is most typically observed at the age of 6 to 10 weeks in the presence of low titres of 
MDA (Labarque et al., 2000, Meerts et al., 2004). The onset and efficacy of the 
cellular immune response of the host towards PCV2-infection remain undocumented. 
The crucial role of the adaptive immunity in controlling the replication of the virus 
however, has clearly been demonstrated since artificial immunosuppression of 
gnotobiotic pigs by Cyclosporin A (CysA) treatment before and during PCV2-infection 
resulted in a dramatic increase in PCV2-titres in the pigs (Krakowka et al., 2002).  
When literature is reviewed, indications are found that the immune response of the 
pig against PCV2 is not always capable of efficiently removing PCV2 from the body. 
In a number of studies, experimentally PCV2-inoculated piglets developed 
exceptionally high PCV2-titres compared to their group mates (Kennedy et al., 2000; 
Ladekjær-Mikkelsen et al., 2002; Sanchez et al., 2004). In two of these studies the 
level of PCV2 replication was followed in time by determining infectious titres in 
lymphoid organs of pigs euthanised at different time points (Sanchez et al., 2004) or by 
determining the number of PCV2 genome copies in the blood of pigs at different time 
points (Ladekjær-Mikkelsen et al., 2002). It was observed that PCV2-replication 
evolved with reasonable variation during the first 10 days of infection. Starting from 
approximately 14 dpi two different PCV2-replication patterns appeared in both of these 
studies. One group of pigs (3/4 and 6/10) showed a decrease of the level of PCV2 
replication after 14 dpi. A second group of pigs (1/4 and 4/10) suffered a significantly 
higher PCV2-replication. PCV2-replication in these pigs even intensified after 14 dpi. 
In one study (Ladekjær-Mikkelsen et al., 2002) these pigs with high PCV2 replication 
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died of PCV2-associated disease (postweaning multisystemic wasting syndrome) 
before the end of the study. This observation indicates that some pigs are less able to 
remove the virus or virus-infected cells from their body. The most credible explanation 
for this event would be a difference in the efficiency of the immune response to cope 
with the replicating virus, rendering a limited fraction of pigs more susceptible to 
PCV2-replication and subsequently to the development of PCV2-associated disease. 
Revealing the mechanism responsible for this difference in susceptibility, would be an 
important step in understanding the pathogenesis of a PCV2-infection.  
 
 
1.5. PORCINE CIRCOVIRUS TYPE 2 RELATED SYNDROMES 
 
1.5.1. Postweaning Multisystemic Wasting Syndrome 
 
Clinical presentation 
After the first description of the porcine circovirus now known as porcine 
circovirus type 1 (PCV1) (Tischer et al. 1982), the virus was demonstrated to be 
endemically present in the pig population. At that time, PCV1 was not associated with 
any disease in pigs. Experimental PCV1-inoculations in seronegative pigs indicated 
that PCV1 only caused a subclinical infection (Tischer et al., 1986; Allan et al., 1995). 
These findings resulted in a lack of interest and need for further investigation of the 
virus. This vision was dramatically reconsidered when in 1998 a new type of porcine 
circovirus was identified (Morozov et al. 1998, Ellis et al., 1998). The new virus was 
assigned PCV2 and was found in association with a new emerging disease in pigs: the 
postweaning multisystemic wasting syndrome (PMWS), described for the first time by 
Harding (1996). High titres of PCV2 were isolated from a broad range of tissues of 
clinically affected animals (Allan and Ellis, 2000). The clinical presentation of this 
syndrome was characterized by severe growth retardation or weight loss in pigs after 
weaning. Figure 2 shows a group of PMWS-affected pigs. Besides the obvious signs of 
wasting, the most frequently observed pathological lesions in affected pigs were 
pneumonia and enlargement of lymph nodes. In a lesser proportion of cases also the 
kidneys or the liver were affected (Segalés and Domingo, 2002).  
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Figure 2. Example of PMWS-affected pigs 
 
 
 
 
The pathological lesions described above are not typical for PMWS only but can 
be found in various chronical diseases. Therefore the observed lesions were further 
histologically characterized. Histopathological examinations revealed an interstitial 
inflammation in many affected organs (lungs, kidney, liver and colon) (Segalés and 
Domingo, 2004). A somewhat more pathognomonic microscopical lesion was found in 
the lymphoid tissues. As well in spleen as in lymph nodes, a severe depletion of 
lymphocytes was observed combined with an infiltration of monocytes into the 
lymphocyte areas. Furthermore, multinucleate giant cells could be detected in these 
tissues (Morozov et al., 1998; Rosell et al., 1999). The depleted cell populations in 
lymphoid organs of PCV2-infected pigs were characterized as B-cells and CD4+ or 
CD8+ T-cells (Shibahara et al., 2000; Sanchez et al., 2004). B- and T-lymphocytes 
were depleted not only from lymphoid tissues, in PMWS-affected pigs also a decrease 
in circulating B- and T-lymphocytes was observed (Darwich et al., 2002; Nielsen et 
al., 2003). These changes in lymphocyte populations have been interpreted as 
indications for the immunosuppressive capacities of PCV2 (Rosell et al., 1999; 
Darwich et al., 2004; Segales et al., 2004). However, no mechanism of 
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immunosuppresion due to a PCV2-infection has been described until now, neither has 
any functional test revealed an influence of PCV2 on the general immunological 
capacity of its host. The depletion of lymphocytes has also been observed in 
association with circovirus-infections in other species such as pigeons and finches 
(Woods et al., 1994; Shivaprasad et al., 2004). In Chicken anemia virus (CAV) a 
suppressive effect of the virus on the immunity of the host has been revealed. In CAV-
infected animals, it has been shown that the virus disabled the host to generate 
pathogen-specific T-cells (Markowski-Grimsrud and Schat, 2003). 
 
Diagnosis 
In order to differentiate PMWS from other chronical diseases causing a similar 
clinical picture in weaned pigs, Sorden (2000) proposed a way to diagnose PMWS 
based on the presence of clinical, pathological and histopathological lesions, combined 
with the demonstration of PCV2 in the affected organs. Using this definition, a positive 
diagnosis of PMWS could be made on an animal level. The presence of a single 
PMWS-affected pig in a herd however, does not embody the severity of the problem in 
that herd. In independent studies, single PMWS-affected pigs could be diagnosed in 
healthy farms with normal mortality rates, that did not experience important economic 
losses due to PMWS (Rodriguez-Arrioja et al., 2003; Meerts et al., 2004; Segalés 
personal communication). Therefore, a PMWS-affected farm was theoretically defined 
by Segalés et al. (2003) as a farm with an increased prevalence of PMWS-affected pigs 
compared to the historical background. Since the prevalence of PMWS is never being 
followed on a healthy conventional farm with the proper diagnostic tools, this 
definition might be more useful for scientific purposes than for everyday use by swine 
practitioners. This is the reason why scientists are still looking for a better definition of 
a PMWS-affected farm. 
 
Prevalence and economical importance 
The importance of PMWS rapidly increased in most Western-European countries 
during the late nineties. In 2000, the first diagnosis of PMWS was made in Belgium 
(Vyt et al., 2000). Contrastingly, PCV2 was shown to be present in the pig population 
long before PMWS was diagnosed. Archived sera originating from pigs from 1967 
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were tested and found to contain antibodies against the virus (Sanchez et al., 2000). 
This indicates that the association between PMWS and PCV2 has to be addressed with 
caution. Therefore, a study was performed to monitor PCV2-infections in PMWS-
affected and healthy farms in Belgium and to detect correlations with the appearance of 
the disease (Meerts et al., 2004).  
In this study, the prevalence of PMWS affected pigs was determined in three 
PMWS affected farms and in four control farms with no suspicion of PMWS in 
Belgium. The diagnosis of PMWS was based on the combined presence of four 
criteria: the presence of growth retardation, gross lesions and histopathological lesions 
suggestive for PMWS and the presence of high PCV2 titres in lymphoid organs. In  
PMWS affected farms, 2% of the piglets died of PMWS during the observation period. 
In the control farms, one out of 1000 piglets was found to be affected with PMWS. 
Serological examinations showed that all piglets became infected with PCV2 on all 
farms and no differences in serological profiles were seen between farms or litters with 
or without PMWS-affected piglets. This study showed that at that time PMWS was 
clearly not a problem of major importance in the Belgian pig population while at the 
same time the disease was causing high economical losses in other Western European 
countries. It could be concluded that the prevalence of PMWS in a population was 
influenced by unknown regional differences in the pig industry and not by the 
prevalence of PCV2. Another important conclusion in this study was the fact that a 
single PMWS-affected pig could be found in a healthy farm. This indicated that 
PMWS can be present in a farm without causing a lot of damage and that the 
experience of a PMWS-problem in a farm, might be inflicted by an increase in the 
number of PMWS-affected pigs, rather than by an introduction of the disease. The low 
prevalence of PMWS in Belgium described in this study was quite contrasting with the 
reports of high economic losses due to the disease in other European countries such as 
France and the United Kingdom. At the time of this description, two other European 
countries, Denmark and Sweden, were also reporting a low importance of PMWS in 
their pig herds. However, in both countries a dramatic increase in PMWS-affected 
farms was observed between 2003 and 2004 (Hassing et al., 2003; Wallgren et al., 
2004).  
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From this study, 2 important questions rise: 1. what causes the difference between 
Belgium and its surrounding countries with regard to the prevalence of PMWS in their 
pig herd and 2. what mechanism is important in inducing PMWS in some pigs, while 
their littermates, although they are raised in identical conditions, remain completely 
unaffected. In this thesis some answers will be given to solve a part of this puzzle. 
 
1.5.2. Porcine circovirus type 2 associated abortion 
 
Field observations 
In 1999, PCV2 was for the first time isolated from a litter of aborted foetuses 
(West et al., 1999). In one foetus, a diffuse myocarditis was associated with an 
extensive immunohistochemical staining for PCV2 antigens. From these aborted 
foetuses, no other agents that are being associated with reproduction problems in sows 
or abortions, could be isolated. After this first description of PCV2-induced abortion, 
several other descriptions were made. A common factor in many of these cases was the 
fact that the affected herd experienced problems at the time when they housed a high 
number of sows that were possibly seronegative for PCV2. In one case, a Specific 
Pathogen Free (SPF) farm known to be free of the virus got infected with PCV2 
(Ladekjær-Mikkelsen et al., 2001), resulting in abortion of several sows. In two other 
occasions, new startup farms with new populations of gilts got affected by PCV2-
associated abortion (O’Connnor et al., 2001; Farnham et al., 2003). From these data, it 
could be concluded that PCV2-related abortion was most likely to occur in PCV2-
seronegative sows that got infected with PCV2. Regarding the endemic spread of 
PCV2 in nearly all pig farms (Sanchez et al., 2000), this may be considered as a rare 
event. 
 
Experimental reproduction 
In a series of experimental transuterine inoculations, Sanchez et al. (2001) 
investigated the susceptibility of foetuses at different gestational ages to PCV2-
infection. The PCV2-titres obtained from inoculated foetuses were negatively 
correlated with the gestational age at the time of inoculation. Only in foetuses 
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inoculated at 57 days of gestation, gross lesions were observed (congestion of internal 
organs). These lesions were not observed in foetuses inoculated at later stages of 
gestation (75 or 92 days). This study clearly showed that porcine foetuses are 
susceptible for PCV2 and possibly die of the consequences of the infection.  
In an attempt to demonstrate vertical transmission of the virus towards the 
foetuses, pregnant PCV2-seronegative gilts were inoculated with PCV2 (Pensaert et 
al., 2004). In this study, spread of the virus towards the foetuses could not be 
demonstrated. Recently however, another study described experimental reproduction 
of abortion by inoculation of PCV2 seropositive sows with PCV2 (Nielsen et al., 
2004). In this study, 1 out of 2 inoculated pregnant sows farrowed at 118 days of 
gestation. The litter contained one dead-dorn and several unthrifty piglets. Pre-colostral 
antibodies against PCV2 were detected in sera of these piglets and PCV2 antigens 
could be retrieved from their organs. These studies indicate that vertical transmission 
of PCV2 to the foetuses after infection or re-infection of the sow is possible but does 
not occur in every pregnant sow that is (re-)infected with PCV2. Field surveys indicate 
that PCV2-associated reproductive failure does occur under field conditions but 
represent only a small fraction of the total number of reproductive disorders diagnosed 
in pig farms (Bogdan et al., 2001; Kim et al., 2004). 
However, the importance of PCV2 in inducing reproductive disorders could be 
underestimated. It was recently demonstrated that early stages of porcine embryo’s 
become susceptible to PCV2-infection as soon as they are hatched out of the zona 
pellucida (Mateusen et al., 2004). From this study, it could be hypothesized that 
infectious PCV2, transmitted through semen during mating or artificial insemination, 
would be able to infect these early stages of embryonic development and result in early 
embryonic death. PCV2 genomic material has already been detected in semen of boars 
(Hamel et al., 2000; Larochelle et al., 2000). Further research will have to point out if 
this association of PCV2 with early embryonic death is purely academic, or if it does 
occur in field conditions. 
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1.5.3. Others 
 
PMWS and PCV2-associated abortion share the property that they can be 
reproduced, albeit with varying success, by inoculating pigs in specific conditions with 
PCV2. Besides these diseases, others have been mentioned in association with a PCV2 
infection in pigs. However none of these syndromes have been experimentally 
reproduced, rendering the link between the disease and the virus controversial. A list of 
all syndromes and clinical signs that have been associated with PCV2 infection in the 
past, is presented in Table 2 
 
 
Table 2. Overview of the diseases that have been associated with PCV2 infections. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The best described syndrome in this list is a syndrome that was observed in pigs 
starting from the mid-nineties. Pigs, usually in the fattening unit, showed a systemic 
necrotizing vasculitis resulting in skin lesions on the caudoventral part of the body, in 
combination with glomerulonephritis (Hélie et al., 1995; Thibault et al., 1998). Based 
on the predominant lesions, the disease was named Porcine Dermatitis and 
Harding, 2004noProliferating and necrotizing pneumonia
Harms et al., 2002noPorcine respiratory distress complex
Kim et al., 2004noEnteritis
Wattrang et al., 2002noExudative epidermitis
Stevenson et al., 2001noCongenital tremor
Rosell et al., 2000noPorcine dermatitis and nephropathy syndrome
West et al., 2000yesAbortion
Harding, 1996yes
Postweaning 
multisystemic wasting 
syndrome
Reference
Reproduced by 
experimental PCV2-
inoculation?
Disease
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Nephropathy Syndrome (PDNS). PCV2 was detected in tissues of PDNS-affected pigs 
(Rosell et al., 2000). The etiologic involvement of PCV2 in this disease is currently 
under debate since it was observed that PCV2 viral loads in PDNS-affected animals 
were not higher compared to the load in subclinically infected animals (Olvera et al., 
2004). From this observation it could be concluded that the lesions associated with 
PDNS are not very likely due to an acute PCV2-infection since in that case high PCV2 
titres should be present. When the lesions observed in affected pigs are compared to 
lesions seen in other animal species, they seem to match with lesions typically seen in 
association with a type III hypersensitivity reaction (Janeway et al., 2001). An 
indication for the involvement of PCV2 in the disease was found in the fact that 
PDNS-affected pigs showed significantly higher antibody-titres against the virus 
compared to subclinically infected animals (Wellenberg et al., 2004). This finding 
supports the hypothesis of a type III hypersensitivity since high antibody-titres against 
PCV2 would be able to form complexes that could initiate the hypersensitivity 
reaction. In PDNS-affected farms, the morbidity and mortality rates due to the disease 
are quite low (Thomson et al., 2002). However, since PDNS often affects pigs at the 
end of the fattening period, the economical consequences of the disease can be 
considerable. The syndrome seems to gain in importance in the Western European 
countries (Elbers et al., 2000). 
 
 
1.6. EXPERIMENTAL MODELS TO REPRODUCE THE POSTWEANING MULTISYSTEMIC 
WASTING SYNDROME 
 
Starting from the first detection of PCV2 in PMWS-affected pigs, researchers have 
been continuously investigating the role of PCV2 in the pathogenesis of the disease. In 
order to fulfil Koch’s postulates, the reproduction of the disease by inoculation of the 
virus in susceptible pigs was mandatory. The results of these experiments were in 
many occasions very discouraging. When PCV2-replication was monitored in 
experimentally inoculated pigs, the only constant finding was the very high variation in 
replication between pigs (Balash et al., 1999; Allan et al., 2000a; Allan et al., 2000b; 
Kennedy et al., 2000; Ladekjær-Mikkelsen et al., 2002; Sanchez et al., 2003; Sanchez 
et al., 2004). Also the reproduction of PMWS-associated gross lesions and/or clinical 
symptoms showed high variation. Only a limited number of studies described the 
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successful reproduction of PMWS-associated gross lesions and clinical symptoms by 
inoculating pigs with PCV2 only (Kennedy et al., 2000; Bolin et al., 2001; Ladekjær-
Mikkelsen et al., 2002; Okuda et al., 2003; Allan et al., 2003). The number of studies 
describing PCV2-inoculations in pigs without reproducing PMWS are much more 
abundant (Allan et al., 2000a; Krakowka et al., 2000; Krakowka et al., 2001; Allan et 
al., 2000b; Rovira et al., 2002; Krakowka et al., 2002; Sanchez et al., 2003; Opriessnig 
et al., 2003; Opriessnig et al., 2004a; Resendes et al., 2004; Sanchez et al., 2004; 
Opriessnig et al., 2004b). In all of the above-mentioned studies, pigs with no detectable 
titres of MDA against PCV2 were used. Seroconversion of the inoculated pigs against 
PCV2 was always detected, indicating that the variation in successfully reproducing 
PMWS by inoculating pigs with PCV2 was not due to a difference in susceptibility of 
the pigs to PCV2-infection. When the degree of PCV2-replication is compared 
between pigs from different studies by means of virus titres in affected organs, it is 
observed that certain high virus titres in one study were associated with disease, 
whereas in another study, equally high titres were found in clinically healthy animals. 
This indicates that the reproduction of the disease was not only associated with the 
level of virus replication, but also with unidentified variables in-between different 
experiments. One lesion was constantly observed in all studies. The depletion of 
lymphocytes and infiltration of monocytes in lymphoid organs in the presence or 
absence of clinical symptoms or macroscopical lesions, were always correlated with 
the presence of high PCV2 titres in these organs. The conclusion that could be drawn 
from this was that the microscopical lesions observed in PMWS-affected pigs could be 
induced by PCV2-infection but that for the reproduction of the macroscopical lesions 
and clinical signs associated with PMWS, other factors had to be considered.  
In a series of experimental studies, the influence of secondary infections on the 
reproduction of PMWS in combination with a PCV2 infection was determined. Many 
of these secondary infections were selected based on their high prevalence in piglets at 
the time they experience PCV2 infections and PMWS under field conditions. However, 
the first successful identification of a possible cofactor was obtained by coincidence. In 
1999, Allan et al. inoculated gnotobiotic piglets with a PCV2-stock that was 
accidentally contaminated with porcine parvovirus (PPV). In this experiment it was 
observed that pigs inoculated with both viruses had a higher chance of developing 
PMWS compared to pigs that were inoculated with a PCV2-stock without PPV. To 
check whether this was specific to the combination of PCV2 and PPV, another dual 
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inoculation was performed. In this second study, PCV2 was inoculated alone or in 
combination with the porcine reproductive and respiratory syndrome virus (PRRSV). 
Here again a higher chance of developing PMWS was observed in the dually 
inoculated pigs compared to the control pigs that were only inoculated with PCV2 
(Allan et al., 2000b; Rovira et al., 2002). Pigs that were inoculated with both viruses 
showed a higher replication of PCV2.  
At the time when these dual inoculations were performed, it was unknown which 
mechanism, which was activated both by PPV and PRRSV infection, was responsible 
for the enhanced PCV2-replication. To check if this could be accredited to the 
induction of an immune response, gnotobiotic pigs were injected with keyhole limpet 
hemocyanin (KLH) in Freund’s incomplete adjuvant at the same time of PCV2-
inoculation (Krakowka et al., 2001). By doing so, a reproducible immune response was 
induced in these pigs. All gnotobiotic pigs that received KLH together with the PCV2-
inoculation developed PMWS, while the control pigs that were only inoculated with 
PCV2 only experienced a subclinical infection. This was the first study to indicate that 
an immune response of the host was able to influence the intensity of PCV2-replication 
and the induction of clinical symptoms upon this infection. Which part of the immunity 
was responsible for this enhancement, was still unkown. Surprisingly, the effects 
induced by KLH-injection in gnotobiotic piglets could not be reproduced in 
conventional specific pathogen free (SPF) pigs when the same protocol was applied 
(Ladekjær-Mikkelsen et al., 2002). In this experiment, PMWS was observed in both 
the KLH-inoculated and the mock-inoculated animals. This difference in susceptibility 
to develop PMWS upon PCV2-infection between gnotobiotic and conventional pigs 
might be caused by their different background.  
A number of other studies were performed in which PCV2-inoculated pigs were 
inoculated or treated with other factors. A third infectious agent that was found to 
exacerbate the clinical outcome of a PCV2 infection in experimentally inoculated pigs 
was Mycopasma hyopneumoniae (Opriessnig et al., 2004). This infection might be of 
importance in the pathogenesis of PMWS in field conditions since Mycoplasma 
hyopneumoniae infections can occur in very young piglets. Injection of experimentally 
PCV2-inoculated pigs with vaccine-adjuvant (Resendes et al., 2004) or a bacterin 
(Opriessnig et al., 2003) did not result in the induction of clinical signs but they did 
induced a higher PCV2 replication. An overview of the studies in which the influence 
of possible cofactors was investigated, is given in Table 3. 
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Table 3. Overview of studies describing the clinical outcome of PCV2-inoculation in 
pigs with or without secondary infections or treatments. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Although it is now generally accepted that PCV2-infection is required for the 
induction of PMWS, it is also accepted that secondary factors play a crucial role. The 
mechanism by which these cofactors influence the clinical outcome of a PCV2-
infection remains to be elucidated. This thesis will focus on this question. 
 
 
 
yesnoM. HyopneumoniaeconventionalOpriessnig et al., 2004
nonoVaccine adjuvantconventionalResendes et al., 2004
yesnoporcine parvovirusconventionalOpriessnig et al., 2004
nonobacterinconventionalOpriessnig et al., 2003
nonocyclosporin ACDCDKrakowka et al., 2002
yesyeskeyhole limpet hemocyaninconventionalLadekjær-Mikkelsen et al., 2002
yesnoPRRSVconventionalRovira et al., 2002
yesnoPRRSVCDAllan et al., 2000
yesnokeyhole limpet hemocyaninCDCDKrakowka et al., 2001
yesnoporcine parvovirusCDCDKrakowka et al., 2000
yesnoporcine parvovirusCDAllan et al., 2000
yesyesporcine parvovirusconventionalKennedy et al., 2000
PCV2-inoculated pigs + 
additional 
inoculation/treatment
PCV2-inoculated pigs
Wasting observed in …
Secondary inoculation or 
treatmentStatus of pigsStudy reference
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Porcine circovirus type 2 (PCV2) is a recently discovered virus in pigs that is 
endemically present in the population. Infections of pigs with this virus, have been 
associated with various diseases and syndromes. Two of these syndromes have been 
successfully reproduced by inoculating susceptible animals with PCV2, the 
postweaning multisystemic wasting syndrome (PMWS) and PCV2-associated 
abortion. The target cells of PCV2 replication in postweaning pigs and foetuses have 
already been identified but the replication cycle of the virus in these cells remains to 
be established. 
Postweaning multisystemic wasting syndrome has been associated with a 
continuously high level of PCV2 replication in pigs typically between 4 and 14 weeks 
of age. Upon experimental inoculation of seronegative pigs, only a minority of pigs 
experienced this high and persisting PCV2 replication. The mechanism that 
determines the difference in degree of PCV2 replication between pigs is unknown. 
This thesis aims to identify host-specific factors that are able to influence the 
replication of PCV2 in vivo during the early stages of the infection, but also factors 
that lie at the base of the persistent infection that is seen in naturally PMWS-affected 
animals as well as in experimentally inoculated pigs. 
 
The aims of this thesis can be more specified as follows: 
• To determine the replication cycle of PCV2 in its natural target cells and in 
fully susceptible porcine cell lines, in order to investigate the influence of 
cytokines on PCV2-replication in vitro and subsequently in vivo. 
• To characterize the immunological response of the host against a PCV2-
infection in order to find correlations with the evolution of PCV2-replication 
in that host. 
• To confirm observations, made in this thesis during experimental PCV2-
inoculations, in naturally PMWS-affected animals.  
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Summary 
 
In this in vitro study, the replication kinetics of porcine circovirus type 2 (PCV2) 
in porcine alveolar macrophages (PAM) and fetal cardiomyocytes (FCM), two target 
cells in vivo, was compared with that in PK-15 cells. Cultures were inoculated with 
either the postweaning multisystemic wasting syndrome (PMWS)-associated strain 
Stoon-1010 or the abortion-associated strain 1121. Viral proteins were visualized and 
virus production was determined. In PK-15 cells, the capsid protein was expressed 
between 6 and 12 hours post inoculation (hpi), it relocated to the nucleus between 12 
and 24 hpi. At that time Rep protein was also detected in the nucleus. This sequence 
of events also occurred in FCM and PAM but nuclear localized antigens appeared 
later (48 hpi) and in a lower percentage of cells. In PAM, clear differences in 
susceptibility were seen between pigs. In PAM from two out of five tested pigs, no 
nuclear localized antigens could be detected, whereas in PAM from three other pigs 
they were seen in up to 20% of the antigen-positive cells. Virus production was 
observed in PK-15 but not in PAM or FCM cultures. In a second study, the replication 
kinetics of seven different PCV2 strains were compared in PK-15 cells. It was shown 
that 2 abortion-associated strains had different replication kinetics in comparison with 
PMWS or porcine dermatitis and nephropathy syndrome associated strains. With the 
abortion-associated strains, a higher number of infected cells was observed after 24 
hours, the fraction of these cells with nuclear localized antigens was lower compared 
to the other strains. 
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Introduction 
 
The genus circovirus in the family Circoviridae contains 2 porcine viruses: 
porcine circovirus type 1 (PCV1) and porcine circovirus type 2 (PCV2). PCV1 was 
first described by Tischer et al. (1982) as a contaminant in the porcine kidney cell line 
PK-15. Experimental inoculations with this virus in susceptible pigs did not result in 
clinical signs or pathological lesions (Tischer et al., 1987; Allan et al., 1995) and as a 
result, PCV1 was generally recognised to be non-pathogenic. PCV2 was first isolated 
in 1997 from a piglet affected by the postweaning multisystemic wasting syndrome 
(PMWS) (Ellis et al., 1998). More recently, this virus was also detected in aborted 
and stillborn foetuses (West et al., 1999; Ladekjær-Mikkelsen et al., 2001). 
Experimental inoculations with PCV2 strain Stoon-1010 that was isolated from a case 
of PMWS (Ellis et al., 1998) and with PCV2 strain 1121, isolated from aborted 
foetuses (Meehan et al., 2001) have confirmed the crucial role of PCV2 in the 
reproduction of both syndromes (Allan and Ellis 2000; Sanchez et al., 2001).  
The circovirus structure is characterized by its relative simplicity. The 1.8 kb 
single-stranded genome consists of a single circular ambisense DNA molecule 
(Tischer et al., 1982). Transcripts of 2 open reading frames have been characterized in 
PCV1-infected cells. Open reading frame 1 (ORF1), situated on the viral DNA strand, 
is transcribed into two collinear transcripts: Rep and Rep’ (Mankertz et al., 1998; 
Steinfeldt et al., 2001). Both proteins form a complex that is involved in the 
replication of the virion ssDNA replication (Mankertz and Hillebrand, 2001). Open 
reading frame 2 (ORF2), situated on the complementary DNA strand, codes for the 
capsid protein (Nawagitgul et al., 2000) that has a molecular weight of 30-35 kDa 
(Cheung and Bolin, 2002; Nawagitgul et al., 2000). In order to express the capsid 
protein, it is believed that the complementary strand has to be synthesized through the 
intermediate double-stranded replication form (RF) as described for geminiviruses 
(Gutierrez 1999; Tischer and Bukh, 1988). Since circoviruses do not code for their 
own DNA-polymerase for the production of the double-stranded RF, they depend on a 
host DNA-polymerase to complete the replication of their genome. The requirement 
for host DNA-polymerases accounts for the observation that PCV1 requires PK-15 
cells in the S-phase of the mitosis cycle to complete its infectious cycle (Tischer et al., 
1987).  
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Immunophenotyping of the target cell of PCV2-replication in vivo has shown that 
the susceptible cell population in the pig depends on the stage of development of the 
host at the time of infection. In in utero inoculated fetuses, infected cells were 
identified as cardiomyocytes, hepatocytes and macrophages during early gestation and 
mainly macrophages towards the end of gestation (Sanchez et al., 2003). Postnatally, 
in the majority of pigs showing low or moderate PCV2-replication, the infected cells 
were demonstrated to be macrophages (SWC3+/sialoadhesin+). In contrast in the low 
percentage of pigs showing high PCV2 replication, infiltrating monocytes 
(SWC3+/sialoadhesin-) were also positive for PCV2 antigens (Sanchez et al., 2004).  
In the continuous cell line PK-15, a productive infection has been demonstrated, 
starting with detection of viral antigens in the cytoplasm and the nucleus of infected 
cells at 18 hours post inoculation (hpi) and a release of progeny virus at 32 hpi 
(Cheung and Bolin, 2002). This replication cycle differs with in vitro observations in 
PCV2-inoculated porcine monocytes and macrophages in which PCV2 capsid protein 
was detected in the cytoplasm but for which no evidence of further virus replication 
was found (Allan et al., 1994; Gilpin et al., 2003). In the absence of any evidence of 
active virus replication, it was presumed that the presence of capsid protein inside the 
cell was due to accumulation of viral antigens derived from the inoculum rather than 
from expression upon transcription of the virus’ genome. 
Although the genetic similarity between PCV2 strains from cases of PMWS or 
abortion is high (>95%), differences in biological properties between strains may still 
exist. Small genetic differences may have important consequences in tropism of 
viruses as has been described for closely related viruses such as transmissible 
gastroenteritis virus and porcine respiratory coronavirus (Rasschaert et al., 1990). 
Consequently, although a spectrum of closely related PCV2 genotypes have been 
characterized from a wide range of clinical syndromes, little information is available 
regarding possible differences in pathogenicity or tropism. 
The aims of this study were (i) to examine the PCV2 replication kinetics in 
porcine fetal cardiomyocytes and porcine alveolar macrophages, two major target 
cells in vivo and to compare it with replication kinetics in PK-15 cells and (ii) to 
investigate if differences in replication kinetics exist between PCV2 strains. 
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Material and methods 
 
Viruses and cells 
Seven PCV2 strains were enclosed in this study. The origin and passage history 
of these strains are shown in Table 1.  
PCV negative PK-15 cells were seeded on glass coverslips (BELLCO®, Vineland 
USA) at 150,000 cells per 3.15 cm2 in minimal essential medium (MEM) with Earle’s 
salts (GIBCO BRL®, Grand Island, USA) supplemented with 5% fetal bovine serum 
(FBS), 0.3 mg/ml glutamine, 100 U/ml penicillin, 0.1 mg/ml streptomycin and 0.1 
mg/ml kanamycin. Cells were maintained at 37°C in the presence of 5% CO2 for 24 
hours to obtain a 50% confluent monolayer.  
Fetal cardiomyocytes (FCM) were obtained by trypsinisation of heart muscle 
tissue of foetuses at 75 to 100 days of gestation. Fetal hearts were collected and 
washed in PBS. The heart muscle tissue was minced and incubated for 5 minutes in 
PBS containing trypsin (Sigma, Bornem, Belgium) (2.5 mg/ml) at 37°C. Trypsinized 
cells were collected, filtered, cooled to 4°C in FBS and centrifuged at 300 x g for 10 
minutes. The cell pellet was resuspended in MEM with Hank’s salts (GIBCO BRL®, 
Grand Island, USA) with 10% FBS, 0.3 mg/ml glutamine, 100 U/ml penicillin, 0.1 
mg/ml streptomycin and 0.1 mg/ml kanamycin. The cells were then seeded onto 
coverslips and incubated at 37°C. After 24 hours of incubation, medium was replaced 
by MEM with 10% FBS, 0.3 mg/ml glutamine, 100 U/ml penicillin, 0.1 mg/ml 
streptomycin and 0.1 mg/ml kanamycin. Cardiomyocytes were incubated at 37°C in 
the presence of 5% CO2 until the culture reached 50% confluency. Cardiomyocytes 
were identified by immunofluorescence stainings with monoclonal antibodies directed 
against desmin (DAKO Diagnostics, Glostrup, Denmark). Cell cultures from fetal 
heart tissue contained 90-100% desmin-positive cells showing mitosis in culture.  
Porcine alveolar macrophages (PAM) were isolated from lungs of 4-week-old 
conventional piglets as previously described (Labarque et al., 2000). Briefly, the 
lungs were flushed with cold phosphate-buffered saline (PBS). The washing fluid was 
centrifuged and cells were resuspended in cooled RPMI 1640 medium (GIBCO 
BRL®, Grand Island, USA) supplemented with 10% dimethyl sulfoxide (DMSO), 
30% FBS, 100 U/ml penicillin and 0.1 mg/ml streptomycin, frozen and stored in 
liquid nitrogen. For subsequent experimentation, PAM were thawed and seeded at 
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1x106 cells per glass coverslip. After 2 hours of incubation in RPMI 1640 medium 
supplemented with 0.3 mg/ml glutamine, 100 U/ml penicillin, 0.1 mg/ml 
streptomycin, 0.1 mg/ml kanamycin, 1% non-essential amino acids 100x (GIBCO 
BRL®, Grand Island, USA) and 1 mM sodium pyruvate at 37°C in the presence of 5% 
CO2, coverslips were washed to remove non-adherent cells and 1.5 ml of the above 
mentioned medium supplemented with 10% FBS was added. Batches of PAM derived 
from five different piglets were used in this study. Cells in lung washing fluids were 
found to contain > 95% macrophages, using the monoclonal antibodies SWC3 and 
41D3 directed against cells of the monocyte/macrophage lineage and against 
differentiated macrophages respectively (Blecha et al., 1994; Vanderheijden et al., 
2003). 
 
 
Table 1. Origin and passage history of porcine circovirus 2 strains enclosed in this 
study. PMWS: postweaning multisystemic wasting syndrome; PDNS: porcine 
dermatitis and nephropathy syndrome 
 
Origin 
Strain 
isolated from … country (reference) 
Passage level 
in PK-15 cells 
Stoon-
1010 
PMWS affected piglet 
Canada (Ellis et al., 
1998) 
25 
1121 aborted fetuses 
Canada (Meehan et al., 
2001) 
21 
1103 aborted fetuses 
Canada (Meehan et al., 
2001) 
20 
48285 PMWS affected piglet 
France (Meehan et al., 
2001) 
16 
VC2002 PMWS affected piglet 
Belgium (Meerts et al., 
2004) 
16 
1206 PMWS affected piglet Belgium 23 
1147 PDNS affected piglet 
UK (Meehan et al., 
2001) 
15 
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Inoculation 
Cultures of PK-15 cells, FCM or PAM were inoculated with 104.2 TCID50 of the 
respective strains, suspended in 0.5 ml MEM (PK-15, FCM) or RPMI (PAM). After 1 
hour of incubation at 37°C in the presence of 5% CO2, cell cultures were washed once 
with medium and further incubated in fresh medium. A mock-inoculated control was 
included in each experiment. 
 
Fixation and stainings 
At 0, 6, 12, 24, 36, 48 and 72 hours post inoculation (hpi) (cell cultures 
inoculated with reference strains 1010 and 1121) or 0, 12, 24, 48 and 72 hpi (cell 
cultures inoculated with other strains), the supernatant of inoculated cultures was 
collected, centrifuged at 15,000 x g for 10 minutes and stored at –70°C until virus 
titration. Cell cultures on coverslips were fixed in acetone at –20°C for 20 minutes, 
dried and stored at –20°C.  
PCV2 antigen-positive cells were stained by subsequent incubation with 
biotinylated, purified monospecific porcine polyclonal antibodies against PCV2 and 
streptavidin-FITC (Molecular Probes, Leiden, The Netherlands). The total number of 
PCV2 antigen-positive cells was determined by counting the positive cells present in a 
total of 50,000 to 100,000 cells, depending on the confluency of the culture. The 
positive cells were further sub-divided into two fractions: cells with exclusive 
cytoplasmic localization of antigens and cells with nuclear and cytoplasmic 
localization of antigens. All experiments were repeated three times and mean values 
were calculated. To confirm that a positive signal was due to expression of viral 
proteins and not due to viral antigens taken up by the cell, PK-15 cells and PAM were 
inoculated with UV-treated strain Stoon-1010 and stained as described above. 
Western blot analysis of the porcine polyclonal antibodies showed that the 
antibodies detected a 35 kDa protein which corresponds to the molecular size of the 
PCV2 capsid protein. No specific bands could be detected in the region of the Rep or 
Rep’ protein, indicating that the polyclonal antibodies only recognized the capsid 
protein. This result was confirmed by performing double immunofluorescence 
stainings using the biotinylated porcine polyclonal antibodies and mouse monoclonal 
antibodies (Mab) directed against PCV2 proteins (F210 directed against Rep protein 
and F217 or F190 against capsid protein) (McNeilly et al., 2001) on PCV2-infected 
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PK-15 cells. Mab F217 positive signals always colocalized with polyclonal antibody 
positive signals, indicating that both antibodies recognised the same protein. In 
contrast, some cells positive for F210 were not stained by the polyclonal antibodies, 
indicating that the polyclonal antibodies did not recognise the Rep protein. These 
findings correspond with the results in a previous study in which it was shown that 
porcine hyperimmune serum only reacted with capsid protein (Cheung and Bolin, 
2002).  
Expression kinetics of both known PCV2 proteins (capsid and Rep protein) were 
assessed using Mab F210 (directed against Rep protein) and F217 or F190 (against 
capsid protein). Bound Mab were visualised with goat-anti-mouse-FITC or goat-anti-
mouse-Texas Red (Molecular Probes, Leiden, The Netherlands). Double 
immunofluorescence stainings were performed to detect both viral proteins and their 
colocalization in PK-15 cells. Inoculated cell cultures were incubated with Mab F210 
(IgG1) against Rep protein and F190 (IgG2b) against capsid protein. Bound Mab were 
visualised with isotype specific secondary antibodies (Serotec, Oxford, United 
Kingdom). Hoechst 33342 (Molecular Probes, Oregon, USA) at a concentration of 10 
µg/ml was used in all immunofluorescence stainings to visualize the nucleus. Viral 
antigen positive cells were counted by fluorescence microscopy. Digital images were 
made using a Leica TCS SP2 laser scanning spectral confocal system (Leica 
Microsystems GmbH, Heidelberg, Germany). 
 
Virus titration of culture supernatant 
Progeny virus titres in culture supernatants were determined by inoculation of 10-
fold dilution series on PK-15 cells. After 72 hours of incubation at 37°C in the 
presence of 5% CO2, supernatant was removed, cells were fixed in 10% 
paraformaldehyde in PBS and viral antigens were detected using an 
immunoperoxidase monolayer assay (IPMA), as described elsewhere (Meerts et al., 
2004 ). 
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Results 
 
PCV2 replication kinetics of reference strains Stoon-1010 and 1121 in PK-15 cells 
Considerable differences were observed between replication kinetics of strains 
Stoon-1010 and 1121 (Figure 1). After inoculation with strain Stoon-1010, cells with 
viral antigens in the cytoplasm were detected starting from 12 hpi using the 
polyclonal antibodies and the numbers of positive cells increased in time. At 24 hpi, 
0.3% of the cells expressed viral antigens, a maximum of 1.8% viral antigen positive 
cells was reached at 48 hpi. Starting from 24 hpi, nuclear localized viral antigens were 
seen in up to 25% of the positive cells. Inoculation with strain 1121 resulted in viral 
antigen-positive cells detectable from 6 hpi and rapidly increasing in time to 1.8% at 
24 hpi and a maximum of 3.0% at 48 hpi. Starting from 12 hpi, nuclear localized viral 
antigens were seen in 1-5% of the positive cells. Foci of infected neighbouring cells 
were seen starting from 36 hpi with both strains. Inoculation with UV-inactivated 
PCV2 resulted in the absence of a signal after staining with polyclonal or monoclonal 
antibodies. The changes of antigen expression patterns in Stoon-1010 inoculated PK-
15 are shown in Figure 2. 
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Figure 1. Number of porcine circovirus 2 antigen-positive PK-15 cells and antigen 
expression pattern at different time points after inoculation with strains Stoon-1010, 
1121, 48285, 1103, 1206, 1147 and VC2002.  
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Figure 2. Changes in antigen expression patterns in porcine circovirus 2 infected PK-
15 cells. Evolution in antigen expression pattern in Stoon-1010 inoculated PK-15 cell 
cultures, stained with polyclonal anti-PCV2 antibodies. A: PCV2 antigens in the 
perinuclear region of the cytoplasm at the early stage of infection (12 hpi). B: 
expression of PCV2 antigens in cytoplasm and nucleus (24 hpi). C: foci of infected 
cells (36 hpi). D: irregularly shaped cell with intense viral antigen positive cytoplasm 
and a viral antigen negative and deformed nucleus (arrow) (48 – 72 hpi). Bar = 30 µm 
 
 
 
 
Mab F217 and F210 were used to detect respectively PCV2 capsid and Rep 
proteins in Stoon-1010 and 1121 inoculated PK-15 cells. Capsid protein was the first 
viral protein detected. In early stages, the protein was only seen in the perinuclear 
region of the cytoplasm. Starting from 12 hpi in 1121-inoculated and 24 hpi in Stoon-
1010 inoculated cells, the capsid protein was also detected in the nucleus of infected 
cells. Starting from 48 hpi, irregularly shaped cells with condensed nuclei were seen. 
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In these cells, the nucleus was negative for capsid protein while an intense signal was 
observed in the cytoplasm. During the early stages of cytoplasmic PCV2 capsid 
protein expression, Rep protein was not detected in infected cells. At 12 hpi in 1121 
inoculated cultures and at 24 hpi in Stoon-1010 inoculated cultures, Rep protein was 
clearly apparent in the nucleus of infected cells. Rep protein was never detected in 
cytoplasm of infected cells except in low amounts in irregularly shaped cells starting 
from 48 hpi. Double IF stainings with monoclonal antibodies F210 and F190 showed 
that all cells with nuclear localized capsid protein, also contained Rep protein in their 
nucleus. In contrast a low fraction of cells (< 5% of cells with nuclear localized PCV2 
antigens) was found to contain only Rep protein in their nucleus (Figure 3).  
 
 
Figure 3. Expression of Rep and capsid protein in porcine circovirus 2 infected PK-
15 cells at 72 hpi. A: PCV2 Rep protein is detected in the nucleus of 3 infected PK-15 
cells. B: PCV2 capsid protein is detected in the nucleus of 2 infected PK-15 cells and 
in the cytoplasm of 2 other infected cells. C: merged image of both stainings showing 
2 cells with both capsid and Rep proteins in the nucleus and one cell with only Rep 
protein in the nucleus. Bar = 30 µm 
 
 
 
 
Virus titres in culture supernatants at different stages of infection are shown in 
Figure 4. A time-dependent rise of titres was seen starting from 36 hpi for both PCV2 
strains, with a maximum titre of 2.1 log10 TCID50 for strain 1121 and 3.9 log10 TCID50 
for strain Stoon-1010. 
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Figure 4. Evolution in porcine circovirus 2 titres in supernatant of PK-15 cell cultures 
inoculated with strains Stoon-1010 or 1121. Mean values and standard deviations are 
shown. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Evolution of the number of FCM and PAM expressing viral antigens upon PCV2 
inoculation 
The replication patterns of strains Stoon-1010 and 1121 in PAM and FCM are 
shown in Figure 5.  
In FCM, a similar pattern was seen as in PK-15 cells although the percentage of 
viral antigen positive cells was approximately 10 times lower. In Stoon-1010 
inoculated cell cultures, positive cells were detected starting from 24 hpi resulting in a 
limited number of cells expressing viral antigens in the nucleus at 48 hpi. Cell 
cultures inoculated with strain 1121 showed cytoplasmic positive cells starting from 6 
hpi and nuclear positive cells starting from 36 hpi. For both strains, the number of 
positive cells was still increasing with both strains at 72 hpi.  
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Figure 5. Evolution of the number of porcine alveolar macrophages and fetal 
cardiomyocytes expressing porcine circovirus 2 antigens after inoculation with strains 
Stoon-1010 or 1121. The results in PAM represented in this figure, are the results 
obtained in one batch of PAM from one pig. In four other batches of PAM from other 
pigs, a lower fraction or no PCV2 antigen positive cells contained antigens in their 
nucleus. 
 
 
In PAM of one piglet, the number of viral antigen-positive cells increased in a 
time-dependent manner from 0.03% at 12 hpi to 0.25% at 72 hpi with strain Stoon-
1010 and from 0.22% at 6 hpi to 1.1% at 72 hpi with strain 1121. Up to 48 hpi, 
antigens were exclusively localized in the cytoplasm and the signal increased in 
intensity with time. The first nuclear localization of viral antigens in PAM of this 
piglet was observed at 48 hpi (Stoon-1010) or at 72 hpi (1121). At 72 hpi, in Stoon-
1010 inoculated cultures, 0.05% of the cells showed nuclear localized antigens (20% 
of the total number of positive cells) and in 1121 inoculated cultures, 0.03% of the 
cells showed nuclear localized antigens (3% of the total number of positive cells). The 
results obtained in this batch of PAM are shown in figure 5. Nuclear PCV2 antigen 
positive cells were confirmed to be macrophages by double immunofluorescence 
stainings with monoclonal antibodies F210 for the PCV2 Rep protein and SWC3 and 
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41D3 as shown in Figure 6. Of particular significance the number of PAM showing 
nuclear localization of PCV2 antigens varied strongly between batches of PAM 
derived from different piglets. In two batches of PAM, cells exclusively contained 
PCV2 antigens in their cytoplasm and nuclear localized PCV2 antigens were never 
seen. In two other batches, nuclear antigens were rarely seen (<1%) in the antigen 
positive cells, while in one batch up to 20% of the total PCV2 positive PAM 
contained antigens in the nucleus. Inoculation with UV-inactivated PCV2 resulted in 
the absence of a signal after staining with the polyclonal or monoclonal antibodies. 
Supernatants of FCM and PAM cultures were titrated but no significant rise in 
virus titre was detected. 
 
 
Figure 6. Porcine circovirus 2 infection in alveolar macrophages. Triple 
immunofluorescence staining showing nuclear localization of PCV2 Rep protein in a 
SWC3+ macrophage. A: PCV2 Rep protein, B: SWC3, C: Hoechst visualizing the 
nucleus of the cell. Nuclear localization of PCV2 antigens remained a rare event since 
the majority of antigen positive PAM only contained antigens in the cytoplasm. Bar = 
30 µm 
 
 
Comparison of replication kinetics of different PCV2 strains in PK-15 cells 
The replication kinetics of five additional strains are shown in Figure 1. Four 
strains (1206, 48285, VC2002, 1147) showed an evolution in number of viral antigen 
positive cells and in intracellular distribution of antigens similar to strain Stoon-1010, 
using the polyclonal antibodies. Some variation in the absolute numbers of infected 
cells was observed. Strain 1103, which is an abortion-strain from Canada, similar to 
strain 1121, showed similar replication kinetics as strain 1121. A rapid increase in 
A CB
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cytoplasmic positive cells was observed during the first 24 hours of the experiment. 
The percentage of infected cells showing nuclear localization of viral antigens in 1103 
infected cell cultures was comparable with 1121 (1% at 24 hpi) infected cell cultures 
and lower compared to cell cultures inoculated with PMWS or PDNS-associated 
PCV2 strains (≥ 10% at 24 hpi).  
 
 
Discussion 
 
In the present study, new insights were gained in the replication characteristics of 
PCV2 in PK-15 cells and the natural target cells, alveolar macrophages and fetal 
cardiomyocytes. Furthermore, indications for biological differences between PCV2 
strains were found in the replication kinetics of the strains in PK-15 cells. 
PCV2 replication in PK-15 cells was studied as a reference and positive control 
for the full replication cycle of the virus. The earliest detectable viral protein in 
infected PK-15 cells was the capsid protein, which was mainly found in the 
perinuclear region of infected cells during the earliest stages of infection. Absence of 
immunofluorescence signal after inoculation with UV-inactivated PCV2 
demonstrated that the early-detected capsid protein was newly produced in the 
infected cell, rather than derived from captation of viral antigens from the inoculum. 
ORF2, which codes for the capsid protein, is located on the complementary strand of 
the virus’ genome (Nawagitgul et al., 2000) and can thus only be transcribed from the 
double stranded replication form. The early expression of capsid protein in PK-15 
cells suggests that the complementary strand was formed very shortly after infection 
of the cell, as has been described for monopartite geminiviruses (Donson et al., 1984). 
Starting from 12 hpi, capsid protein was found in the nucleus of infected cells. At that 
time point also Rep protein was found in the nucleus of the infected cells. Although 
Rep protein, like any other protein, has to be produced in the cytoplasm, it was 
immediately observed in the nucleus of the infected cell, indicative for a strong 
affinity for the nucleus. At present however, no nuclear localization signal (NLS) has 
been described for this protein. Double immunofluorescence stainings for both PCV2 
capsid and Rep protein showed that most of the cells with nuclear localized PCV2 
antigens contained both capsid and Rep. A low percentage of cells contained only Rep 
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protein without expression of capsid (nuclear or cytoplasmic). This indicated that, 
although the capsid protein is the first viral protein detected in most of the infected 
cells, Rep protein can occasionally be the first expressed viral protein. The cellular or 
viral mechanisms that form the basis for this event remain to be elucidated. The fact 
that capsid protein was never found in the nucleus of an infected cell in the absence of 
Rep protein, although it can be abundantly present in the cytoplasm of that cell, 
suggests that the capsid interacts in some way with the Rep protein to cross the 
nuclear membrane. The inability of the capsid protein to reach the nucleus on itself in 
our study is surprising since Liu et al. (2001) identified a nuclear localization signal 
and detected the capsid protein in the nucleus upon transfection.  
The rise in virus titre in culture supernatant at 36 hpi coincided with the 
appearance of the first foci of infected cells. This indicates that the full replication 
cycle of PCV2 in the PK-15 cell has a duration between 24 and 36 hours. These data 
agree with a previous study in which the first detectable progeny virus was found at 
32 hpi (Cheung and Bolin, 2002). Starting from 48 hpi and increasing in numbers at 
72 hpi, detaching cells were observed with capsid protein abundantly expressed in 
their cytoplasm. Only in these cells, Rep protein was detected in the cytoplasm, most 
likely as a result of leakage from the degrading nucleus. These cells showed irregular 
formed nuclei with condensation of genomic material, indicating that infection of PK-
15 cells with PCV2 probably leads to cell death.  
Similar viral protein expression patterns were observed in primary porcine cells 
and in PK-15 cells. In cardiomyocytes, PCV2 capsid protein and subsequently Rep 
protein were detected. The low absolute number of infected cells may be the reason 
for the absence of progeny virus in culture supernatant. Mitotic activity of 
cardiomyocytes in vitro is lower compared to PK-15 cells and this may explain why 
only 0.2 % of the cells were infected. This accurately reflects the situation in vivo 
where it was observed that with further development of the fetus towards parturition, 
the cardiomyocytes lose their susceptibility for PCV2 infection together with their 
ability to divide (Sanchez et al., 2003).  
PCV2 capsid antigens have already been described in the cytoplasm of 
monocytes and alveolar macrophages (Gilpin et al., 2003). It was, however, 
questioned if this positive signal was due to transcription of the viral genome or due 
to accumulation of virus present in the inoculum. In the present study, capsid protein 
was detected in the cytoplasm of a low percentage of macrophages (<1%). The 
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number of positive cells increased in a time dependent manner. UV-inactivation of the 
inoculum resulted in absence of an immunofluorescence signal at any time after 
inoculation, indicating that the observed signal was due to expression of newly 
formed viral antigens. Limited numbers of infected macrophages (SWC3+/41D3+) 
contained PCV2 antigens in their nucleus. The low number of macrophages showing 
this nuclear staining is comparable with the in vivo situation, where antigens are 
mainly found in the cytoplasm of cells of the monocyte/macrophage lineage in PCV2 
inoculated-piglets (Sanchez et al., 2004). Macrophages with nuclear expression of 
PCV2 antigens were not described in previous studies (Gilpin et al., 2003), which can 
be explained by the differences in origin of the cells or in the inoculation dose or 
duration. In the present study, nuclear expression of viral proteins was observed in 
PAM originating from some specific piglets only. It is unclear if this in vitro 
difference between piglets can form the base of a different clinical outcome of a 
PCV2 infection in vivo.  
Replication of PCV2 in macrophages, which are fully differentiated cells, seems 
contradictory with the fact that the virus depends on the mitosis cycle of PK-15 cells 
and FCM to replicate in these cell types. The cell cycle dependency of PCV2 to 
complete its replication cycle is credited to the expression of DNA-polymerase 
expressed during the S-phase of the cell cycle (Tischer et al., 1987). Although 
macrophages do not divide, it has been shown that they can express high DNA 
polymerase activity in response to damage to their DNA (Williams et al., 2002), an 
event which might be misused by PCV2 to complete its replication in these cells. 
In this study, biological differences in-between PCV2 strains besides genetical 
differences were described for the first time. It is not fully understood if the 
contrasting behaviour of strains 1121 and 1103 in comparison with the other strains 
can be explained by their origin (abortion cases) or by the fact that the geographical 
regions where they were isolated, were close to each other. The importance of 
differences in the in vivo replication kinetics is not fully understood and will be the 
subject of further investigations. 
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Summary 
 
Stimulation of the porcine immune system results in increased replication of 
porcine circovirus type 2 (PCV2) in vivo. In the present study it was investigated if a 
range of cytokines (IL-1, IL-6, IL-10, TNF-alpha, IFN-alpha and IFN-gamma) were 
able to influence PCV2-infection in vitro. No changes were observed in IL-1, IL-6, 
TNF-alpha or IL-10-treated cells. However, it was demonstrated that IFN-alpha and 
IFN-gamma influenced PCV2 infection in porcine kidney cells (PK-15) and porcine 
monocytic cells (3D4/31). IFN-gamma, added to the culture medium before, during or 
after inoculation, increased the number of PCV2-antigen positive cells with 418, 171 
or 691% in PK-15 cells and with 706, 114 or 423% in 3D4/31 cells. IFN-alpha pre-
treatment decreased the number of infected PK-15 cells. When it was added after 
inoculation, it enhanced PCV2 infection with 529% in PK-15 cells and 308% in 
3D4/31 cells. The effect of both interferons on PCV2 infection was dose-dependent 
and could be blocked with IFN-alpha or IFN-gamma neutralizing antibodies. 
Leukocyte-derived porcine IFN-gamma induced a similar effect on PCV2-infection. 
Treatment of PK-15 cultures with IFN-gamma resulted in a 20 times higher 
production of progeny virus. Confocal microscopy studies showed that the enhancing 
effect of IFN-gamma on PCV2-infection was achieved by increased internalization of 
PCV2 virion-like particles (VLPs). Binding of the VLPs to the cell or expression 
kinetics of PCV2-proteins in infected cells, were not altered by IFN-gamma 
treatment. To our knowledge, this study reports the first enhancement of a viral 
infection by treatment with type I or type II interferons.  
 
 
 
 
 
 
 
 
 
 
 
Effect of interferon alpha and gamma on PCV2 infection in vitro 69 
___________________________________________________________________________________________________________________________________________ 
Introduction 
 
Porcine circovirus 2 (PCV2) is a member of the Circoviridae. It is a very small 
virus with a relatively simple structure. The circular ambisense 1.7 Kb genome codes 
for two major proteins (Morozov et al., 1998). Open reading frame (ORF) 2 codes for 
the capsid protein (Nawagitgul et al., 2000) and ORF1 codes for two non-structural 
proteins Rep and Rep’ which form a complex that is involved in replication of the 
viral genome (Mankertz and Hillebrand, 2001). Besides these proteins, no other viral 
proteins have been characterized yet. PCV2 does not code for its own DNA-
polymerase and therefore it depends on cellular enzymes to complete its infectious 
cycle (Tischer et al., 1987). With its limited number of viral proteins, PCV2 is not 
well equipped to modify the intracellular conditions in favour of its own needs for 
replication, in contrast with many other more complex viruses (Izumi, 2004; Evers et 
al., 2004; Hay and Kannourakis, 2002). However, relatively simple viruses such as 
PCV2 might profit from specific conditions in the host that have been induced by 
other infectious agents. Recent observations indicate that PCV2 might do so. It has 
been shown that PCV2 was able to replicate better in a host when it was 
simultaneously inoculated with other viruses such as porcine reproductive and 
respiratory syndrome virus (PRRSV) (Allan et al., 2000a; Rovira et al., 2002) or 
porcine parvovirus (PPV) (Allan et al., 2000b; Krakowka et al., 2000; Opriessnig et 
al., 2004). These observations indicate that PCV2 profits from the reaction of the host 
to an infectious insult to increase its replication and in some studies to induce disease 
(Allan et al., 2000a; Rovira et al., 2002; Allan et al., 2000b; Krakowka et al., 2000; 
Opriessnig et al., 2004). PCV2-infection has primarily been associated with 
postweaning multisystemic wasting syndrome (PMWS), a condition in weaned pigs, 
characterized by severe growth retardation. The effect of a stimulation of the immune 
system on the replication of PCV2 and the induction of PMWS was investigated by 
Krakowka et al. (2001). They injected PCV2-inoculated gnotobiotic (caesarean-
derived, colostrum-deprived) pigs with keyhole limpet hemocyanin (KLH) and by 
doing so, induced an immune response. This treatment was found to activate the 
replication of PCV2 and exacerbate the clinical outcome of the infection. Ladekjær-
Mikkelsen et al. attempted to repeat this in conventional specific pathogen free pigs 
(Ladekjær-Mikkelsen et al., 2001) but were not successful. Pigs in this study that 
were not immune-stimulated also developed disease. When literature is reviewed, a 
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general observation is that gnotobiotic piglets are quite resistant to the induction of 
PCV2-associated disease when they are inoculated with PCV2 alone. Two studies 
describe the reproduction of PMWS in gnotobiotic pigs (Bolin et al., 2001; Okuda et 
al., 2003) whereas six studies failed to induce disease by inoculating PCV2 only 
(Krakowka et al., 2000; Krakowka et al., 2001; Krakowka et al., 2003; Sanchez et al., 
2003; Sanchez et al., 2004; Meerts et al., 2005). It has already been shown that 
gnotobiotic pigs, compared to conventional pigs, have an impaired capacity to raise an 
immune response upon an infection due to the absence of regular stimulations of their 
immune system (Butler et al., 2002). It may be hypothesized that the higher resistance 
of gnotobiotic pigs to develop PMWS compared to conventional pigs, may be due to 
an impaired capacity to replicate PCV2 compared to conventional pigs caused by the 
altered immune response. The question arises if PCV2 is able to misuse an ongoing 
immune response to enhance its own replication in its host.  
Comparative studies between germ-free and conventional mice have shown that 
germ-free animals react in a totally different way to infections with regard to the 
cytokine profiles they produce. They produce lower titres of pro-inflammatory 
cytokines interleukin-1 (IL-1), interleukin-6 (IL-6) and tumour necrosis factor-alpha 
(TNF-α) which are important in the earliest phases of the immune response. They 
produce significantly higher titres of interleukin-10 (IL-10), a cytokine to which 
mainly immunosuppressive properties are attributed (Souza et al., 2004; Duarte et al., 
2004). Different cytokines are already known to influence the susceptibility of the 
host towards viral infections. The most studied and best-understood effect of 
cytokines on viral infections is the anti-viral effect of type I and type II interferons 
(Katze et al., 2002; Schroder et al., 2004). But also other cytokines such as TNF-α 
can influence the evolution of an infection (Calabrese et al., 2004). The effect of 
cytokines on PCV2-replication has never been investigated before in vivo nor in vitro. 
The aim of the present study was to check the effect of a selected number of 
cytokines (IL-1, IL-6, TNF-α, IFN-α, IFN-γ and IL-10) on the replication of PCV2 in 
vitro.  
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Materials and methods 
 
Cells, virus and inoculation 
In a first set of experiments, PK-15 cells free of porcine circoviruses were used. 
The cells were seeded and maintained in culture medium containing 5% foetal bovine 
serum (FBS), 0.3 mg/ml glutamine, 100 U/ml penicillin, 0.1 mg/ml streptomycin, 0.1 
mg/ml kanamycin dissolved in minimal essential medium (MEM) (Gibco BRL®, 
Grand Island, USA). Cells were seeded at a concentration of 15 x 104 cells per ml of 
medium. For the detection of total number of viral antigen positive cells, 1.5 x 104 
cells were seeded in every well of a 96-well microtiter plates (Nunc, Roskilde, 
Denmark). To detect the expression of specific viral antigens, 22.5 x 104 cells were 
seeded on sterile cover slips in Leighton tubes and finally progeny virus production 
assays were performed in 24-well plates (Nunc, Roskilde, Denmark) containing 15 x 
104 cells per well. 
In order to use cells more related to the target cells in vivo, the porcine monocytic 
cell line 3D4/31 (Weingartl et al., 2002) was used to confirm the effect of the 
different cytokines on the number of PCV2-infected cells. The 3D4/31 cell line was 
previously shown to be fully susceptible for PCV2-infection (Misinzo et al., 2005). 
These cells were maintained in a monocyte/macrophage medium containing a 1:1 
mixture of RPMI-1640 (Gibco BRL®, Grand Island, USA) and Dulbecco’s modified 
Eagle medium (DMEM) (Gibco BRL®, Grand Island, USA) supplemented with 10% 
foetal bovine serum, 0.3 mg/ml glutamine, 100 U/ml penicillin, 0.1 mg/ml 
streptomycin, 0.1 mg/ml kanamycin and 1% non-essential amino acids 100x (GIBCO 
BRL®, Grand Island, USA). These experiments were performed in 96-well plates 
containing 2 x 104 cells per well.  
PK-15 and 3D4/31 cells were inoculated when they were 50% confluent (24 
hours after seeding). All inoculations were performed with the same PCV2-strain 
(Stoon-1010) at a multiplicity of infection of 0.3. The virus was diluted in MEM for 
inoculation on PK-15 cells and in a 1:1 RPMI-1640/DMEM mixture for inoculation 
on 3D4/31 cells. Medium was removed from the cell cultures and cells were 
inoculated by incubation with virus for 1 hour at 37 °C in the presence of 5% CO2. 
Afterwards, the inoculum was removed, cultures were washed twice with MEM or 
RPMI-1640/DMEM and new culture medium was added.  
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Due to the low number of PCV2 particles in virus stocks propagated in PK-15 
cells, PCV2 VLPs were used to visualize attachment and entry of the virus into the 
infected cell. PCV2 VLPs, produced in Spodoptera frugiperda Q cells infected with 
baculoviruses containing PCV2 ORF2, were kindly provided by Dr. M. Bublot 
(Merial SAS, Lyon, France). 3D4/31 cells were seeded at 2.5 x 104 cells per well in 
monocyte/macrophage medium in an 8-well LAB-TEC® cover glass chamber slides 
(Nalge Nunc International, Naperville, USA) and incubated with VLPs as described 
earlier (Misinzo et al., 2005). 
 
Recombinant porcine cytokines and neutralizing antibodies 
Porcine recombinant IL-1α, IL-6, IL-10 and IFN-γ were purchased from R&D 
systems (Abingdon, UK). Porcine recombinant IFN-α was kindly provided by Dr. B. 
Charley (Institut National de la Recherche Agronomique, Department of molecular 
virology and immunology, France) (Lefevre et al., 1990). TNF-α was produced in 
L929 cells transfected with the pBMGNeo expression-vector containing the porcine 
TNF-α coding cDNA (Von Niederhausern et al., 1993). Activity of recombinant 
TNF-α was measured using the bio-assay described previously (Pauli, 1995). IL-1, 
IL-6, IL-10 and IFN-γ were dissolved according to the manufacturer’s instructions in 
lipopolysaccharide free phosphate buffered saline (PBS) supplemented with 0.1% 
bovine serum albumin (Sigma, Bornem, Belgium) to a concentration of 10 µg/ml. 
Subsequently, the cytokines were diluted in MEM supplemented with 10% FBS to a 
concentration eight times higher than the highest final concentration used in the 
assays and stored at –70 °C.  
Porcine IFN-α neutralizing mouse monoclonal antibodies (K9) were kindly 
provided by Dr. B. Charley. Porcine IFN-γ neutralizing mouse monoclonal antibodies 
(B12) (Kontsek et al., 1997) were kindly provided by Prof. Dr. B. Goddeeris 
(Laboratory of Physiology and Immunology of Domestic Animals, KULeuven, 
Belgium). 
 
Leukocyte-derived porcine cytokines 
To confirm the effects observed with recombinant porcine cytokines, leukocyte-
derived porcine cytokines were included. Peripheral blood mononuclear cells 
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(PBMCs) were isolated from blood of a conventional 4-week-old pig by differential 
centrifugation on Ficoll Paque® (Amersham Bioscience AB, Upsalla, Sweden). These 
PBMCs were cultured in medium as described earlier and stimulated with 5 µg/ml 
concanavalin A (ConA) (Sigma, Heidelberg, Germany) (Verfaillie et al., 2001). 
Simultaneously, a culture of PBMCs was incubated in medium without ConA. After 
16 hours of incubation at 37 °C in the presence of 5% CO2, the supernatants were 
collected and centrifuged to remove cells and cell fragments. The concentration of 
IFN-γ in these supernatants was respectively 20.5 Units/ml (U/ml) (1U = 1 50% 
effective dose (ED50) = 0.030 ng) and below the detection limit as determined by a 
porcine IFN-γ specific ELISA (Biosource, Nijvel, Belgium). Using a bioassay 
described by Rubinstein et al. (1981), IFN-α was not detected in these supernatants. 
 
Effect of recombinant porcine cytokines on the total number of PCV2-antigen positive 
cells 
The effect of the cytokines on the infection of PCV2 in PK-15 and 3D4/31 cells 
was determined by adding two-fold dilution series of the cytokines to the medium of 
the cells before, during or after the inoculation. Two-fold dilutions of all cytokines 
were used in this study. IL-1α (1U = 1 ED50 = 0.013 ng), IL-6 (1U = 1 ED50 = 2.5 
ng), IL-10 (1U = 1 ED50 = 8 ng), TNF-α and IFN-α were used in concentrations 
ranging from 0.25 – 250 U/ml, IFN-γ was used in concentrations ranging from 0.25 to 
1000 U/ml and IL-10 was used in concentrations from 0.13 to 125 U/ml. Cell cultures 
were either pre-treated with the cytokines for 24 hours before inoculation, treated 
during the inoculation (1 hour) or the cytokines were added in the medium after 
inoculation (until fixation). After 36 hours of incubation at 37 °C in an environment 
supplemented with 5% CO2, after the first replication cycle of PCV2, the cells were 
dried and frozen at –20 °C. The plates were stained with an immunoperoxydase 
monolayer assay (IPMA) as described before (Meerts et al., 2005) and the number of 
PCV2-antigen positive cells was counted by light microscopy. In each plate, mock-
treated cells (treated with MEM + 10% FBS without cytokines) were inoculated with 
an equal dose of PCV2. The average number of antigen positive cells in these wells 
was used as the reference and all results were expressed as a percentage of this 
reference. 
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Effect of IFN-γ on the attachment and internalization of recombinant PCV2-like 
virions 
The attachment of PCV2 VLPs to untreated 3D4/31 cells and 3D4/31 cells pre-
treated (24 hours) with 500 U/ml IFN-γ was studied as previously described by 
Misinzo et al. (2005). Briefly, treated and untreated 3D4/31 cells were chilled on ice 
and washed before PCV2 VLPs (2.7 x 1010 particles per 2.5 x 105 cells) were added 
and allowed to attach for 0, 1, 5, 10, 15, 30 and 60 minutes at 4 °C. Unbound PCV2 
capsids were washed-off and cells were fixed with 3% (w/v) paraformaldehyde in 
phosphate-buffered saline with calcium and magnesium (PBS+) at room temperature 
for 10 minutes. In order to stain the PCV2 VLPs, cells were incubated with biotin-
conjugated anti-PCV2 swine polyclonal antibodies followed by streptavidin-FITC 
(Molecular Probes, Leiden, The Netherlands) each for 1 hour at room temperature. 
Successive images from the apex to the base of a stained single cell were taken using 
a Leica TCS SP2 laser scanning spectral confocal system (Leica Microsystems 
GmbH, Heidelberg, Germany) linked to a Leica DM/IRB inverted microscope (Leica 
Microsystems GmbH, Wetzlar, Germany) and merged. The fluorescence area of 
individual fluorescence spots in images of stained PCV2 VLPs was calculated using 
image analysis software (SigmaScan Pro 5.0, Jandel Scientific GmbH, Erkrath, 
Germany) as described before. The fluorescence area of attached PCV2 VLPs per cell 
was counted for ten cells at each time point to establish their binding kinetics on 
3D4/31 cells. 
To study the influence of IFN-γ on internalization of PCV2 VLPs in 3D4/31 
cells, PCV2 VLPs were incubated with 3D4/31 cells pre-treated for 24 hours with 500 
U/ml IFN-γ or with non-treated 3D4/31 at 37°C. Thirty minutes after the addition of 
PCV2 VLPs on the cells, cells were fixed with a 3% solution of paraformaldehyde in 
PBS+ for 10 minutes. Thereafter, cells were washed with PBS+, and permeabilized 
with 0.1% Triton X-100 in PBS+. PCV2 VLPs were stained as described above. In 
order to visualize the cell border, an actin staining was performed by incubating the 
cells with Phalloidine-Texas red (Molecular probed, Oregon, USA) for 1 hour at 
37°C. By confocal microscopy, the percentage of cells with PCV2 VLPs inside the 
actin rim was calculated and considered as the percentage of cells that were 
internalizing the VLPs. From these internalizing cells a digital image was taken 
through their centre and the percentage of fluorescing signal inside the actin rim was 
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calculated using image analysis software as described above. This was considered to 
be the percentage of internalized PCV2 VLPs in that cell. 
 
Effect of IFN-γ on the expression kinetics of PCV2 proteins 
To determine the effect of IFN-γ on the expression kinetics of PCV2 proteins 
(Capsid protein and Rep), PK-15 cells were inoculated on glass cover slips in 
Leighton tubes. After inoculation, the inoculum was removed, cultures were washed 
once in MEM and culture medium was added with or without 500 U/ml IFN-γ. At 0, 
6, 12, 24, 36, 48 and 72 hpi the cells were fixed in methanol at –20°C. Afterwards, a 
triple immunofluorescence staining was performed to visualize both viral proteins and 
the cell nucleus as described previously (Meerts et al., 2005). At each time point the 
percentage of PCV2-infected cells was calculated by counting the total number of 
cells and the number of PCV2-infected cells and the presence and localization of both 
PCV2 proteins was determined. 
 
Effect of IFN-γ on the production of PCV2 
The influence of IFN-γ on the production of progeny virus in PCV2-infected cells 
was determined by inoculating PK-15 cells with the standard PCV2-stock. After 
inoculation, culture medium was added supplemented with 500 U/ml of IFNγ. At 0, 
12, 24, 36, 48 and 72 hours post inoculation (hpi) the supernatant was collected. 
Subsequently, the culture was washed once with PBS. Both the supernatant and the 
washing fluid were centrifuged for 10 minutes at 15,000 x g to pellet cells and debris. 
The centrifuged supernatant and washing fluids were combined and the extracellular 
virus was determined. Both pellets and the cell culture were resuspended in PBS and 
freeze-thawn three times for determination of intracellular virus. Intra- and 
extracellular virus titres were titrated on PCV-negative PK-15 cells as described 
previously (Meerts et al., 2005) and expressed as titre per 105 cells. 
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Effect of leukocyte-derived porcine cytokines on the total number of PCV2-infected 
cells 
Supernatants of ConA and mock-stimulated PBMCs were added to the culture 
medium of PK-15 cells after inoculation in concentrations ranging from 6.15 to 50%. 
After 36 hours of incubation, PK-15 cultures were fixed and stained as described 
above and the number of PCV2-antigen positive cells was determined.  
 
Statistical analysis 
All experiments were repeated three times independently. The results presented 
in this publication represent the mean values obtained from these three experiments. 
The variation between different experiments is represented by the standard error of 
the mean (SEM). Differences were considered to be significant when p < 0.05 (p-
value calculated with the Mann-Whitney test). Due to limited material, the 
experiments with IL-10 were performed only once. 
 
 
Results 
 
Effect of cytokines on the total number of PCV2-infected PK-15 cells 
The results of the effects of dilution series of different cytokines on the total 
number of PCV2-infected PK-15 cells are shown in Figure 1. With TNF-α, IL-1, IL-6 
and IL-10, no significant change in the number of PCV2-antigen positive cells was 
observed at any concentration or at any time of treatment (before, during or after 
inoculation). Absolute numbers of infected cells in non-treated cultures agreed with 
previous published data (Meerts et al., 2005). With both interferons (IFN-α and IFN-
γ) significant changes in the number of PCV2-antigen positive cells were observed.  
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Figure 1. Effect of cytokines on the number of PCV2-infected PK-15 cells. PK-15 
cells were treated with recombinant porcine cytokines before (black bar), during (grey 
bar) or after (white bar) PCV2-inoculation + SEM. The number of PCV2-antigen 
positive cells in cytokine-treated cells was counted after 36 hours of incubation and 
compared to the number of PCV2-antigen positive cells in non-treated cells.  
 
 
 
IFN-γ induced a dose-dependent increase in the number of PCV2-antigen positive 
cells regardless of the time point when it was added to the medium of the cells 
(before, during or after the inoculation). The highest increase was achieved at the 
highest concentration tested in the experiment (1000 U/ml). When this concentration 
of IFN-γ was supplemented to the medium before, during or after inoculation, an 
increase in PCV2-antigen positive cells of 518 ± 134%, 270 ± 57% or 791 ± 105% 
respectively was observed. The lowest concentrations of IFN-γ that induced a 
significant increase of PCV2-antigen positive cells when administered before, during 
or after inoculation were 16, 2 and 2 U/ml respectively. Figure 2 shows a light 
microscopic picture of PK-15 cells without IFN-γ (negative controls) and with 500 
U/ml IFN-γ added in the medium after inoculation. The effects induced by treatment 
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of cells with IFN-γ could be neutralized when IFN-γ was incubated for 2 hours at 37 
°C with IFN-γ neutralizing antibodies (Kontsek et al., 1997), prior to incubation with 
the cells.  
 
Figure 2. Light microscopic pictures of the effect of IFN-γ treatment (500 U/ml) on 
the number of PCV2 positive cells in PK-15 and 3D4/31 cells. Pictures were taken at 
a magnification of 100x. 
 
 
IFN-α induced a significant increase of PCV2-antigen positive cells when 
administered during or after inoculation, but it induced a significant reduction of 
infected cells when the cells were pre-treated. At the highest concentration used (250 
U/ml) an increase of 341 ± 114% and 629 ± 59% PCV2-infected cells was observed 
when added respectively during or after inoculation. After pre-treatment, a reduction 
of 31 ± 6% PCV2-infected cells was observed. The lowest concentrations of IFN-α 
inducing a significant effect when added before, during or after PCV2-inoculation 
were 31, 16 and 8 U/ml respectively. The effects induced by treatment of cells with 
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IFN-α could be neutralized when IFN-α was incubated for 1 hour at 37 °C with IFN-
α neutralizing antibodies, prior to treatment of the cells.  
 
Effect of cytokines on the total number of PCV2-infected 3D4/31 cells 
In 3D4/31 cells, treatment with TNFα, IL-1, IL-6 and IL-10 before, during or 
after inoculation did not induce a significant change in the number of PCV2-antigen 
positive cells at any concentration. Similar observations were made in these cells 
compared to PK-15 cells when the 3D4/31 cells were treated with IFN-α or IFN-γ. 
IFN-γ induced a dose-dependent increase in the number of PCV2-positive cells when 
cells were treated before, during or after inoculation. A maximal increase in PCV2-
infected cells of 806 ± 88%, 214 ± 16% and 523 ± 115% was observed when cells 
were treated before, during or after inoculation respectively. When cells were treated 
with IFN-α before inoculation, no significant changes were observed. When IFN-α 
was added to the cells during or after inoculation, an increase in infected cells of 
respectively 115 ± 10% and 408 ± 35% was detected. The results are shown in Figure 
3. Figure 2 shows a light microscopic picture of 3D4/31 cells without IFN-γ (negative 
controls) and with 500 U/ml IFN-γ added in the medium before inoculation. 
The effects induced by treatment of cells with IFN-α or IFN-γ could be 
neutralized when they were incubated for 1 or 2 hours respectively at 37°C with IFN-
α or IFN-γ neutralizing antibodies, prior to incubation with the cells.  
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Figure 3. Effect of cytokines on the number of PCV2-infected 3D4/31 cells. 
3D4/31cells were treated with recombinant porcine cytokines before (black bar), 
during (grey bar) or after (white bar) PCV2-inoculation + SEM. The number of 
PCV2-antigen positive cells in cytokine-treated cells was counted after 36 hours of 
incubation and compared to the number of PCV2-antigen positive cells in non-treated 
cells. 
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Effect of IFN-γ on attachment and internalization of PCV2 VLPs. 
Effect of IFN-γ on attachment of PCV2 VLPs 
No significant differences were observed in the number of attached PCV2 VLPs 
per 3D4/31 cell, nor in the speed of the VLPs binding to 3D4/31 cells treated or non-
treated with IFN-γ. The results are shown in figure 4. Both in the IFN-γ treated and 
non-treated cells, the number of attached PCV2 VLPs per cell increased quickly 
within 5 minutes and reached a maximum at 15 minutes after incubation. Attached 
PCV2 VLPs were observed on all cells both in IFN-γ treated and non-treated cultures. 
Similar observations have been described before (Misinzo et al, 2005). 
 
 
Figure 4. Effect of IFN-γ on attachment of recombinant PCV2 VLPs to 3D4/31 cells 
The results represent the average number of VLPs attached to 10 cells ± standard 
deviation in an IFN-γ treated culture (black symbols) and a non-treated culture (empty 
symbols). 
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Effect of IFN-γ on entry of PCV2 VLPs 
In IFN-γ treated 3D4/31 cell cultures, 4.5% of the cells were found to internalize 
PCV2 VLPs at 30 minutes after incubation with the VLPs compared to 2.5% of the 
cells in non-treated cultures. PCV2 VLP internalizing cells in IFN-γ treated cultures, 
contained more VLPs inside the actin rim (18.7 ± 10.1%) compared to internalizing 
cells in non-treated cultures (4.0 ± 3.0%). 
 
Effect of IFN-γ on PCV2 protein expression kinetics 
When the evolution in the number of capsid and Rep protein positive cells was 
compared in IFN-γ treated and non-treated PK-15 cultures, similar kinetics were 
observed in both cultures. The only difference was that in IFN-γ treated cultures 
approximately 5 times more cells were positive for the capsid or Rep protein 
compared to the non-treated cultures. No differences were observed in the time point 
at which the first capsid or Rep proteins could be detected. The fraction of capsid 
protein positive cells against the Rep protein positive cells was not altered by 
treatment of the cell cultures with IFN-γ. Figure 5 shows the evolution in the number 
of PK-15 cells expressing PCV2 capsid protein and Rep protein in PK-15 cultures 
with or without IFN-γ treatment.  
 
Figure 5. Evolution in the number of cells expressing capsid (squares) or Rep protein 
(circles) in IFN-γ treated (black symbols) and non-treated (empty symbols) PK-15 
cultures 
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Effect of IFN-γ on the production of PCV2 
Since IFN-γ increased the number of PCV2-antigen positive PK-15 cells 
independently of the time point when it was added to the medium of the cells, this 
cytokine was selected to investigate the effect on the production of progeny virus at a 
concentration of 500 U/ml. The results of the production experiment are presented in 
Figure 6. Both extracellular and intracellular virus production were increased in the 
IFNγ-treated cells compared to the non-treated control cells. A significant higher titre 
in IFN-γ treated cells could be demonstrated starting from 36 hpi. At 72 hpi, the 
intracellular and extracellular PCV2 titres in the non-treated culture were 3.7 ± 0.3 
log10 TCID50 and 2.9 ± 0.6 log10 TCID50 per 105 cells respectively while in IFN-γ 
treated cultures intracellular and extracellular PCV2 titres were 5.0 ± 0.3 log10 TCID50 
and 4.2 ± 0.4 log10 TCID50 per 105 cells. IFN-γ treatment increased both intracellular 
and extracellular PCV2 titres 20 times (1.3 log10).  
 
 
Figure 6. Kinetics of intracellular (squares) and extracellular (circles) PCV2 titres in 
PK-15 cells treated with 500 U/ml IFN-γ (black symbols) compared to non-treated 
(empty symbols) cells. 
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Effect of leukocyte-derived porcine cytokines on the total number of PCV2-antigen 
positive cells 
The results of the incubation of PK-15 cells with the leukocyte-derived porcine 
cytokines are shown in Figure 7. The supernatant of ConA-stimulated PBMCs caused 
a dose-dependent increase in PCV2-antigen positive cells when it was added to the 
medium of PCV2-inoculated PK-15 cells. When a concentration of 50% of this 
supernatant was added to the cells, an increase of 215 ± 22% was observed. Again the 
supernatant of non-stimulated PBMCs did not influence the number of PCV2-infected 
cells. Incubation of the supernatants with IFN-γ neutralizing monoclonal antibodies 
prior to treatment of PK-15 cells, but not with IFN-α neutralizing antibodies, 
inhibited the increased infection of PCV2.  
 
 
Figure 7. Effect of supernatant of ConA and mock-stimulated PBMCs on the number 
of PCV2-infected PK-15 cells + SEM. IFN-γ concentrations (U/ml) in dilutions of 
ConA stimulated PBMC supernatants are shown on top of the corresponding bars. 
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Discussion 
 
In the present study, it was shown that type I and type II interferons are able to 
enhance PCV2-infection and production in PK-15 and 3D4/31 cells. This is a very 
important finding to understand the interaction of circoviruses with their host cell but 
also in view of the pathogenesis and reproduction of postweaning multisystemic 
wasting syndrome in PCV2-infected pigs.  
Interferons are mainly known for their antiviral activity. This antiviral effect has 
been demonstrated for many viruses and has been found to be so consistent and potent 
that recombinant interferons have been commercialized to control viral infections in 
humans and animals (Davis, 1997; Martin et al., 2002). To our knowledge, the present 
study is the first study to show an enhancement of a viral infection by both type I and 
type II interferons. Previously virus-enhancing properties were already attributed to 
IFN-γ with relation to the cell-mediated transmission of Human Immunodeficiency 
Virus (HIV) (Dianzani et al., 1996). Both interferons (IFN-α and IFN-γ) included in 
the present study were able to increase PCV2-infection in continuous porcine cell 
lines under specific conditions. IFN-γ was found to have the most consistent pro-viral 
effect on PCV2 in PK-15 and 3D4/31 cells independent of the time point of exposure. 
In contrast, IFN-α treatment of the cells had a pro-viral effect on PCV2 only when 
used during or after inoculation and had a mild but significant antiviral effect in PK-
15 when used before inoculation. Since IFN-γ induced the most consistent increase of 
PCV2-infection (independent on the time of treatment), this work further focussed on 
the effect of this cytokine on the interaction between PCV2 and its target cell. The 
effect of recombinant IFN-γ on PCV2-infection in PK-15 cells was confirmed by 
using leukocyte-derived cytokines. The PCV2-infection enhancing effect of 
supernatant of ConA-stimulated PBMCs could be completely inhibited by IFN-γ 
neutralizing antibodies, indicating that IFN-γ was indeed the factor responsible for the 
enhancement of the infection. IFN-γ treatment rendered PK-15 cell cultures more 
susceptible to PCV2 infection. When the same PCV2-stock was titrated on IFN-γ pre-
treated (500 U/ml) or non-treated PK-15 cells, a 10 times higher titre was obtained in 
the treated cell cultures (data not shown). This shows that the sensitivity of the 
classical PCV2-titration assay on PK-15 cells can be increased at least 10 times by 
IFN-γ treatment. 
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In the present study, a first step was made to understand the influence of IFN-γ on 
PCV2-infection in vitro. Different steps of the virus-cell interaction were analyzed in 
IFN-γ treated and non-treated cells. It was observed that the increased infection of 
IFN-γ treated cells was not induced by an increased binding of the virus to the cell 
surface, but by an increased internalization of bound virions into the cell. Since no 
increased binding of PCV2 VLPs to the cell membrane was observed, it could be 
concluded that IFN-γ treatment did not increase the expression of the PCV2-
receptor(s) on the cell membrane. The increased internalization of the virus into the 
cell was most probably induced by an influence on a further step in the internalization 
cascade. It looks like IFN-γ is able to activate or increase cytoplasmic or membrane-
spanning factors that play a role in the endocytosis of the virus-receptor complex. 
Further research is necessary to identify the exact mechanism involved. Once inside 
the cell, the viral genome should be transported towards the nucleus of the cell. 
Influences of IFN-γ on the intracellular trafficking of PCV2 and the nuclear import of 
its genomic material have not been investigated in the current study and remain 
possible. Both known PCV2 proteins could be detected for the first time at the same 
time points in IFN-γ treated or non-treated cultures. The only difference that could be 
observed upon IFN-γ treatment (500 U/ml) was that a higher number of cells 
contained these proteins. Progeny virus was detected starting from the same time 
point in both cultures. In IFN-γ treated cultures, 20 times more progeny virus was 
detected, indicating that the increased progeny virus yield was not only due to a 
higher number of infected cells, but also due to a higher production of progeny virus 
per infected cell. For another virus with a circular ssDNA genome that uses the same 
DNA replication mechanism (phage φX), it has already been shown that the amount 
of produced progeny virus is correlated with the number of early formed double 
stranded DNA replication forms and thus with the number of virions infecting the cell 
(Koths et al., 1980). A similar mechanism might be involved in PCV2-replication 
since PCV2 VLP internalizing cells in IFN-γ treated cultures contained approximately 
5 times more VLPs inside their cell membrane compared to internalizing cells in non-
treated cultures.  
When IFN-α or IFN-γ was added to PK-15 cells both before and after 
inoculation, IFN-γ increased whereas IFN-α reduced the number of infected cells 
(data not shown). This combination of pre and post-treatment resembles best the 
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effect that can be expected in vivo. When the data obtained in this in vitro study are 
extrapolated to the in vivo situation, the most important PCV2-enhancing effect in this 
situation can be expected from IFN-γ. The present observations have important 
consequences on the current PCV2 research with relation to postweaning 
multisystemic wasting syndrome. IFN-γ is generally produced during an immune 
response. If the interferon-induced increase of PCV2-replication observed in vitro, 
also takes place in vivo, this might be the common event in all studies that have 
shown to activate the replication of PCV2 in animals by inducing immune 
stimulations (Allan et al., 2000a; Rovira et al., 2002; Allan et al., 2000b, Krakowka et 
al., 2001). The observations made in this study may also explain why gnotobiotic pigs 
are more resistant to PCV2-infection and disease. Since gnotobiotic pigs do not 
encounter regular immunological stimulations, PCV2 might not have an ideal 
environment created by type I or type II interferons to replicate to high levels.  
PCV2 is highly related to PCV1, another porcine circovirus that has not been 
associated with any disease. It was quite interesting to see that type I and type II 
interferons did not influence PCV1-infection in PK-15 cells (data not shown). The 
question can be asked if the influence of interferon on infection is involved in the 
higher virulence of PCV2 compared to PCV1 in vivo. The mechanism used by PCV2 
to profit from type I or type II interferons produced in response to other infections, 
may also be important for other related viruses. TT-virus (TTV) is also a member of 
the circoviridae (Nishizama et al., 1997). It is a small human-infecting virus with a 
circular ssDNA genome that is widely spread in the population. In literature, 
indications are already present that promotion of TTV-infection and replication might 
occur through a similar mechanism. It was demonstrated that human PBMCs were 
able to sustain productive TTV infection only when they were stimulated with a 
combination of lipopolysaccharide, IL-2 and phytohemagglutinin (PHA) (Mariscal et 
al., 2002). Similar to ConA, PHA is a mitogen that, besides other activities, stimulates 
T-cells to proliferate and produce IFN-γ amongst other cytokines (Verfailly et al., 
2001). The role of IFN-γ was not investigated in that study. TTV is in some cases 
associated with hepatitis. Another important virus causing hepatitis is the hepatitis C 
virus (HCV). Both viruses are often found to be present at the same time in affected 
patients. A common treatment of HCV-infected patients is the administration of 
recombinant human IFNα (Maggi et al., 2001). Since it has been shown in the present 
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study that the closely related PCV2 is able to profit from interferon treatment, it is 
important that the interaction between TTV and type I and type II interferons is also 
investigated.  
The effect of type I and type II interferons on PCV2-infection offers many 
possibilities to better understand the pathogenesis of PCV2 and possibly also of other 
circoviruses. Further research will therefore focus on the cell-biological effects of 
interferons with regard to circovirus infection and on the importance of this 
mechanism in the induction of PMWS in the natural host. 
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Summary 
 
Previously, it has been shown that interferon-gamma (IFN-γ) enhances porcine 
circovirus type 2 (PCV2)-replication in vitro. In the present study, it was investigated 
if the PCV2-enhancing properties of IFN-γ, could also be demonstrated in the natural 
host of PCV2. Gnotobiotic pigs were injected with Concanavalin A (ConA) or 
recombinant IFN-γ (rIFN-γ) 12 hours before PCV2-inoculation and afterwards every 
3 days during a period of 9 days. The replication of PCV2 was monitored at 3 
different time points in individual pigs by taking lymph node biopsies at 10 and 15 
days post inoculation (dpi) and by collecting the remaining parts of the lympn nodes 
at euthanasia at 21 dpi. In non-treated control pigs and rIFN-γ inoculated animals, 
PCV2 could be detected starting from 15 dpi. No significant differences in the level of 
PCV2-replication between pigs from these different groups were found. In 
gnotobiotic pigs treated with ConA, PCV2 could already be isolated from inguinal 
lymph nodes starting from 10 dpi. At 15 dpi, the level of PCV2-replication was 
significantly higher in ConA-treated pigs compared to the pigs of other groups. 
Although ConA treatment significantly increased PCV2-replication, no signs of 
disease were observed in any of the inoculated or non-inoculated animals. These 
experiments indicate that ConA-treatment enhances the replication of PCV2 in vivo, 
however it could not be demonstrated that this effect was IFN-γ dependent. 
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Introduction 
 
Porcine circoviruses are very small and relatively simple viruses (Tischer et al., 
1982). Until present, only 3 different viral proteins have been described that are being 
expressed in porcine circovirus-infected cells (Morozov et al., 1998; Mankertz and 
Hillebrand, 2001). It is not hard to accept that this limited array of viral proteins 
makes the virus incapable of intensively manipulating the environment in its host in 
favour of its own replication. As far as it is known today, circoviruses do not possess 
proteins that for instance are able to modify the immune response of their host, as 
other more complex viruses do (Tortorella et al., 2000). This might account for the 
observation that the replication of porcine circovirus 2 (PCV2) is intensively 
influenced by host specific, as well as by external factors. Pigs with identical 
environmental backgrounds are not equally able to cope with a PCV2-infection, 
which is an indication for a genetical base of their susceptibility (Ladekjær-Mikkelsen 
et al., 2002; Sanchez et al., 2003; Meerts et al., 2005a). The impact of the 
environment on the susceptibility of the pigs to the infection and subsequently to its 
clinical outcome, has also been documented. Coinfections with other agents may have 
important effects on the clinical outcome of a PCV2-infection in field conditions. 
Porcine parvovirus, porcine reproductive and respiratory syndrome virus (PRRSV) 
and Mycoplasma Hyopneumponiae infections in PCV2-inoculated pigs all enhance 
the replication of PCV2 and exacerbate the clinical outcome of the infection (Allan et 
al., 2000a; Allan et al., 2000b; Rovira et al. 2002; Opriessnig et al., 2004). Injection 
of Keyhole limpet hemocyanin (KLH) in PCV2-inoculated gnotobiotic pigs suggested 
that the induction of an immune response might be the key factor in the induction of 
the increased PCV2-replication although this increased PCV2-replication could not be 
reproduced in conventional SPF pigs (Krakowka et al., 2001; Ladekjær-Mikkelsen et 
al., 2002). A mechanism by which an immune response against another infectious 
agent would be able to enhance the replication of PCV2 remains unidentified.  
Recently, it was shown that interferon-alpha (IFN-α) and interferon-gamma 
(IFN-γ) are able to enhance PCV2-replication in vitro when administered under 
certain conditions. Especially IFN-γ was effective in enhancing PCV2 replication 
(Meerts et al., 2005c). IFN-γ is a Th1-specific cytokine that is generally produced 
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during the onset of a cellular immune response. It has been demonstrated that 
PRRSV-infections (Batista et al., 2004), parvovirus infections (Kerr et al., 2004) and 
the injection of KLH (Connor et al., 2001), all lead to the production of IFN-γ as a 
component of the initiation of the immune response. Furthermore, vaccine adjuvants 
are being composed in a way that they elicit a better cellular immune response against 
the immunogen. This way they initiate a higher production of IFN-γ (Avramidis et al., 
2002). Previously, it has also been shown that vaccine adjuvants are able to enhance 
the level and duration of PCV2-replication in pigs and exacerbate the clinical outcome 
of the infection (Opriessnig et al., 2003). In the studies mentioned above, the IFN-γ 
response was never monitored.  
It was the aim of the present study to investigate if IFN-γ also enhances PCV2-
infection in vivo as was observed in vitro. 
 
 
Materials and methods 
 
Virus, recombinant IFN-γ and Concanavalin A 
In the present study, The PCV2 strain 1121 was used (Meehan et al., 2000) at a 
fourth passage level on PK-15 cells. Recombinant IFN-γ (rIFN-γ) was purchased from 
R&D systems (Abingdon, UK), Concanavalin A (ConA) was purchased from Sigma 
(Heidelberg, Germany). ConA is a lectin that induces proliferation of Th1 cells. It will 
stimulate Th1 cells to produce high concentrations of Th1-specific cytokines amongst 
which IFN-γ both in vitro (Verfailly et al., 2001) and in vivo (Tiegs, 1997). 
 
Pigs and experimental design 
Seventeen gnotobiotic pigs were derived by caesarian section from 2 Landrace 
sows. They were raised in sterile conditions in individual isolators. Pigs were 
randomly divided in 5 groups. An overview of these groups and their specific 
treatments is given in Table 1. 
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Table 1. Distribution of pigs in different groups with specific manipulations per 
group  
 
Group n PCV2-inoculation Treatment Pig numbers 
A 4 yes - 1 to 4 
B 4 yes ConA 5 to 8 
C 4 yes rIFN-γ 9 to 12 
D 3 no ConA 13 to 14 
E 2 no rIFN-γ 15 to 16 
 
 
At 19 days of age, all pigs from groups A (PCV2/-), B (PCV2/ConA) and C 
(PCV2/IFN-γ) were inoculated intraperitoneally and oronasally with a total dose of 
104.3 TCID50 of PCV2 strain 1121 propagated in PK-15 cells. This route of 
inoculation was chosen to obtain a reproducible infection in all pigs without 
interference of the primary site of replication. Pigs of groups D (-/IFN-γ) and E (-
/ConA) were mock-inoculated with equal volumes of cell culture medium. 
Pigs from groups C (PCV2/IFN-γ) and D (-/IFN-γ) were injected every three days 
with rIFN-γ at a dose of 100,000 units (3 µg of recombinant protein) per treatment: 
50,000 units were injected intramuscular and 50,000 units were injected subcutaneous 
in the lower abdomen. The first injection was administered 12 hours before the 
inoculation of the pigs and repeated at 2, 5 and 8 days post inoculation (dpi).  
Pigs from groups B (PCV2/ConA) and E (-/ConA) were treated at the same time 
points with ConA at a dose of 1.5 mg/kg bodyweight. Even lower doses were found to 
induce a significant IFN-γ production in mice (Miyagi et al., 2004). Half the dose was 
injected intramusculary and the other half was injected subcunateous in the lower 
abdomen.  
Pigs were monitored for a period of 21 days after PCV2-inoculation and 
euthanized afterwards. 
 
Clinical monitoring and sampling 
Pigs were monitored daily for the appearance of clinical signs that are associated 
with the postweaning multisystemic wasting syndrome (PMWS). These clinical signs 
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include cachexia, depression, respiratory distress and jaundice. Plasma was collected 
from all pigs at 0, 7, 10, 15 and 21 dpi to monitor the production of anti-PCV2 
antibodies as well as PCV2-neutralizing antibodies.  
In order to follow the degree of PCV2-replication in all individual pigs, inguinal 
lymph node biopsies were collected at different time points as described before 
(Meerts et al., 2005). At 10 days post inoculation (dpi) a biopsy was taken from the 
left inguinal lymph node and at 15 dpi a biopsy was taken from the right inguinal 
lymph node. In order to take lymph node biopsies, the pigs were anaesthetized by 
intramuscular injection of 2.2 mg tiletamine and 2.2 mg zolazepam (Zoletil®, Virbac) 
dissolved in 0.22 ml 2% Xylazine (XYL-M® 2%, VMD) per kilogram body weight. 
An incision was made in the overlaying skin and half the inguinal lymph node was 
excised. The wound was closed by mersilene sutures (Mersutures®, Ethicon). At the 
time of euthanasia (21 dpi) the remaining parts of both left and right inguinal lymph 
nodes were collected. Ten % suspensions were made from the biopsies and the lymph 
nodes and the level of PCV2-replication in these organs was determined by PCV2-
titration on PK-15 cells. The detection limit of this technique was 102.4 TCID50/g. 
 
Analysis of the humoral immune response against PCV2 
Plasma samples were used to detect the total anti-PCV2 antibody titre by an 
immunoperoxidase monolayer assay (IPMA) described previously (Labarque et al., 
2000). PCV2-neutralizing antibodies were determined by calculating the percentage 
of inhibition of PCV2-infection by the sensitive seroneutralization assay (sensitive 
SN) (Meerts et al., 2005b). Briefly, a standard infectious dose of PCV2 (103.7 
TCID50/ml) was incubated for 1 hour at 37°C with 25% of the serum. Afterwards, this 
virus-serum mixture was inoculated on PCV-negative PK-15 cells. After 1 hour, the 
inoculum was removed, the cell cultures were washed 2 times, new cell medium was 
added and cultures were maintained at 37°C in the presence of 5% CO2. After 36 
hours of incubation, after the first replication cycle of PCV2 in PK-15 cells was 
completed, the cells were fixed and stained for PCV2 antigens using an 
immunoperoxidase technique. The number of PCV2-infected cells was counted and 
compared to the number of infected cells in a PK-15 culture inoculated with a mock-
treated stock. The result of this seroneutralization assay is expressed as a percentage 
of reduction of PCV2-infection. 
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Statistical analysis 
The statistical significance of differences between medians of different groups 
was tested by applying two-sided Mann-Whitney tests. Differences were considered 
significant when p < 0.05. 
 
 
Results 
 
Clinical monitoring 
During the study, clinical signs suggestive of PMWS were not observed in any of 
the pigs. Pig 6 (PCV2/ConA) died during blood sampling at 15 dpi. At the time of 
euthanasia, no differences in general appearance were observed between PCV2-
inoculated and non-inoculated pigs or between pigs of groups that received different 
treatments. Starting from the first time when a biopsy was taken, up to the end of the 
study, it was observed that inguinal lymph nodes of pigs treated with rIFN-γ or ConA, 
were noticeably enlarged and pale compared to the lymph nodes of non-treated pigs. 
This enlargement of the inguinal lymph nodes was independent of the PCV2-
inoculation.  
 
PCV2 replication 
The evolution of PCV2 replication in the inguinal lymph nodes of individual pigs 
is shown in Figure 1. In pigs of groups D and E (non-inoculated pigs), PCV2 was not 
isolated at any time point during the study. From all PCV2-inoculated pigs, PCV2 
was isolated at at least one time point. PCV2 could be detected for the first time at 15 
dpi in pigs of groups A (PCV2/-) and C (PCV2/IFN-γ). In pigs of group B 
(PCV2/ConA), PCV2 was already isolated from the lymph node biopsies taken at 10 
dpi. Titres at this time point ranged between 103.1 and 104.3 TCID50/g. At 15 and 21 
dpi, PCV2 titres in ConA-treated pigs were generally higher than titres at the same 
time point in other pigs but due to the high variation in PCV2-titres between pigs in 
the same groups and due to the limited number of pigs, a significant difference could 
only be demonstrated between the mean titres of groups B (PCV2/ConA) and C 
(PCV2/IFN-γ) at 15 dpi. 
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The general evolution of PCV2-replication in time was similar in all pigs except 
one. Eleven out of twelve PCV2-inoculated pigs showed a peak of PCV2-replication 
at 15 dpi. Afterwards the PCV2-titres decreased in all these pigs. However pig 7 
(PCV2/ConA) showed a gradual increase in PCV2 titre until the end of the study. 
 
 
Figure 1. Evolution of PCV2-replication in inguinal lymph node biopsies of PCV2-
inoculated gnotobiotic pigs, non-treated or treated with Concanavalin A (ConA) or 
recombinant Interferon-gamma (rIFN-γ). The dashed line represents the detection 
limit of the assay (102.4 TCID50/g). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Anti-PCV2 antibodies (IPMA) 
The evolution in IPMA antibodies against PCV2 is shown in Figure 2. 
Seroconversion against PCV2 was not detected in any of the pigs from groups D or E 
(non-inoculated pigs). Anti-PCV2 antibodies (IPMA antibodies) were demonstrated 
in all PCV2-inoculated pigs except the pig that died at 15 dpi 6 (PCV2/ConA). 
Differences were observed in the time point at which anti-PCV2 IPMA antibodies 
were detected for the first time. Pigs from group A (PCV2/-) seroconverted at 10 or 
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15 dpi. In Groups B (PCV2/ConA) and C (PCV2/IFN-γ), only 2 out of 4 pigs showed 
IPMA antibodies against PCV2 at 15 dpi. In the other pigs, seroconversion against the 
virus was delayed until 21 dpi. During the study, no significant differences could be 
detected between the mean IPMA antibody titres of different groups.  
 
 
Figure 2. Evolution of anti-PCV2 antibody titres (IPMA) in PCV2-inoculated 
gnotobiotic pigs, non-treated or treated with Concanavalin A (ConA) or recombinant 
Interferon-gamma (rIFN-γ). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PCV2-neutralizing antibodies (sensitive SN) 
PCV2-neutralizing antibodies generally followed the same evolution compared to 
the IPMA antibodies. Their evolution in individual pigs can be followed in Figure 3. 
Neutralizing antibodies were detected for the first time at 10 dpi in pigs of group A 
(PCV2/-). Pigs in groups B (PCV2/ConA) and C (PCV2/IFN-γ) that showed a delayed 
production of IPMA antibodies, also showed a delayed production of PCV2-
neutralizing antibodies. Again, no statistical differences were demonstrated between 
the SN titres at 21 dpi between different groups. 
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Figure 3. Evolution of PCV2-neutralizing antibody titres (SN) in PCV2-inoculated 
gnotobiotic pigs, non-treated or treated with Concanavalin A (ConA) or recombinant 
Interferon-gamma (rIFN-γ). 
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Discussion 
 
In the present study, it was shown that treatment of gnotobiotic pigs with 
Concanavalin A (ConA) rendered the pigs more susceptible to an increased 
replication of PCV2. This increased PCV2-replication could not be induced by 
injecting the pigs with recombinant IFN-γ alone, following the protocol used in the 
present study. 
The different outcome of the ConA and rIFN-γ treatment can be due to various 
mechanisms. The first mechanism that might be responsible for the difference 
between the ConA-treated and the rIFN-γ injected animals is that ConA-treatment 
induces much higher concentrations and a more prolonged production of IFN-γ in 
animals compared to the IFN-γ concentration that can be reached by injecting the 
recombinant form of IFN-γ in the pig. It has been demonstrated that rIFN-γ, injected 
in an animal is very quickly removed from the body (Lortat-Jacob et al., 1996) while 
ConA induces a continuous production of IFN-γ by the T-cells of the animal itself. A 
preliminary study in conventional pigs showed that after rIFN-γ injection, a peak in 
serum concentration of IFN-γ was reached at 12 hours after injection. The 
concentration of IFN-γ rapidly decreased afterwards and could no longer be detected 
at 24 hours after injection. ConA treatment induced concentrations of IFN-γ in serum 
up to 4 times higher which were detectable for several days (data not shown). Using 
the same newly developed and not yet validated technique, IFN-γ could not be 
detected in the serum of the gnotobiotic pigs in the present study, indicating that the 
levels of IFN-γ circulating in the blood were very low. This could be caused by 
efficient binding of the cytokine to its receptors. The treatment of pigs with rIFN-γ or 
ConA were clearly effective since inguinal lymph nodes of treated pigs were clearly 
enlarged. Secondly, it is known that ConA, by stimulating Th1 cells to proliferate, 
also induces the production of other cytokines and alters the state of the T-cells. These 
changes might also have an influence on the pig’s susceptibility to PCV2. The results 
from the present study are indicative that the influence of ConA treatment on PCV2-
replication was not merely due to IFN-γ alone. More research needs to be performed 
to settle this issue. 
One of the common effects that was observed by rIFN-γ injection and ConA 
treatment was the effect on the onset of the humoral immune response against PCV2. 
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Two out of four pigs in each group (IFN-γ injected and ConA-treated) showed a 
delayed onset of the humoral immune response against PCV2. Such an effect of ConA 
or IFN-γ has not been demonstrated in vivo before. A possible mechanism responsible 
for this effect is the inhibitory effect of IFN-γ on the early stages of activation or 
homing of B-cells (Abed et al., 1994; Ben Jilani et al., 2001; Flaishon et al., 2001).  
In the present study, it was again demonstrated that gnotobiotic pigs are very 
resistant to PCV2-induced disease. Even in the ConA-treated pigs that experienced an 
increased PCV2-replication, no clinical signs were observed. Still, the ConA-
treatment might provide scientists with a valuable tool to investigate the pathogenesis 
of PMWS and more precisely the link between the replication of the virus and the 
disease since it is quite cheap and easy to perform. Several treatments of gnotobiotic 
pigs have been described until now. When these techniques are compared, we come to 
a remarkable result. It has been demonstrated that an immune-stimulation (Krakowka 
et al. 2001) or mimicking a part of the immune response (the present study), is able to 
increase PCV2 replication in pigs. However, an artificial immune suppression induced 
by Cyclosporin A (CysA) treatment resulted in a similar effect on the replication of 
the virus in its host (Krakowka et al., 2003; Meerts et al., 2005). Thus, activating T-
cells (ConA) as well as blocking T-cells (CysA) enhances PCV2-replication in the 
pig. The difference in virological outcome between these two treatments was that 
CysA-treatment induced a higher replication of the virus but was not able to expedite 
the replication, whereas ConA-treatment induced both. Probably the effect induced by 
CysA is merely due to the inhibition of the specific immune response while ConA 
causes a PCV2-replication enhancing effect. This observation indicates that there is an 
unstable equilibrium between a specific immune response that is able to neutralize 
PCV2 and PCV2-infected cells and an immune response that facilitates the replication 
of the virus in the pig. This fragile balance might be the underlying mechanism 
responsible for the high variation that is observed in PCV2-replication and clinical 
outcome between individual pigs and the even higher variation between different 
studies. 
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Summary 
 
PCV2-replication is characterized by a high variation between infected pigs. This 
study investigated the role of immunologic responses in causing this variation. 
Twelve gnotobiotic pigs were inoculated with PCV2. Four of these pigs were treated 
with Cyclosporin A (CysA) to monitor the effect of the adaptive immunity on the 
development of the PCV2-infection. Through lymph node biopsies at 10, 15 and 21 
days post inoculation (dpi), PCV2-replication in lymphoid tissues was monitored. The 
production of total PCV2-specific and PCV2-neutralizing antibodies was followed, 
together with interferon-gamma (IFN-γ) mRNA expression levels in peripheral blood 
monocytes as a marker for cellular immunity. Generally, the CysA-treated pigs 
showed the highest PCV2-titres, indicating that the adaptive immunity is necessary to 
restrain PCV2-replication. Three different PCV2-replication patterns were observed 
in non-CysA-treated pigs. Pattern 1: in two pigs, PCV2 was not detected. They had 
the highest neutralizing antibody titres, appearing from 15 dpi. In these pigs a good 
cellular response was indicated by a peak in IFN-γ mRNA at 15 dpi. Pattern 2: five 
pigs contained low to moderate PCV2 titres at 15 dpi, remaining constant or 
decreasing towards 21 dpi. Lower neutralizing antibody titres were observed and no 
rise in IFN-γ was detected. Pattern 3: in one pig, a low PCV2-titre at 15 dpi 
dramatically increased towards 21 dpi. Although an antibody-response against PCV2 
was mounted, no PCV2-neutralizing antibodies were detected. This pig also showed 
no rise in IFN-γ. The study indicates that variation in the onset of the adaptive 
immunity may account for variation in PCV2-replication between pigs. Absence of 
PCV2-neutralizing antibodies may be an important factor in the development of an 
increased virus replication. 
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Introduction 
 
Porcine circovirus 2 (PCV2), a small single stranded DNA virus, is a member of 
the family of circoviridae. Amongst various other animal viruses, the circoviridae 
also contain some recently identified human viruses (Sagir et al., 2004). PCV2 is a 
widespread virus. In pig dense regions, it is known to infect all weaned pigs in 
conventional farms. In farms affected by the postweaning multisystemic wasting 
syndrome (PMWS), a disease that has been associated with PCV2-infection (Ellis et 
al., 1998; Morozov et al., 1998), the majority of PCV2 infections remain subclinical. 
In subclinically infected pigs, a humoral immune response is induced as shown by the 
production of antibodies (Labarque et al., 2000; Meerts et al., 2004) and the virus is 
efficiently cleared from the body. In some cases, in conditions that have not yet been 
elucidated, the infection of susceptible pigs will lead to the development of PMWS 
(Allan and Ellis, 2000). A characteristic feature of this disease is the presence of high 
amounts of PCV2 in lymphoid and non-lymphoid organs of affected pigs 
(Calsamiglia et al., 2002; Segalés and Domingo, 2002), while at the same time non-
affected littermates are virologically negative or contain very low titres of PCV2 in 
their organs. The presence of high amounts of PCV2 in lymphoid organs of naturally 
PMWS-affected pigs is correlated with the presence of B and T lymphocyte depletion 
and monocyte infiltration (Quintana et al., 2001; Darwich et al., 2002), possibly clue 
factors in the pathogenesis of the disease.  
During experimental inoculations of the virus, similar observations were made. 
When PCV2 was inoculated in susceptible pigs, high variation was observed in the 
level of PCV2-replication. In some pigs the virus was hardly detectable, whereas in 
others high titres of PCV2 were detected several weeks after inoculation (Allan et al., 
2000a; Ladekjær-Mikkelsen et al., 2002; Rovira et al., 2002; Sanchez et al., 2003). 
Only in pigs with a high level of PCV2-replication, the typical histopathological 
lesions as described above were observed (Nielsen et al., 2003; Sanchez et al., 2004). 
When the clinical signs of PMWS could be reproduced in some of these studies, they 
were always found in pigs with a high level PCV2-replication (Ladekjær-Mikkelsen 
et al., 2002). The combined results of field and experimental studies suggest that pigs 
which experience high PCV2-replication are predisposed to develop PMWS, whereas 
pigs with low PCV2-replication are very unlikely to develop the disease. The 
elucidation of the mechanism that forms the basis of this event, could be an important 
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step in further understanding the pathogenesis of PCV2-infection and possibly of 
PMWS.  
Since not all experimentally inoculated pigs with high PCV2-replication 
developed clinical symptoms, research has been focussed on identifying cofactors that 
influence the reproduction of the disease. Up till now, a synergy has been described 
between PCV2 and 2 other viruses: porcine reproductive and respiratory disease virus 
(PRRSV) (Allan et al., 2000a; Rovira et al., 2002) and porcine parvovirus (PPV) 
(Allan et al., 2000b). A general stimulation of the immune system has also been 
shown to influence the clinical outcome of the infection in gnotobiotic pigs 
(Krakowka et al., 2001). The mechanism of the synergistic effect between PCV2-
infection on the one hand and other viruses or immune stimulation on the other hand, 
is not clarified. At present, the onset of the adaptive immune response against PCV2 
and its influence on the kinetics of the PCV2-replication in the host have only 
partially been characterized. Starting from 10-14 days post inoculation (dpi) PCV2-
specific antibodies (Ab) have been detected (Ladekjær-Mikkelsen et al., 2002; 
Sanchez et al., 2001). The appearance of the Ab coincided with a drop of PCV2 DNA 
copies in the blood of the host (Ladekjær-Mikkelsen et al., 2002; Pensaert et al., 
2004). Neutralizing antibodies have only been described starting from 28 dpi 
(Pogranichnyy et al., 2000). The onset of the cellular immunity upon PCV2-infection 
and its influence on PCV2-replication, remain undocumented. Therefore, the aims of 
this study were to monitor the humoral and cellular immune responses upon PCV2-
infection and to examine which immunological mechanism determines the 
development of the PCV2 replication kinetics in the pig and by this way possibly the 
clinical outcome of the infection. 
 
 
Materials and methods 
 
Pigs 
Sixteen gnotobiotic piglets were derived from two Belgian landrace sows at 114 
days of gestation by caesarean section. They were raised individually in a sterile 
environment in Horsfall-type isolators. At 19 days of age, they were randomly divided 
in 4 groups (group A: 4 pigs; group B: 8 pigs; group C: 2 pigs; group D: 2 pigs). 
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Virus inoculation 
At 19 days of age, the pigs of group A (A1, A2, A3, A4) and group B (B1, B2, 
B3, B4, B5, B6, B7, B8) were oronasally and intraperitoneally inoculated with 104.3 
TCID50 of PCV2 strain 1121 (Meehan et al., 2001). This PCV2 stock was propagated 
by four passages in PK-15 cells. The pigs of group C (C1, C2) and group D (D1, D2) 
were mock-inoculated with equal volumes of cell culture medium.  
 
Cyclosporin treatment 
Starting from 12 hours prior to the PCV2 or mock inoculation up to the end of the 
study, the pigs of groups A and C were treated with cyclosporin A (CysA) (Neoral-
Sandimmun, Novartis Pharma, Vilvoorde) at a dose of 23 mg/kg/day (Matsuda and 
Kojasu, 2000) administered in 2 feedings per day, diluted in milk. By artificially 
suppressing the onset of the adaptive immune response upon the PCV2-infection with 
CysA, the influence of the adaptive immunity on the development of PCV2-infection 
was monitored. 
 
Clinical monitoring and sampling 
During the study, the pigs were monitored for clinical signs that have been 
described in association with PMWS: cachexia, depression, respiratory distress and 
jaundice (Allan and Ellis, 2000). At the end of the study, the pigs were weighed and 
the average weight of each group was calculated and compared as a marker for the 
general clinical condition of the pigs throughout the study.  
In order to longitudinally follow the replication of PCV2 in the inguinal lymph 
nodes of the pigs, the lymph nodes were surgically sampled. At 10 days post 
inoculation (dpi) a biopsy was taken from the left inguinal lymph node and at 15 dpi a 
biopsy was taken from the right inguinal lymph node. In order to take lymph node 
biopsies, the pigs were anaesthetized by intramuscular injection of 2.2 mg tiletamine 
and 2.2 mg zolazepam (Zoletil®, Virbac) dissolved in 0.22 ml 2% Xylazine (XYL-M® 
2%, VMD) per kilogram body weight. An incision was made in the overlaying skin 
and half the inguinal lymph node was excised. The wound was closed by mersilene 
sutures (Mersutures®, Ethicon). At 21 dpi, all pigs were euthanized and the remaining 
parts of both left and right inguinal lymph nodes were collected.  
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At 0, 10, 15 and 21 dpi, blood was taken (with 15 U/ml heparin) from all pigs in 
order to monitor the onset and evolution of both humoral and cellular immunity 
against PCV2.  
All animal experiments performed in this study were approved by the ethical 
committee of the Faculty of Veterinary Science, Ghent University, Belgium. 
 
Longitudinal monitoring of PCV2-replication in inguinal lymph nodes  
Since it has been shown that the PCV2 titre in the inguinal lymph nodes is very 
well correlated with the titre in other lymphoid and non-lymphoid target organs 
(Ladekjær-Mikkelsen et al., 2002; Sanchez et al., 2003), the titre in the inguinal 
lymph node can be considered to be a good marker for the general replication of the 
virus in the body of the host. At 10, 15 and 21 dpi, PCV2 titres were determined in the 
biopsies and inguinal lymph nodes of all pigs. Ten % tissue suspensions were made of 
a part of the biopsies and lymph nodes and the PCV2 titre was determined by virus 
titration on PK-15 cells as described elsewhere (Sanchez et al., 2001). The detection 
limit of this assay was 102.4 TCID50 PCV2/gram lymph node tissue. 
 
Monitoring of the adaptive immune response 
Peripheral blood mononuclear cells (PBMCs) were separated from blood, 
collected at different time points, by density centrifugation at 750 x g on Ficoll-
Paque® (Amersham Pharmacia Biotech AB, Upsalla, Sweden) in order to monitor the 
cellular immune response. Plasma was collected to determine the humoral immune 
response against PCV2. 
1. Humoral immune response: The presence of PCV2-specific antibodies in 
plasma was determined by an immunoperoxidase monolayer assay (IPMA) as 
described earlier (Sanchez et al., 2001). This assay detects all antibodies that react 
with PCV2 antigens and does not discriminate between neutralizing or non-
neutralizing antibodies. This discrimination was made by using a seroneutralization 
assay adapted from the one described by Delputte et al. (2004). Briefly, 103.7 TCID50 
PCV2 was incubated for 1 hour with 25% of plasma at 37°C. Subsequently this 
mixture of virus and plasma was inoculated on PCV-negative PK-15 cells. After 1 
hour of incubation, the inoculum was removed, cell cultures were washed twice and 
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new medium was added. At 36 hours post inoculation, after the first replication cycle 
of PCV2 was completely finished (Meerts et al., 2004), the cultures were fixed and 
PCV2-infected PK-15 cells were stained by an immunoperoxidase reaction using 
polyclonal anti-PCV2 antibodies. The number of infected cells was counted by light 
microscopy. The PCV2-neutralizing capacity of the plasma was determined by 
calculating the reduction in PCV2-infected cells when compared to cells inoculated 
with PCV2 incubated with plasma of the same pig from day 0 (before PCV2-
inoculation).  
2. IFN-γ response: In this study, the level of IFN-γ mRNA in freshly isolated 
PBMCs was determined by real-time reverse transcriptase PCR as described by 
Verfaillie et al. (2001). Briefly, RNA from PBMCs was extracted with the Trizol® 
reagent (invitrogen, Carlsbad, USA) according to the manufacturer’s instructions. In a 
next step, RNA was transformed into cDNA by means of reverse transcriptase 
(SuperscriptTM II reverse transcriptase, invitrogen, Carlsbad, USA). In a final step, the 
number of cDNA copies coding for IFN-γ and cyclophilin was determined by REAL-
time PCR using the Lightcycler FastStart DNA Master SYBR Green I kit (Roche 
applied science, Penzberg, Germany) in a Roche LightCycler (Roche applied science, 
Penzberg, Germany). The level of IFN-γ mRNA was compared with the level of 
mRNA transcription of the household gene cyclophilin that served as an internal 
control. The level of IFN-γ mRNA was determined by calculating the ratio of IFN-γ 
mRNA to cyclophilin mRNA. To circumvent individual variation between pigs, the 
results of this test were expressed as the IFN-γ mRNA expression level at the day of 
testing, divided by the level at day 0.  
 
Statistical analysis 
The statistical significance of differences between medians of different groups 
was tested by applying two-sided Mann-Whitney tests. Bonferroni corrections for 
multiple comparisons at different time points were used. Differences were considered 
significant when p < 0.05. 
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Results 
 
Clinical monitoring of pigs 
During the study, no clinical signs were observed in pigs of group B (non-CysA-
treated/PCV2-inoculated) and group D (non-CysA-treated/non-PCV2-inoculated). All 
pigs in groups A and C (respectively CysA-treated/PCV2-inoculated and CysA-
treated/non-PCV2-inoculated) showed diarrhoea starting between the fifth and the 
tenth day of CysA treatment, lasting up to the end of the study. At the end of the study 
these pigs showed a moderate jaundice. Other clinical signs such as respiratory 
distress, anorexia or depression were not observed during the study. The excision of 
lymph node biopsies did not cause noticeable discomfort to the pigs. At the end of the 
study, no major differences were observed between the mean body weight of pigs of 
different groups (group A: 5.1 kg; group B: 4.9 kg, group C: 5.3 kg; group D: 5.4 kg) 
or between body weights of individual pigs in the same group.  
 
Longitudinal monitoring of PCV2-replication in inguinal lymph nodes 
The results of the evolution of PCV2 replication in inguinal lymph nodes of the 
pigs are shown in Figure 1. In the inguinal lymph nodes of non-PCV2-inoculated pigs 
(groups C and D), PCV2 was never detected. At 10 dpi, PCV2 could not be detected 
in the inguinal lymph nodes of any of the PCV2-inoculated pigs. Starting from 15 dpi, 
PCV2 was detected in inguinal lymph nodes of 10 out of 12 PCV2-inoculated pigs 
and different evolutions in PCV2-titres over time were observed. The pigs from group 
A (CysA-treated/PCV2-inoculated) showed significantly higher median titres at 15 
and 21 dpi compared to the pigs from group B. Two of these pigs (A2 and A3), the 
pigs with the highest titre at 15 dpi (respectively 106.2 and 105.2 TCID50/gram lymph 
node tissue), reached the maximal level of PCV2 replication at this time point, the two 
other pigs in this group (A1 and A4) showed an increase in PCV2-titre from 15 dpi 
(103.7 TCID50/gram lymph node tissue) to 21 dpi (105.2 and 105.4 TCID50/gram lymph 
node tissue).  
In group B (non-CysA-treated/PCV2-inoculated), three different patterns in 
PCV2-replication were observed. From the lymph nodes of two out of eight pigs in 
this group (B1 and B5), PCV2 could never be isolated during the study (pattern 1). 
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PCV2 could be isolated from the inguinal lymph nodes of the six other pigs in this 
group at various amounts. Five of these pigs (B2, B4, B6, B7, B8) showed a maximal 
PCV2-titre at 15 dpi (between 102.7 and 103.7 TCID50/gram lymph node tissue), after 
which the titre remained similar or decreased towards 21 dpi (pattern 2). In one pig 
(B3) a very distinct evolution in PCV2 replication was observed. At 15 dpi this pig 
showed one of the lowest PCV2-titres of group B (102.7 TCID50/gram lymph node 
tissue). A dramatic increase in PCV2-replication was observed towards 21 dpi (104.9 
TCID50/gram lymph node tissue) (pattern 3). The evolution in PCV2-replication in 
this pig was comparable with the evolution in pigs A1 and A4 (CysA-treated/PCV2-
inoculated) in which also a steep increase in the PCV2-titre was observed between 15 
and 21 dpi. At 21 dpi, the PCV2-titre in the inguinal lymph nodes of this pig was 
between 1.6 and 2.2 log10 times higher compared to the titres in the other pigs of 
group B and was situated closer to the mean of the titres of the artificially 
immunosuppressed pigs of group A than it was to the mean of group B. 
 
 
Figure 1. Evolution of PCV2 titres in inguinal lymph nodes of PCV2-inoculated and 
non-PCV2-inoculated pigs. The PCV2-titres at 10 and 15 dpi are titres in the lymph 
node biopsies, excised at that day. The titres at 21 dpi are the average titres of the 
remaining parts of left and right inguinal lymph nodes collected at euthanasia. 
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Monitoring of the PCV2-specific adaptive immune response 
1. Humoral immune response: The IPMA Ab titres against PCV2, as determined 
in the plasma of pigs at different time points during the study, are shown in Figure 2. 
The non-PCV2-inoculated pigs of groups C and D did not show PCV2-specific 
antibodies during the study. This confirms that they were not infected with PCV2. All 
PCV2-inoculated pigs showed seroconversion against PCV2 during the study. In all 
pigs of group B (non-CysA-treated/PCV2-inoculated), anti-PCV2 Ab were detected 
for the first time at 15 dpi (IPMA titres ranging from 41.7 to 42.7), clearly showing that 
all pigs in group B got infected upon PCV2-inoculation. The IPMA Ab titre increased 
in these pigs towards 21 dpi (IPMA titres ranging from 43.7 to 45.7). The pigs of group 
A (CysA-treated/PCV2-inoculated) also seroconverted against PCV2 but Ab were 
detected for the first time at 21 dpi. At this time point the Ab titres in these pigs were 
similar to the Ab titres in pigs of group B at 15 dpi (IPMA titres ranging from 41.7 to 
42.7).  
 
 
Figure 2. Evolution of anti-PCV2 antibodies (IPMA) in plasma of PCV2-inoculated 
and non-PCV2-inoculated pigs 
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The evolution of PCV2-neutralizing Ab (neutralization of PCV2-infection) in 
plasma is shown in Figure 3. Pigs of groups C and D (non-PCV2-inoculated pigs) did 
not contain neutralizing Ab in their plasma during the study. At 10 dpi, the median 
outcome of the PCV2-inoculated pigs did not differ significantly from the median of 
the non-PCV2-inoculated pigs, indicating that at this time no evidence for the 
presence of PCV2-neutralizing Ab in the plasma of PCV2-inoculated pigs was found. 
At 15 and 21 dpi a significant difference was found between the median outcome of 
non-PCV2-inoculated and PCV2-inoculated pigs indicating the presence of PCV2-
neuralization in the sera of PCV2-inoculated pigs. Starting from 15 dpi, PCV2-
neutralizing Ab were detected in 10 out of 12 PCV2-inoculated pigs (all except A2 
and B3). The PCV2-neutralization at this time point ranged from 30% to 62%, 
increasing towards 21 dpi (ranging from 41% to 93%). At 21 dpi, neutralization was 
also found in plasma of pig A2 (neutralization of 38%). In the plasma of one pig of 
group B, pig B3 (the pig with the strong increase in PCV2-replication between 15 and 
21 dpi), PCV2 neutralization could not be detected during the course of the study. The 
highest PCV2 neutralization at 21 dpi was found in plasma of pigs B1 and B5, the 
pigs from which no PCV2 could be isolated during the study. 
 
 
Figure 3. PCV2-neutralizing activity in plasma of PCV2-inoculated and non-PCV2-
inoculated pigs. The lines represent values of individual PCV2-inoculated pigs. The 
grey area represents the range (minimal and maximal value) in which the values of the 
four non-PCV2-inoculated pigs were situated 
 
 
122  Chapter 5 
___________________________________________________________________________________________________________________________________________ 
2. IFN-γ response: In all pigs, a basal level of IFN-γ gene transcription in PBMCs 
was detected prior to PCV2-inoculation. The evolution of IFN-γ mRNA expression 
levels in PBMCs of individual pigs during the study is shown in Fig. 4. Due to poor 
RNA-quality after isolation, the results of some pigs at some time points were not 
available (C1: 10 dpi; A2: 10 and 21 dpi; A4: 21 dpi). Non-PCV2-inoculated pigs 
(groups C and D) generally showed low IFN-γ mRNA expression levels (between 
0.02 and 1). All pigs from group A (CysA-treated/PCV2-inoculated) and six out of 
eight pigs from group B (non-CysA-treated/PCV2-inoculated) showed IFN-γ mRNA 
expression levels ranging in-between 0.1 and 2.3. In these pigs, no clear peak in IFN-γ 
mRNA expression levels in PBMCs was observed during the study. Two pigs from 
group B (B1 and B5) showed a peak in IFN-γ mRNA at 15 dpi (respectively to 5.8 
and 4.6), decreasing (B1) or remaining at the same level (B5) towards 21 dpi. These 
pigs were the two inoculated pigs from which no PCV2 could be isolated during the 
study. 
 
 
Figure 4. IFN-γ mRNA expression levels in PBMCs of PCV2-inoculated and non-
PCV2-inoculated pigs 
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Discussion 
 
In the present study, an effect of the PCV2-adaptive immune response on the 
replication of the virus was observed. A detectable humoral and cellular immune 
response was observed in some pigs and was correlated with a replication level of the 
virus below the detection limit of the used assay. On the other hand, a correlation was 
described between a complete absence of PCV2-neutralizing antibodies and the 
presence of an increased PCV2-replication in one pig. This study was performed in 
gnotobiotic piglets that did not encounter any immunologic stimulation before PCV2-
infection and therefore their immune response might deviate to some extent from pigs 
raised in a more conventional environment (Mehrazar et al., 1993). 
In this study, PCV2-replication in lymphoid organs was for the first time 
followed by using a method of inguinal lymph node biopsies. This way, titres could 
be obtained at different time points in the same pig and PCV2-replication kinetics 
could be compared between individual pigs. Through this technique, the number of 
pigs, necessary to demonstrate significant differences, could be reduced. At 10 dpi, a 
discrepancy was detected between the experimental inoculation performed in the 
present study and similar inoculations performed previously in our laboratory 
(Sanchez et al., 2003). In previous experimentally inoculated piglets, PCV2-titres 
could already be detected starting from 10 dpi. At this time, the titres in the internal 
organs of the piglets (including the inguinal lymph nodes) were relatively high. In the 
present study, PCV2 could not be detected in the inguinal lymph nodes of the 
inoculated piglets at 10 dpi despite identical procedures. The only differences between 
these pigs were their age at inoculation (1 days of age versus 19 days of age in this 
study) or minor environmental factors that may have occurred without our knowledge. 
It shows that minor factors can have important consequences on the further evolution 
of PCV2-replication in its host. This possibly explains the high variation in 
virological and clinical results from different PCV2-inoculation experiments 
performed by different research groups (Ladekjær-Mikkelsen et al., 2002, Sanchez et 
al., 2003).  
Although the eight PCV2-inoculated/non-CysA-treated pigs used in this study, 
were derived from only two litters, three distinct patterns in PCV2-replication were 
observed. Pattern 1: from the lymph nodes of two out of these eight pigs (25%) no 
PCV2 could be isolated. These pigs did get infected by the virus as shown by their 
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normal IPMA antibody response. Pattern 2: five pigs (63%), the majority of the pigs, 
showed a low to moderate PCV2-replication remaining constant or decreasing 
towards the end of the study. Pattern 3: a very different evolution was observed in the 
last pig (1/8 or 13%) which suffered an intense increase in PCV2-replication from 15 
to 21 dpi. To fully understand the pathogenesis of a PCV2-infection in its host, it is 
important to understand the basis for these different patterns.  
An important mechanism contributing to the variation in virus replication seems 
to be represented by the onset and efficacy of the adaptive immune response of the 
individual pig against PCV2-infection. This could be concluded from correlating the 
PCV2-replication patterns with the immunologic parameters investigated in this 
study. During the study, four PCV2-inoculated pigs were treated with CysA to 
artificially suppress their adaptive immunity (group A). CysA is known to interrupt 
the T-cell receptor signal transduction pathway and by doing this, inhibiting T-cell 
proliferation (Ho et al., 1996; Matsuda and Koyasu, 2000). By this mechanism, CysA 
treatment inhibits the onset of the cellular immune response and the thymus-
dependent humoral immune response upon virus-infection (Charan et al., 1986). 
CysA treatment has already been shown to render pigs more susceptible to PCV2-
replication (Krakowka et al., 2002). The CysA-treated pigs showed a delay in 
production of IPMA-antibodies against PCV2 and low levels of neutralizing 
antibodies compared to the non-CysA-treated pigs. The late onset of antibody 
production indicates that the CysA treatment inhibited the humoral immunity but did 
not completely block it. Since IFN-γ is produced by activated Th1-cells, its 
transcription in a virus-inoculated host can be used to monitor the onset of the cellular 
immunity against infection (Johnsen et al., 2002). No rise in IFN-γ mRNA expression 
was detected in the CysA-treated pigs. At 21 dpi, all four of the CysA-treated piglets 
contained PCV2-titres which were significantly higher compared to the titres in seven 
out of eight non-CysA-treated, PCV2-inoculated pigs at the same time point, 
indicating that the adaptive immunity plays an important role in controlling PCV2-
infection. When the evolution in PCV2-replication in CysA-treated pigs and in non-
CysA-treated pigs is compared, it is clear that the pigs with replication pattern 1 and 2 
mounted an adaptive immune response upon PCV2-infection that was able to control 
the level of PCV2 replication. The PCV2-titre at 21 dpi of the non-CysA-treated pig 
with pattern 3, did not significantly differ from the titres of the CysA-treated pigs, 
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indicating that the virus was able to replicate as intensively in this pig as in the 
artificially immunosuppressed pigs. Pigs with pattern 1 mounted the most efficient 
adaptive immune response against the virus. This was shown by the peak in IFN-γ 
mRNA in PBMCs, indicating a Th1-mediated immune response and by their very 
high PCV2-neutralizing antibody levels. The efficient immunological response in 
these pigs coincided with a strong protection against the virus. In contrast, the pig 
showing pattern 3 did not show a peak in IFN-γ mRNA, neither did it produce any 
PCV2-neutralizing antibodies in its plasma. This coincided with a weak virological 
protection. In between these opposites, the pigs with pattern 2 did not show an IFN-γ 
mRNA peak but did have PCV2-neutralizing antibodies. Differences in IFN-γ mRNA 
expression levels were most likely not induced by other infectious agents. 
Bacteriological examinations of internal organs and faeces demonstrated that the pigs 
were bacteriologically negative and serologic examinations confirmed that the pigs 
remained seronegative to various common porcine viruses throughout the study (data 
not shown). From our study it cannot be concluded whether the pigs in which an 
increase in IFN-γ mRNA expression level in PBMCs was not detected, mounted no 
cellular immune response at all. It is possible that an increase in IFN-γ mRNA could 
have been present in lymphocytes present in lymph nodes or other target organs. This 
was not investigated in the present study.  
The present study is the second study describing the existence of PCV2-
neutralizing antibodies. In contrast to the previous study (Pogranichnyy et al., 2000), 
in which the neutralizing antibodies were detected starting from 28 dpi, neutralizing 
antibodies could be detected starting from 15 dpi, simultaneously with the onset of the 
total anti-PCV2 antibody production. The difference between these results is probably 
based on a difference in sensitivity of the applied techniques. The total absence of 
neutralizing antibodies in the pig with pattern 3, while at the same time other pigs had 
relatively high levels, was a remarkable finding since this pig was able to produce 
IPMA PCV2 antibody titres similar to its group mates. A possible explanation for the 
absence of neutralizing antibodies is a difference in epitope-specific responses as has 
been shown for other viruses (Green et al., 1990; Jacobs and Kimman 1994; Lambkin 
and Dommock, 1995). The inability of a subpopulation of pigs to raise neutralizing 
antibodies against PCV2 may have an important effect on the further evolution of the 
infection and perhaps on its clinical outcome. It indicates that high titres of IPMA 
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anti-PCV2 antibodies do not always represent a good protective immunity of the host, 
a feature that will have to be considered when vaccines against PCV2 are optimised.  
In the present study, all CysA-treated pigs developed diarrhoea and jaundice 
during the study. However, these clinical signs were observed in both PCV2-
inoculated and PCV2-non-inoculated pigs, indicating that they were not caused by the 
infection. The presence of an increased and prolonged PCV2-replication in one pig 
did not induce clinical symptoms as described in PMWS-affected pigs during the time 
of the study. When PMWS was reproduced in PCV2-inculated animals, the first 
clinical signs always appeared within the first two or three weeks (Harms et al., 2001; 
Ladekjær-Mikkelsen et al., 2002). The absence of clinical signs in the present study 
suggests that an additional factor is needed for the reproduction of disease. When it is 
considered that a high PCV2-replication is crucial in the pathogenesis of PMWS, as 
sufficiently shown in literature, it can be assumed that pigs in field conditions which 
are not able to mount neutralizing antibodies, will have a higher chance to suffer the 
consequences of the infection compared to pigs that are able to efficiently clear the 
virus. In order to prevent PCV2-related clinical signs and their associated economic 
losses, two different strategies can be followed. The first strategy implies the 
identification and elimination of the second factor responsible for the induction of 
disease upon high PCV2-replication. This might be a complicated matter, especially 
when this factor would be an enzootic virus as has been suggested (Rovira et al., 
2002; Allan et al., 2000b) or even a general stimulation of the immunity (Krakowka et 
al., 2001). The second strategy involves the ability of the pig to control the PCV2-
replication. In the present study, a gradation was observed in the ability of pigs to 
mount a good adaptive immune response against PCV2-infection. The pig with 
pattern 3 (high PCV2-titres) was clearly more susceptible to PCV2-replication than 
the two pigs showing pattern 1 (no PCV2 detected) with the majority of the pigs (five 
showing pattern 2) caught in between. The differences in susceptibility to PCV2-
infection and sustained replication were in this study correlated with the adaptive 
immune response mounted in the pigs. The results indicate that on long term, the 
selection of pigs towards pattern 1 may be the best way to avoid PCV2-related 
problems. 
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Summary 
 
In a previous study, it was demonstrated that high replication of Porcine 
circovirus 2 (PCV2) in one gnotobiotic pig was correlated with the absence of PCV2-
neutralizing antibodies. In the present study, it was shown that this correlation could 
also be found in SPF pigs in which PMWS was experimentally reproduced and in 
naturally PMWS-affected pigs. When looking at the total anti-PCV2 antibody titres, 
PMWS-affected and healthy animals seroconverted at the same time point and titres 
in PMWS-affected animals were only slightly lower compared to those in healthy 
animals. In healthy animals, the evolution of PCV2-neutralizing antibodies coincided 
with that of total antibodies. In PMWS-affected animals, neutralizing antibodies could 
not be found (field studies) or were detected in low titres between 7 and 14 dpi 
(experimentally inoculated SPF pigs). Differences were also found in the evolution of 
specific antibody isotype titres against PCV2. In healthy pigs, IgM antibodies 
persisted until the end of the study whereas in PMWS-affected pigs they quickly 
decreased or remained at low titres. The mean titres of other antibody isotypes (IgG1, 
IgG2 and IgA), were slightly lower in PMWS-affected pigs compared to their healthy 
group mates at the end of each study. This study describes important differences in 
the development of the humoral immune response between pigs that get subclinically 
infected with PCV2 and pigs that experience a high level of PCV2-replication which 
in 3 of 4 experiments led to the development of PMWS. These observations may 
contribute to a better knowledge of the pathogenesis of a PCV2-infection.  
 
 
 
 
 
 
 
 
 
 
Absence of PCV2-neutralizing antibodies in PMWS-affected pigs 135 
___________________________________________________________________________________________________________________________________________ 
Introduction 
 
Porcine circovirus type 2 is a member of the Circoviridae family. This family 
contains small viruses with a circular single stranded DNA genome, including a 
number of avian and mammal viruses that are known to cause persistent infections in 
their host. Porcine circovirus 2 (PCV2) and chicken anemia virus are able to maintain 
a high level of replication up to one month or longer after experimental inoculation 
(Bolin et al., 2001; Imai et al., 1999). The human hepatitis-related TT-virus, also a 
member of the circoviridae family (Nishizawa et al., 1997), is able to maintain a 
constant viremia for a period of more than 3 years in infected patients (Lefrère et al., 
2000). The ability of these small viruses to persist and replicate for such a long time 
in the infected host, indicates a failure of the host’s immunologic response to 
efficiently recognize and/or remove virus particles or virus-infected cells from the 
body.  
The economical importance of PCV2 lies in its association with the postweaning 
multisystemic wasting syndrome (PMWS) (Ellis et al., 1998), a condition in weaned 
pigs observed for the first time in 1991 (Harding et al., 1996). The syndrome is 
characterized by clinical signs such as anaemia, jaundice and severe weight loss and 
histopathological signs including lymphocyte depletion and infiltration of monocytes. 
It is generally accepted that secondary factors including other viral infections such as 
porcine parvovirus (Allan et al., 2000a) or porcine reproductive and respiratory 
syndrome virus (Allan et al., 2000b) or stimulations of the immune system 
(Krakowka et al., 2001), influence the clinical outcome of the infection. A high and 
persisting PCV2-replication level was found to form a crucial factor in the 
pathogenesis of the disease. The demonstration of an intense PCV2-replication was 
therefore incorporated in the case definition of PMWS in order to differentiate the 
disease from other chronical disorders leading to the manifestation of similar clinical 
symptoms (Segalés and Domingo, 2002).  
After experimental PCV2-inoculation, a high variation in virus replication level 
and duration has been described between pigs (Ladekjær-Mikkelsen et al., 2002; 
Sanchez et al., 2003). In a previous study, the evolution in PCV2-replication was 
monitored in individual gnotobiotic pigs (Meerts et al., 2005). During the first two 
weeks of the experiment, the evolution of the PCV2-titre in inguinal lymph nodes of 
inoculated pigs showed little variation. At later stages of the infection, two patterns 
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developed. In most pigs, PCV2-titres decreased between 15 and 21 dpi. One of the 
PCV2-inoculated pigs, showed a dramatic increase in PCV2-replication in this period, 
resulting in a significantly higher level of PCV2-replication at 21 dpi. Similar 
observations were made in other studies (Ladekjær-Mikkelsen et al., 2002; Sanchez et 
al., 2003). From these observations, it could be concluded that not all pigs are equally 
able to deal with a PCV2-infection. When the relation between the onset of the 
adaptive immune response against PCV2 was monitored in these pigs, an interesting 
observation was made. Using a very sensitive PCV2-neutralization assay, PCV2-
neutralizing antibodies could be detected in all PCV2-inoculated pigs starting from 15 
dpi, except in the pig with high PCV2-replication. This study suggested a correlation 
between the absence or delayed production of PCV2-neutralizing antibodies and an 
increased level of replication of the virus in experimentally inoculated pigs. The latter 
study was performed in gnotobiotic piglets. Previously, it has been shown that the 
adaptive immune response against viral infections in gnotobiotic pigs which are raised 
in a sterile environment may deviate to some extent from the response of pigs in a 
conventional environment (Mehrazar et al., 1993; Butler et al., 2002; Souza et al., 
2004). Therefore, the observation made in PCV2-inoculated gnotobiotic piglets 
should be confirmed in naturally infected and experimentally inoculated conventional 
pigs.  
The aim of the present study was to investigate whether the lack of PCV2-
neutralizing antibodies could also be detected in natural or experimentally reproduced 
PMWS-affected pigs and to characterize more in detail the humoral immune response 
against PCV2 in PMWS-affected and healthy animals. 
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Materials and methods 
 
Sera  
An overview of the sera used in the present study, is shown in Table 1. Sera 
originating from four different studies were included. A first set of sera were derived 
from two experimental PCV2-inoculation studies, one performed in 19-day-old 
gnotobiotic pigs and another performed in 21-day-old PCV2-negative conventional 
specific pathogen free (SPF) pigs. A second set of sera originated from two field 
studies performed in Belgium and Denmark.  
1. Experimentally inoculated gnotobiotic pigs (Meerts et al., 2005): 8 gnotobiotic 
piglets were inoculated with PCV2 (104.3 TCID50 of strain 1121 intraperitoneally and 
oronasally) at 19 days of age. Blood was taken from these piglets at 0, 10, 15 and 21 
days post inoculation (dpi). In this experiment, PMWS was not observed but one pig 
showed a high level of PCV2-replication at the end of the experiment (104.3 TCID50/g 
inguinal lymph node) compared to the other PCV2-inoculated pigs (average of 102.3 
TCID50/g inguinal lymph node). This pig produced no PCV2-neutralizing antibodies. 
2. Experimentally inoculated SPF pigs (Ladekjær-Mikkelsen et al., 2002): 10 
PCV2-negative SPF-pigs were inoculated with PCV2 (106.3 TCID50 of strain OSU3 
intranasally) at the age of 3 weeks. Blood was taken at 0, 3, 7, 10, 14 and 21 dpi. Four 
out of 10 inoculated pigs developed PMWS and died before the end of the study (2 
pigs at 14 dpi, 2 pigs at 21 dpi). These pigs showed high titres of PCV2 at the time 
they died (average of 105.1 TCID50/g inguinal and prescapular lymph node). At the 
end of the study, no PCV2 could be isolated from lymph nodes of pigs that did not 
develop PMWS. 
3. Belgian field study (Meerts et al., 2004): during this study, blood was taken 
every two weeks from 9 piglets originating from 2 litters on PMWS-affected farms in 
Belgium. This serological follow-up started before the appearance of PMWS-related 
clinical signs (4 weeks of age) and ended at 14 weeks of age, the age after which new 
cases of PMWS seldom occur. In each litter, one piglet developed PMWS during the 
study and died before the end of the study. 
4. Danish field study (Kristensen et al., 2005): in this field study, pigs originating 
from PMWS-affected and healthy farms were weaned and brought to the same unit. 
Blood was taken at the day the pigs were mingled (day 0) and 3 and 6 weeks later. 
138  Chapter 5 
___________________________________________________________________________________________________________________________________________ 
During the study, a number of pigs developed PMWS and some of these affected pigs 
died before the end of the study. In the present study, sera were included originating 
from 13 subclinically infected pigs (healthy) and 13 pigs that developed PMWS 
during the follow-up. Eight affected pigs died before the last blood sampling 
occurred, five pigs developed PMWS but survived until the end of the study.  
 
 
Table 1. Sera used in the present study. high*: ≥ 104.3 TCID50/gram lymph node: 
NA**: not available since PCV2-titres were not obtained from healthy pigs. All 
PMWS-affected pigs did contain high titres of PCV2 
 
Number of pigs with Origin of 
pigs 
PCV2-
infection 
Serum samples 
available high* PCV2-replication 
clinical signs 
of PMWS 
Gnotobiotic experimental 0, 10, 15, 21  dpi 1/8 0/8 
SPF 
conventional experimental 
0, 7, 10, 14, 21 
dpi 4/10 4/10 
Field cases 
(Belgium) natural 
4, 6, 8, 10, 12, 
14 weeks of age NA** 2/10 
Field cases 
(Denmark) natural 
0, 3, 6, 9 weeks 
after mingling NA** 13/26 
 
 
Immunoperoxidase monolayer assay (IPMA) 
The total titre of anti-PCV2 antibodies (IPMA-Ab) was determined using the 
IPMA as described previously by Labarque et al. (2000a). This assay does not 
discriminate between neutralizing and non-neutralizing antibodies nor does it detect 
specific antibody isotypes. 
 
Isotype-specific IPMA 
The individual levels of antibody isotypes IgG1, IgG2, IgA and IgM against 
PCV2 in sera were determined by an isotype specific IPMA. PCV2-infected PK-15 
cell cultures were fixed and incubated with 4-fold dilution series of the tested sera. 
After 90 minutes of incubation, the cell cultures were washed thoroughly (4 times in 
phosphate buffered saline + 0,1% Tween 80) to remove unbound antibodies. 
Afterwards, monoclonal antibodies directed against porcine IgM, IgA, IgG1 or IgG2 
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were added and incubated for 60 minutes (Labarque et al., 2000b). After additional 
washing, peroxidase-conjugated goat polyclonal antibodies against mouse 
immunoglobulins were added (Goat-anti-Mouse-HRP, DAKO) and peroxidase 
activity was visualized by adding 3-amino-5-ethylcarbazole. 
 
Classical seroneutralization assay (Classical SN) 
With this assay, PCV2-neutralizing antibodies were detected using the classical 
protocol as has been described for many other viruses (Nauwynck et al., 1999; Van 
Reeth et al., 2003). Two-fold dilution series of the tested serum were prepared in 
MEM. The lowest dilution used in the test was 50%. Twenty-five µl of these serial 
diluted sera were incubated for 1 hour at 37°C with a fixed number of infectious 
particle of PCV2 (103.7 TCID50 of strain Stoon-1010 in 25 µl). This mixture was 
afterwards added to 50% confluent PK-15 cells in a 96-well plate. After 1 hour of 
incubation at 37°C, the inoculum was removed, cell cultures were washed twice with 
MEM and culture medium was added. Inoculated cultures were further incubated at 
37°C in an atmosphere containing 5% CO2. After 36 hours of incubation, the cells 
were fixed and stained with the immunoperoxidase assay as described before. By light 
microscopy, it was observed at which concentration of the serum, PCV2-positive cells 
could still be seen. The neutralization titre with this assay was calculated as the 
reciprocal of the highest dilution of the serum that was able to completely block 
PCV2-infection in PK-15 cells. Since the lowest serum dilution contained 25% serum, 
the detection limit of this assay was 2. 
 
Sensitive seroneutralization assay (sensitive SN) 
It has previously been shown that PCV2-neutralizing antibody titres are only 
slowly induced (Pogranychnyy et al., 2000). Therefore, a more sensitive technique 
was developed. When no PCV2-neutralizing antibodies could be detected with the 
Classical SN, PCV2-neutralizing antibodies were detected by using the more sensitive 
seroneutralization described by Meerts et al. (2005). A similar neutralization assay 
had previously also been used to detect neutralizing antibodies against porcine 
reproductive and respiratory syndrome virus (Delputte et al., 2005). Briefly, a 
standard infectious dose of PCV2 (103.7 TCID50 of strain Stoon-1010) was incubated 
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for 1 hour at 37°C with 25% of the serum. Afterwards, this virus-serum mixture was 
inoculated on PCV-negative PK-15 cells. After 1 hour, the inoculum was removed, 
the cell cultures were washed 2 times, new cell medium was added and cultures were 
maintained at 37°C in the presence of 5% CO2. After 36 hour of incubation, when the 
first replication cycle of PCV2 in PK-15 cells is completed, the cells were fixed and 
stained for PCV2 antigens using an immunoperoxidase technique. The number of 
PCV2-infected cells was counted and compared to the number of infected cells in a 
PK-15 culture inoculated with a PCV2 stock treated with the serum of the pig before 
inoculation. The result of this seroneutralization assay is expressed as a percentage of 
reduction of PCV2-infection. 
 
Statistical analysis 
Statistical significance of differences between mean antibody titres of groups of 
subclinically infected pigs or pigs that developed PMWS, was calculated using the 
Kruskal-Wallis test. Differences were considered significant when p < 0.05. 
 
 
Results 
 
Total PCV2-specific and PCV2-neutralizing antibody titres in experimentally 
inoculated gnotobiotic and conventional SPF pigs 
The total anti-PCV2 antibody profiles in experimentally inoculated gnotobiotic 
and conventional SPF pigs are shown in Figure 1. The first anti-PCV2 antibodies 
were detected at 10 dpi in SPF pigs. At that time PMWS-affected SPF pigs showed 
significantly higher IPMA titres compared to their healthy group mates (p = 0.037). In 
gnotobiotic pigs no antibodies were detected before 15 dpi. Antibody titres increased 
in a time-dependent manner until the end of the study or until the pig died. Only in 
one PMWS-affected SPF pig (pig 3), a plateau was reached starting from 10 dpi. At 
21 dpi, the antibody titre in this pig was low (2.7 log4) when compared to the other 
pigs (5.7 – 6.7 log4).  
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Figure 1. Course if IPMA and SN (sensitive) antibody titres in experimentally PCV2-
inoculated gnotobiotic and conventional SPF pigs. Full symbols: pigs with low PCV2 
replication (gnotobiotic) or subclinically infected pigs (SPF); empty symbol: pig with 
high PCV2-replication (gnotobiotic) or PMWS-affected pigs (SPF). Full line: mean 
antibody titre of the pigs with low PCV2 replication (gnotobiotic) or healthy pigs 
(SPF). Dashed line: antibody titre of pig with high PCV2-replication (gnotobiotic) or 
mean antibody titre of PMWS-affected pigs (SPF). When the difference between both 
means was significant, the p-value was shown. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
With the Classical SN, no PCV2-neutralizing antibodies were detected in any pig 
until the end of the studies at 21 dpi. Therefore, the sensitive SN was applied in these 
studies. With this assay, PCV2-neutralizing antibodies were detected in gnotobiotic 
and SPF pigs starting from the same time point when anti-PCV2 antibodies were 
detected with the IPMA (10 dpi in SPF and 15 dpi in gnotobiotic pigs). In seven 
gnotobiotic pigs (pigs with low PCV2-replication) and in six SPF pigs (pigs that did 
not develop PMWS) the evolution in PCV2-neutralizing antibody titres followed the 
evolution of the total anti-PCV2 antibody titre. In these pigs, the PCV2-neutralizing 
antibody titres increased in a time dependent manner until the end of the study. 
However, one gnotobiotic pig (the pig with high PCV2-replication) and four SPF pigs 
(pigs that developed PMWS) showed a PCV2-neutralizing antibody profile that 
significantly differed from their total anti-PCV2 antibody pattern and from the 
neutralizing antibody pattern observed in the other pigs in the experiment. In the 
gnotobiotic pig with the high PCV2-replication, no significant PCV2-neutralizing 
antibodies could be detected using the sensitive SN at any time during the study. The 
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four PMWS-affected SPF pigs showed a peak in PCV2-neutralization at 10 dpi but 
afterwards the neutralization titres declined until the moment the pigs died (two pigs 
at 14 dpi) or until neutralization could no longer be detected (2 pigs at 21 dpi). SN-
titres in PMWS-affected SPF pigs were significantly lower compared to SN titres in 
healthy pigs at 14 (p = 0.011) and 21 dpi (p = 0.046). 
 
Total PCV2-specific and PCV2-neutralizing antibody titres in naturally PCV2-
infected pigs 
Total PCV2-specific antibody titres (IPMA) and PCV2-neutralizing titres 
(classical SN) detected in naturally PCV2-infected pigs are presented in Figure 2. All 
piglets enclosed in both field studies showed maternally derived antibody (MDA) 
titres between 3.7 and 6.7 log4. A gradual decline of total anti-PCV2 antibodies was 
detected in all pigs except one (pig 6) in the Danish study. Seroconversion was 
observed in the Danish pigs between 3 and 6 weeks after mingling and in the Belgian 
pigs between 6 and 12 weeks of age. In the Danish study, IPMA antibody titres at 6 
weeks post mingling were generally lower in PMWS-affected pigs, compared to 
healthy pigs (p = 0.013). However, this difference could not be demonstrated in the 
Belgian field study. 
At the onset of both field studies, SN titres were found above the detection limit 
with the classical SN in all sera due to the presence of MDA. SN titres at the start of 
the studies ranged between 4 and 9. At the start of the study, no significant differences 
in SN Ab titres could be observed between subclinically infected pigs and pigs that 
developed PMWS. SN titres decreased in a time-dependent manner during the first 
weeks of the study. In all subclinically infected pigs, except pig 3 in the Danish study, 
a rise in SN titres could be detected before the end of the study. This seroconversion 
was detected starting from 10 weeks of age in the Belgian study and starting from 3 
weeks after mingling in the Danish study. The majority of the PMWS affected pigs 
died before they reached the age at which a rise in SN titres could be detected (1 pig 
in the Belgian and 8 pigs in the Danish study). However 1 PMWS-affected pig in the 
Belgian study and 5 in the Danish study, survived until the end of the study. In none 
of these pigs, a rise in SN titres was detected. This resulted in a significant lower SN-
titre in the PMWS affected pigs in the Danish study (p = 0.005).  
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Figure 2. Course of IPMA and SN (Classical) antibody titres in naturally PCV2-
infected pigs in Belgian and Danish field conditions. Full symbols: subclinically 
infected pigs; empty symbols: PMWS-affected pigs. Full line: mean antibody titre of 
subclinically infected pigs; dashed line: mean antibody titre of PMWS-affected pigs. 
When difference between mean titres was significant, the p-value was shown. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Course of PCV2-specific antibody isotype titres in experimentally inoculated 
gnotobiotic and SPF pigs 
The titres of specific anti-PCV2 antibody isotypes in gnotobiotic and SPF pigs 
are shown in Figure 3. In gnotobiotic pigs, the different antibody isotypes generally 
followed the course of the IPMA antibody titres. The IgM, IgG1, IgG2 and IgA titres 
found in the pig that experienced a high level of PCV2-replication (pig 3) did not 
differ from the titres of the other pigs. In the pig with high PCV2-replication IgA-type 
antibodies were detected starting from 15 dpi where as in the other pigs IgA-type 
antibodies were detected starting from 10 dpi. 
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Figure 3. Course of isotype-specific antibody titres in experimentally PCV2-
inoculated gnotobiotic and SPF pigs. Full symbols: pigs with low PCV2 replication 
(gnotobiotic) or subclinically infected pigs (SPF); empty symbol: pig with high 
PCV2-replication (gnotobiotic) or PMWS-affected pigs (SPF). Full line: mean 
antibody titre of the pigs with low PCV2 replication (gnotobiotic) or healthy pigs 
(SPF). Dashed line: antibody titre of pig with high PCV2-replication (gnotobiotic) or 
mean titre of PMWS-affected pigs (SPF). When the difference between the mean 
titres was significant, the p-value was shown. 
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In SPF pigs, a clear difference between PMWS-affected and healthy pigs was 
observed in the evolution of the IgM-type antibodies. Between healthy pigs, very little 
variation was detected in IgM titres. Starting from 10 dpi, anti-PCV2 IgM-antibodies 
were detected and they steadily increased until the end of the study. In 2 out of 4 
PMWS-affected pigs, IgM antibodies were detected starting from 7 dpi. At 10 dpi, 
IgM titres in PMWS-affected pigs were significantly higher than the IgM titres in 
healthy pigs (p = 0.018). After 10 dpi, IgM titres in PMWS-affected pigs deceased 
towards the end of the study. At 21 dpi, IgM titres in PMWS-affected pigs were 
significantly lower compared to IgM titres in healthy pigs (p = 0.035). 
IgG1, IgG2 and IgA titres in SPF pigs generally followed the profiles of the 
IPMA antibody titres. Titres increased until the end of the study. At 21 dpi, the mean 
titres of these antibody isotypes in PWMS-affected pigs were lower compared to the 
titres of the healthy pigs. However, only for the IgG2 titres, these differences were 
found to be significant (p = 0.039). 
 
Course of PCV2-specific antibody isotype titres in naturally PCV2-infected pigs 
In naturally PCV2-infected pigs, similar observations were made as in the 
experimentally inoculated animals. In both field studies, the course of the IgM-type 
antibodies against PCV2 differed between healthy and PMWS-affected pigs. In 
healthy pigs, IgM titres were found to increase steadily towards the end of the study, 
resulting in high IgM titres even at 14 weeks of age, 6 weeks after the first IgM 
antibodies were detected in some pigs. PMWS-affected pigs had low titres of IgM 
antibodies. The mean IgM titres in PMWS-affected pigs in the Danish study were 
significantly lower compared to the titres in healthy pigs (p = 0.001). IgG1, IgG2 and 
IgA titres followed the course of the IPMA antibody titres. It was observed that the 
mean of these titres in PMWS-affected pigs was always lower compared to the mean 
titre in healthy pigs. However, these differences were not significant. Due to the 
limited number of PMWS-affected pigs in the Belgian field study, it was not possible 
to detect significant differences but it was clear that also in this study the IgM titre in 
the affected pigs was much lower compared to the titre in their healthy littermates. 
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Figure 4. Course of isotype-specific antibody titres in naturally PCV2-infected pigs. 
Full symbols: subclinically infected pigs, empty symbols: PMWS-affected pigs. Full 
line: mean antibody titre of healthy pigs, dashed line: mean antibody titre of PMWS-
affected pigs. When the difference between the mean values was significant, the p-
value was shown. 
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Discussion 
 
In the present study, it was shown that the absence of PCV2-neutralizing 
antibodies was correlated with high PCV2-replication and with PCV2-related disease 
(PMWS) if present.  
Neutralizing antibodies have important functions in the defence of animals and 
humans against viral infections. Starting from the moment they appear, neutralizing 
antibodies bind and neutralize the virus and prevent further spread in the body by 
inhibiting attachment and infection of new cells. It has been shown that neutralizing 
antibodies against many viruses are more rapidly induced during the immune 
response and reach higher titres compared to antibodies against other viral epitopes 
(Bachmann and Zinkernagel, 1997). In contrast, neutralizing antibodies against PCV2 
could only be detected starting from 10 dpi by using a sensitive SN assay (Meerts et 
al., 2005). These titres rose slowly until they could be detected with the classical SN 
assay starting from 4 weeks after inoculation (Pogranichnyy et al., 2000). The slow 
induction of neutralizing antibodies is a very effective mechanism for the virus to 
ensure a long period of replication in its host. In previous work, the observation was 
made that an increased replication of the virus in one pig, was correlated with a lack 
of neutralizing antibody production (Meerts et al., 2005). In the present study, it was 
confirmed that the absence of PCV2-neutralizing antibodies is indeed a reoccurring 
phenomenon in pigs with high PCV2-replication. In experimentally PCV2-inoculated 
SPF pigs and in two field studies, a good correlation was observed between the 
absence or low titres of neutralizing antibodies against PCV2 and the occurrence of a 
high virus replication and the development of PMWS. This observation reveals a 
possible mechanism that allows the virus to replicate to a higher extent in a limited 
number of pigs. These pigs seem to be unable to recognize or produce antibodies 
against the epitope that is involved in the neutralization of the virus. With relation to 
other viral infections such as pseudorabies virus (Jacobs and Kimman, 1994), 
influenza virus (Lambkin and Dimmock, 1995) or human rotavirus (Green et al., 
1990), it has been shown that different animals do not all recognize the same epitopes. 
Various syndromes have already been ascribed to the inability of certain individuals 
to recognize certain epitopes (susceptibility to mastitis (Lunden et al., 1990), clinical 
outcome of Marek’s disease virus (Wakenell et al., 1996)). The susceptibility to these 
syndromes is highly genetically determined. The difference in prevalence of PMWS 
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between regions also leads to the hypothesis that PMWS would be partly genetically 
determined. Therefore, it would be worth wile to check for a similar mechanism in the 
recognition of PCV2-neutralizing epitope and the subsequent influence on the 
susceptibility of the host to PMWS. 
In the present study, it was shown that maternally derived antibodies in the serum 
were able to neutralize PCV2-infection in the SN assay but could not avoid PCV2-
infection of the pig since seroconversion was observed in pigs with maternal SN titres 
as high as 6 log2. When looking at the total antibody titres (IPMA) in the field 
studies, it was observed that seroconversion against PCV2 never occurred in pigs 
before weaning at the age of 4 weeks (Belgian field study) or before the pigs were 
mingled (Danish study). This suggests that none of the pigs got infected with PCV2 as 
long as they suckled. There are two possible explanations for this. Or the piglets did 
not get in contact with the virus in the farrowing unit, which is hard to believe since 
PCV2 is known as a very resistant virus, or piglets were protected from infection as 
long as they suckled and received lactogenic immunity. This finding may suggest that 
the primary site of PCV2-replication in the pig is located in the mouth cavity or along 
the digestive system. 
In experimentally inoculated SPF pigs that developed PMWS, a small and 
transient peak in PCV2-neutralization was observed at 10 dpi. It was observed that 
these pigs also showed a peak of IgM titres at that same time point. The IgM 
antibodies in these pigs did not lead to the production of neutralizing IgG or IgA 
antibodies, which indicates that the neutralizing epitope was not targeted by the 
humoral immune response. The parallel evolution of the SN and IgM titres in these 
pigs suggests that the IgM antibodies might be responsible for the low level of PCV2-
neutralization that was observed at 10 dpi. Possibly IgM antibodies which are directed 
against non-neutralizing epitopes, are able to neutralize PCV2 to some extent by 
sterical hindrance. Indeed, IgM antibodies are secreted in a pentamere formation that 
is much larger compared to any other antibody isotype. This pentamere form contains 
10 Fab fragments which would enable it to bind PCV2 at different sites. In PMWS-
affected pigs in the Danish field study, a peak in IgM antibodies was not detected 
probably because the time intervals between the different blood collections were too 
long (3 weeks). When comparing IgM profiles in both experimental studies, it is 
observed that in the gnotobiotic pig with high PCV2-replication, low IgM titres were 
detected until the end of the study. In general the humoral immune response in 
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gnotobiotic pigs was delayed compared to the SPF pigs, which might be the reason 
that no decrease in IgM titres was observed in this pig. The low IgM titres in this 
gnotobiotic pig might correspond to the slight increase in PCV2-neutralization (up to 
16% whereas in other pigs they reached 97%) that was observed in this pig. This 
slight neutralization however, was not significantly different compared to the result 
obtained from serum of the same pig before inoculation. 
IgM titres in subclinically infected animals, in contrast with titres in PMWS-
affected pigs, persisted and even increased until the end of the study. After a viral 
infection, IgM-type antibodies are the first antibodies that are being produced. 
Generally, the plasma cells that produce these antibodies go through an isotype switch 
and start producing other isotypes of antibodies resulting in a down-regulation of IgM 
production (Esser and Radbruch, 1997). A persistence of IgM type antibodies has 
already been described during the immune response against other viruses such as the 
coronavirus responsible for the severe acute respiratory syndrome in humans (Woo et 
al., 2004) or the human parvovirus B19 (Yeagashi et al., 1989). However, the 
mechanism of this prolonged presence of IgM antibodies has not been defined yet. It 
is known that in older animals such as breeding sows, very high IPMA antibody titres 
against PCV2 can be found. It may be hypothesized that the persistent presence of 
IgM lies at the base of this observation.  
Although a clear difference in the course of the IgM antibodies was observed 
between healthy and PMWS-affected pigs, the isotype switch occurred in both kinds 
of pigs at the same time point since other antibody isotypes were detected starting 
from the same time point. In PMWS-affected pigs, titres of other antibody isotypes 
against PCV2 were somewhat lower compared to titres in healthy pigs at the end of 
the studies. These differences, although hard to explain, indicate that some important 
changes in the humoral immune response occur. Possibly they are related to the fact 
that PCV2 is able to infect B-cells and causes a severe depletion of especially the B-
cells (Sanchez et al., 2004; Nielsen et al., 2003). Whether these changes are important 
in the induction of PMWS or are merely a consequence of it, remains unclear. 
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With regard to their structure, circoviruses are without doubt the most 
uncomplicated viruses that are known today. Their exceptionally small genome codes 
for only one structural protein (Nawagitgul et al., 1998) and two replication-
associated non-structural proteins. Both non-structural proteins are actually being 
transcribed from one open reading frame (Mankertz and Hillebrand, 2001), again 
compressing the amount of DNA needed to enclose all the genetic information that is 
required for the replication of the virus. The fact that such rudimentary viruses are 
able to infect eukaryotic cells and complete their own replication, is an amazing 
achievement. Except for prions (Stahl and Prusiner, 1991), circoviruses are probably 
the smallest entities that are able to reproduce themselves or better, that are able to get 
themselves reproduced. Circoviruses are not only able to successfully multiply in an 
individual host, they are also very successful in maintaining themselves in the 
population of their respective hosts. This can be deduced from the high prevalence of 
the porcine circoviruses (Labarque et al., 2000), TT-virus (Ali et al., 2002) and 
psittacine beak and feather disease virus (Rahaus and Wolff, 2003). 
Coexistence of viruses and their hosts inflicts an evolutionary pressure on both 
host and virus (Vossen et al., 2002). As such, it can be hypothesized that the 
establishment and optimization of the immune system of higher organisms, is an ever-
improving answer to external threats posed by infectious agents (viruses, bacteria and 
parasites). The immune system is especially designed to decrease the chance of 
survival of these infectious agents in the population of their host. When the structure 
of contemporary viruses is overviewed, it becomes clear that viruses have evolved in 
different directions to cope with this immune system. Viruses of different orders can 
follow quite opposed strategies to fight against the onset and their elimination by their 
host’s immune response.  
One strategy is used by structurally more complex viruses. Through evolution, 
such viruses have developed mechanisms that enable them to actively avoid 
recognition or disturb their host’s immune response. These different viral immune 
evasion strategies have been exhaustively reviewed in literature (Tortorella et al., 
2000; Vossen et al., 2002). The implementation of such mechanisms requires the 
presence of a complex machinery of viral proteins that has to be carried in the genome 
of the virus or in some cases in the virion itself. As a consequence, the virus will 
become more complex as it adapts to various host mechanisms. 
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Structurally more simple viruses such as the circoviruses can follow an opposite 
strategy. By expressing so few viral proteins, circoviruses supply their host with a 
very limited number of epitopes to initiate its immune response against. As a 
consequence, the way for circoviruses to circumvent the onset of an efficient immune 
response is to avoid recognition. As far as it is known today, PCV2 only expresses 
three proteins and in this thesis as well as in a previous publication, it was shown that 
no antibodies against two of these three proteins, the Rep proteins, could be 
demonstrated (Cheung and Bolin, 2002; Meerts et al., 2005a). This leaves only the 
capsid protein as a possible target for the humoral immune response. Unfortunately, 
also the recognition of the capsid protein is not optimal in all pigs.  
In this thesis, the influence of the specific immune response on the development 
of a PCV2-infection in a pig was clarified. It has been shown as well in this thesis as 
by other researchers (Ladekjær-Mikkelsen et al., 2002; Sanchez et al., 2003) that, 
upon experimental inoculation, piglets with identical backgrounds experience 
different evolutions in the replication of PCV2. In the majority of the pigs, a peak in 
PCV2-replication was observed between 10 and 15 days post inoculation, followed by 
a gradual decrease of the virus titre. This decrease coincided with the onset of an 
efficient specific immune response that consisted of the production of PCV2-
neutralizing antibodies and in some cases also of a clearly detectable cellular immune 
response. Similar replication kinetics have already been observed after experimental 
inoculation with many other viruses (Glass et al., 2004; Labarque et al., 2000b; 
Lichtenstein et al., 1995). However, in a number of PCV2-inoculated pigs, the 
replication of the virus continued to increase after the time point at which the other 
pigs reached their peak in PCV2-replication, resulting in considerably higher titres in 
these pigs at the end of the study. It could be demonstrated that in gnotobiotic pigs 
experiencing this pattern of PCV2-replication, the cellular immune response was too 
low to be detected and more important, that no PCV2-neutralizing antibodies were 
detected (Meerts et al., 2005b). This inefficient immune response clearly rendered the 
pigs more susceptible to an increased level of PCV2-replication since the virus was 
able to replicate in these pigs as good as it did in pigs that were artificially 
immunosuppressed by a treatment with Cyclosporin A. These results indicate that the 
specific immune response in general, and more specific the absence of PCV2-
neutralizing antibodies, is the determining factor for the virus to go into the direction 
of a prolonged replication.  
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The economic relevance of PCV2 lies in its association with the postweaning 
multisystemic wasting syndrome (PMWS), a disease which is generally observed in 
pigs a few weeks after weaning. The morbidity in field situations varies between 
0.01% (Meerts et al., 2004) and 30% (Allan and Ellis, 2000). In most cases, the 
disease affected a small fraction of the pigs. The association between PCV2 and this 
disease was made after the observation that PMWS-affected pigs all contained high 
titres of PCV2 in various organs. Only low titres of the virus or no virus could be 
isolated from healthy pigs that were sacrificed at the time at which litter mates died of 
PMWS (Meerts et al., 2004). During several experimental inoculations in pigs in 
which PMWS was reproduced, slight differences in seroconversion against PCV2 
were observed in-between pigs and correlated with the appearance of PMWS: 
PMWS-affected pigs tended to have lower total antibody titres against PCV2 
(Ladekjær-Mikkelsen et al., 2002). Furthermore, it has been noted in several studies 
that pigs, when developing PMWS, seroconvert at later time points compared to 
subclinically infected pigs (Bolin et al., 2001; Rovira et al., 2002; Okuda et al., 2003). 
The mechanisms that form the base of these differences were not fully understood. 
However, they are indicative for some modulations of the humoral immune response 
in pigs that develop PMWS. In the work presented in this thesis, it was shown that the 
absence of PCV2-neutralizing antibodies was a recurring phenomenon in pigs with 
high PCV2-replication (Meerts et al., 2005b; Meerts et al., 2005d). Thereby, it was 
demonstrated that the absence of PCV2-neutralizing antibodies coincided not only 
with a prolonged replication of the virus, but also with the development of PCV2-
related disease (Meerts et al., 2005d). 
 Although pigs with a high level of PCV2-replication did not produce PCV2-
neutralizing antibodies, they did show a normal seroconversion when looking at their 
total anti-PCV2 antibodies. This indicates that these pigs produced antibodies against 
PCV2 but not against a specific epitope that is involved in the antibody-mediated 
neutralization of the virus. With regard to other viruses (pseudorabies virus, type A 
influenza virus, rotavirus), it has already been shown that not all hosts develop 
antibodies to the same extent to all different viral epitopes (Jacobs and Kimman, 
1994; Lambkin and Dimmock, 1995; Green et al., 1990). Most viruses contain a high 
number of epitopes and chances are relatively low that the inability of an animal to 
recognize one of these epitopes may have severe consequences. When a similar event 
occurs with a very small virus such as a circovirus, chances are much higher that not 
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recognizing one of the few available epitopes may have severe consequences on the 
efficiency of the immune system to eliminate the virus.  
Several syndromes in various animal species have already been associated with 
the inability of certain animals to recognize a specific epitope of an infectious agent 
(Lunden et al., 1990; Wakenell et al., 1996). The mechanism that is responsible for 
this event in these syndromes has been identified. It has been shown that the major 
histocompatibility complex class II (MHC-II) is highly polygenic and polymorphic. 
This high diversity allows antigen presenting cells to present as many “non-self” 
epitopes as possible through their MHC-II molecules, in order to initiate an immune 
response against them (Kumanovics et al., 2003). However, when an individual lacks 
the MHC-II haplotype that is responsible for the presentation of a certain epitope, it 
will not react against that epitope. As such it has been described that in chickens, the 
B19 haplotype is associated with susceptibility to Marek’s disease whereas the B21 
haplotype is associated with resistance against the disease when they are infected with 
the virus (Wakenell et al., 1996). In bovines, the MHC II haplotype DQ1A was 
associated with an increased susceptibility to clinical mastitis (Lunden et al., 1990). It 
would therefore be very interesting to identify the epitope on the PCV2 capsid protein 
that is involved in the neutralization of the virus and subsequently to identify the 
MHC-II haplotype that is responsible for presenting this epitope. The MHC-II genes 
are inherited from the parents. Diseases that are linked with specific genotypes are 
highly genetically determined. Related to the field, this results in the existence of 
susceptible and resistant breeds or lines. If a similar mechanism would be at the base 
of the susceptibility of certain pigs to an increased PCV2-replication and subsequently 
to PMWS, this would immediately confirm and explain the presence of a genetical 
influence on the prevalence of PMWS. In the past, it has already been shown that the 
genetic background of pigs has an influence on their susceptibility to PMWS 
(personal observations; Lopez-Soria et al., 2004). However, the search for the 
underlying mechanism has only recently been initiated. The results obtained in this 
thesis might lead the way to a successful identification of this mechanism.  
Our results indicate that the humoral immune response is of major importance in 
the pathogenesis of the PCV2-infection. When this humoral immune response was 
studied in more detail, some more interesting differences between subclinically 
infected and PMWS-affected pigs were found. A general trend was that PMWS-
affected animals showed lower total antibody titres upon infection. The differences 
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between the mean titres of PMWS-affected and subclinically infected animals 
however, were not always significant. It indicates that the total antibody titres were 
only slightly decreased in animals affected with PMWS. This observation had been 
made previously in other studies (Ladekjær-Mikkelsen et al., 2002; Sanchez et al., 
2003). A more obvious difference was observed in the evolution of the IgM-titres 
between the subclinically infected pigs and pigs that developed PMWS. During a 
“normal” humoral immune response against a viral infection, IgM antibodies are the 
first antibodies that can be detected. After a short period, the plasma cells that produce 
these antibodies experience an isotype switch that results in the production of other 
isotypes of antibodies and in the decrease of IgM production (Esser and Radbruch, 
1990). This property of the IgM antibodies has therefore been used in assays to 
diagnose a recent infection of a virus in a single serum sample (Vasquez et al., 2005; 
Sagnelli et al., 2005). This profile of transient IgM-production was observed in pigs 
that developed PMWS. In the healthy pigs, IgM antibodies remained detectable and 
even increased until the end of the studies at 21 days after PCV2 inoculation. From 
these results, it looks like PMWS-affected pigs show the “normal” IgM profile, 
whereas healthy pigs show an “abnormal” profile. Some other viruses are also known 
to cause a persisting IgM production in their host. The coronavirus causing the severe 
acute respiratory syndrome in humans (Woo et al., 2004) as well as the human 
parvovirus B19 (Yaegashi et al., 1989) induce IgM titres in serum that can be detected 
during several months. The mechanism that leads to these persistent IgM antibodies is 
unknown. From the results in this thesis, it could not be concluded whether this 
obvious difference in IgM production profiles between subclinically infected and 
PMWS-affected pigs was the cause of the development of disease or merely a 
consequence of it. The isotype switch of antibodies is highly controlled by different 
cytokines (Kawanishi et al., 1991; Fontana et al., 1992; Gao et al., 2001). Recently, in 
vivo observations made by other research groups have suggested an influence of 
certain cytokines on the replication of the virus and the susceptibility to the disease 
(Hasslung et al., 2005). In this thesis, some indications were found that this might 
indeed be the case. 
One event that will undoubtedly have an impact on the evolution of the humoral 
immune response in pigs with an increased PCV2-replication is the fact that in such 
pigs, B-cells have been found to be major target cells of the virus. Furthermore, high 
PCV2-titres have been correlated in many studies with depletion of lymphocytes and 
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especially with B-cells. This was observed in lymphoid tissues (Sanchez et al., 2004) 
as well as in the blood (Nielsen et al., 2004). This event might be responsible for the 
slightly lower total anti-PCV2 antibody titres that have been found in PMWS-affected 
pigs. 
So far, it has been shown in this thesis that the replication of PCV2 is highly 
influenced by the host’s immune response against PCV2. The full identification of the 
mechanism behind the observed differences is important in understanding the inherent 
susceptibility of an individual pig or a certain breed of pigs to sustain a high level of 
PCV2-replication and subsequently develop PCV2-associated diseases. If these 
mechanisms would be genetically determined, the pig industry would for instance be 
able to select pig breeds that are resistant to high PCV2-replication and associated 
diseases. 
Besides being influenced by the host itself, the course of a PCV2-infection in pigs 
can be influenced by many external factors. One of the earliest observations made 
during the investigation on the pathogenesis of a PCV2-infection in pigs, was that a 
co-infection of pigs with porcine parvovirus (PPV) (Allan et al., 2000a) enhanced the 
replication of PCV2. Thus, PPV created an environment in the host that was 
favourable for PCV2-replication. This was not a unique property for PPV alone. 
Similar experiments with the porcine reproductive and respiratory syndrome virus 
(PRRSV) resulted in a comparable effect on the replication of PCV2 in the pig (Allan 
et al., 2000b). In an attempt to find the mechanism behind the enhancement of PCV2-
replication by these co-infections, gnotobiotic pigs were inoculated with keyhole 
limpet hemocyanin in Freund’s incomplete adjuvant. This treatment also increased the 
susceptibility of pigs to an increased PCV2-replication (Krakowka et al., 2001). A 
common event in all these co-infections or treatments is the induction of an immune 
response. Unfortunately, research focussed mainly on the identification of other 
potential cofactors that were able to enhance PCV2-replication (bacterins, vaccines, 
Mycoplasma Hyopneumoniae) (Opriessnig et al., 2003; Opriessnig et al., 2004a; 
Opriessnig et al., 2004b). The mechanism that was responsible for this increased 
PCV2-replication remained to be identified.  
The initiation of a specific immune response by an infectious agent implies the 
production of a wide array of different cytokines. Many of these cytokines can be 
detected in the blood, indicating that they are distributed throughout the body where 
they induce systemic effects. A number of the cytokines that are produced during an 
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immune response have been found to influence the course of viral infections in 
general in the host. Tumour necrosis factor alpha (TNF-α) (Calabrese et al., 2004) 
and certainly the different types of interferons (Katze et al., 2002), inhibit the 
replication of many viruses both in vitro and in vivo. The antiviral effect of interferon-
alpha (IFN-α) has been found to be so consistent that recombinant protein is used to 
treat various viral infections in humans and animals (Maggi et al., 2001; Martin et al., 
2002). The question rose how it is possible that PCV2 is able to replicate better in 
pigs coinfected with PPV or PRRSV, knowing that such infections induce these 
cytokines with antiviral properties. Therefore the effect of a range of porcine 
cytokines on the replication kinetics of PCV2 in continuous cell lines was investigated 
in this thesis. 
First, the replication kinetics of PCV2 was established in non-treated PK-15 cells 
(Meerts et al., 2005a; Misinzo et al., 2005). In this study, it was observed that the 
completion of the full replication cycle of PCV2 took up to 24 hours, which is very 
long compared to that of other viruses. During the first stages of the infection, the 
structural capsid protein was produced and remained present in the cytoplasm of the 
cell. Subsequently, the replication-associated Rep protein was produced and both 
capsid and Rep protein were relocated to the nucleus to form the infectious virions. 
These observations agreed with the sequence of events that have been described 
during the replication cycle of viruses that follow the rolling cycle replication (Koths 
and Dressler, 1980). A striking result was obtained when these cells were treated with 
IFN-α or IFN-γ. It was demonstrated that IFN-γ and, in more specified conditions, 
also IFN-α were able to enhance the replication of the virus. This was the first 
description of an enhancement of any viral infection by IFN-α and IFN-γ. The 
enhancing effect was mainly due to an increased internalization of the virus into the 
cells to which it was bound. This finding reflects a possible mechanism of major 
importance to understand the interaction between PCV2 and the cell it infects but also 
between the virus and the immune system of its host (Meerts et al., 2005c).  
Although this finding could not be reproduced in vivo by injecting pigs with 
recombinant IFN-γ (rIFN-γ), an enhancement of the replication of PCV2 in pigs could 
be induced with concanavalin A (ConA) (Meerts et al., 2005e). This led to two 
different hypotheses, (1) the effect of the ConA-treatment on the replication of PCV2 
was at least partially IFN-γ dependent but not reproduced with rIFN-γ alone because 
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the obtained concentrations of IFN-γ in the blood after injecting the pigs with rIFN-γ 
were too low or (2) the effect of ConA was IFN-γ independent. Nevertheless, this 
experiment showed that stimulation of T-cells, which is a normal event during an 
immune response, enhanced the replication of PCV2 in the pig. Thus, this mechanism 
might be the cause of the increased PCV2-replication in immunostimulated pigs. 
Both stimulation of T-cells by ConA-treatment and inhibition of T-cell 
proliferation by CyclosporinA (CysA) induced a similar effect. The difference 
between both treatments was that ConA did not only induce higher PCV2 titres 
compared to the control pigs, it also sped up the replication since PCV2 could be 
detected in the lymph nodes of the pigs starting from an earlier time point. Thus, 
ConA seemed to increase the replication of the virus also in the early stage of the 
infection whereas CysA increased the replication merely by inhibiting the specific 
immune response during the late stage of the infection. Nevertheless, these data 
reflect the unique interaction between PCV2 and the immune system of its host. 
This thesis aimed to identify factors that are able to influence the replication of 
PCV2 in its host. It was shown that the efficiency of the cellular and more importantly 
of the humoral immune response had an influence on the development of the PCV2-
infection and subsequently on the pig’s susceptibility to PCV2-related disease. 
Additionally, a mechanism was proposed by which PCV2 could be able to use the 
immune response against another infectious agent to improve its own replication. 
Thus, the evolution of the replication of PCV2 in a pig and its clinical outcome is the 
result of various host specific and external factors of which a few have been 
identified. Further studies on the pathogenesis of a PCV2 infection will therefore 
always have to consider the influence of these factors. Any disease that is associated 
with PCV2 is thus, by definition, a multifactorial disease and neither prevention nor 
treatment of such a disease should focus on PCV2 alone.  
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Summary 
 
Porcine circovirus type 2 (PCV2) is a virus that has been associated with a 
condition in pigs known as the postweaning multisystemic wasting syndrome 
(PMWS). Upon experimental inoculation or natural infection, the replication of the 
virus shows an unusual high variation between individual pigs. This variation 
indicates that the replication of the virus in the pig is influenced by unknown factors. 
In literature, indications can be found that some of these factors are related with the 
immune system of the animal. The present thesis aimed to identify host specific and 
external factors that are able to influence the replication of the virus in the pig. 
 
In the introduction in chapter 1, an overview was given on the classification and 
the structure of the circoviruses. The current knowledge of the pathogenesis of a 
PCV2-infection in a pig and its association with various disease syndromes in pigs 
was reviewed. 
 
Chapter 2 gives the aims of the thesis. These aims were first to establish the 
replication kinetics of PCV2 in continuous cell lines and in its most important target 
cells. Afterwards it was investigated if a range of different cytokines were able to 
influence the replication of PCV2 in vitro and in vivo. Another aim was to study in 
detail the immune response upon a PCV2-infection and to correlate the onset of this 
immune response with the further development of the infection and with the 
occurrence of PCV2-related disease. 
 
Chapter 3 presents a study that was initiated to compare the replication kinetics of 
different strains of PCV2 in the continuous porcine cell line PK-15 and two primary 
porcine cells that were found to be major target cells in vivo: porcine alveolar 
macrophages (PAM) and fetal cardiomyocytes (FCM). The aim of this study was to 
compare the replication kinetics of PCV2 in the different cell types and to investigate 
whether biological differences could be found between PCV2 strains that were 
isolated from pigs with different PCV2-related syndromes. In a first study, PK-15, 
PAM and FCM cultures were inoculated with either the postweaning multisystemic 
wasting syndrome (PMWS)-associated strain Stoon-1010 or the abortion-associated 
strain 1121. Viral proteins were visualized by immunofluorescence stainings and 
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virus production was determined by titrating the culture supernatant on porcine 
circovirus-free PK-15 cells. In PK-15 cells, the capsid protein was expressed between 
6 and 12 hours post inoculation (hpi), it relocated to the nucleus between 12 and 24 
hpi. Starting from 24 hpi, the replication-associated Rep protein was also detected in 
the nucleus. During the early stages of the infection, Rep protein could not be detected 
in the cytoplasm of the infected cell. Only in PK-15 cells that were dying (condensed 
and fragmented nucleus) some Rep protein could be found in the cytoplasm, most 
probably due to leakage from the disorganized nucleus. A similar sequence of events 
also occurred in the primary cell lines FCM and PAM, but nuclear localized antigens 
appeared at a later time point (48 hpi) and in a lower percentage of cells. In PAM, 
clear differences in susceptibility were seen between pigs. In PAM from two out of 
five tested pigs, no nuclear localized antigens could be detected, whereas in PAM 
from three other pigs they were seen in up to 20% of the antigen-positive cells. Virus 
production was observed in PK-15 but not in PAM or FCM cultures. In a second 
study, the replication kinetics of seven different PCV2 strains were compared in PK-
15 cells. It was shown that 2 abortion-associated strains had different replication 
kinetics in comparison with PMWS or porcine dermatitis and nephropathy syndrome 
associated strains. With the abortion-associated strains, a higher number of infected 
cells was observed after 24 hours, the fraction of these cells with nuclear localized 
antigens was lower compared to the other strains. From this study, it could be 
concluded that the replication kinetics of PCV2 in the primary cells PAM and FCM 
was similar but slower compared to the replication kinetics in PK-15 cells. 
Furthermore, it was observed that not all batches of PAM were equally susceptible to 
PCV2. This observation possibly reflects that the state of the macrophages in the pig 
influences the susceptibility of the pig to PCV2-infection. The differences in the 
replication kinetics between the different PCV2 strains indicates that some biological 
differences may occur even though the strains are genetically very similar. 
 
Stimulation of the porcine immune system results in an increased replication of 
porcine circovirus 2 (PCV2) in vivo. Since it is known that a stimulation of the 
immune system coincides with the production of various cytokines, a study was 
performed to investigate the influence of certain cytokines on the infection and 
replication of PCV2. Chapter 4 illustrates particularly the effect of type I and type II 
interferons on the replication of PCV2 in vitro and in vivo. In chapter 4.1 it was 
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investigated if a range of cytokines (interleukin-1 (IL-1), interleukin-6 (IL-6), 
interleukin-10 (IL-10), tumour necrosis factor-alpha (TNF-α), interferon-alpha (IFN-
α) and interferon-gamma (IFN-γ)) were able to influence the course of a PCV2-
infection in vitro. No changes were observed in IL-1, IL-6, TNF-alpha or IL-10 
treated cells. However, it was demonstrated that IFN-α and IFN-γ influenced PCV2 
infection in porcine kidney cells (PK-15) and porcine monocytic cells (3D4/31). IFN-
γ added to the culture medium before, during or after inoculation increased the 
number of PCV2-antigen positive cells with 418, 171 or 691% in PK-15 cells and 
with 706, 114 or 423% in 3D4/31 cells. IFN-α pre-treatment decreased the number of 
infected PK-15 cells. However, when it was added after inoculation, it enhanced 
PCV2 infection with 529% in PK-15 cells and 308% in 3D4/31 cells. The effect of 
both interferons on PCV2 infection was dose-dependent and could be blocked with 
their respective neutralizing monoclonal antibody. Leukocyte-derived porcine IFN-γ 
induced a similar effect on PCV2-infection. Treatment of PK-15 cultures with IFN-γ 
resulted in a 20 times higher production of progeny virus. Confocal microscopy 
studies showed that the enhancing effect of IFN-γ on PCV2-infection was achieved by 
increased internalization of PCV2 virion-like particles (VLPs). Binding of the VLPs 
to the cell or expression kinetics of PCV2-proteins in infected cells, were not altered 
by IFN-γ treatment. To our knowledge, this study reported the first enhancement of a 
viral infection by treatment with type I and type II interferons.  
In chapter 4.2 an attempt was made to reproduce the findings made in chapter 4.1 
in vivo. In this study, gnotobiotic pigs were intramuscularly and subcutaneously 
injected with Concanavalin A (ConA) or recombinant porcine IFN-γ (rIFN-γ) 12 
hours before experimental PCV2-inoculation and every 3 days for 9 days during the 
infection. ConA is a lectin that activates Th1, this goes along with the production of 
IFN-γ by these cells. The replication of PCV2 was monitored at 3 different time 
points in individual pigs by taking lymph node biopsies. The evolution in PCV2-
replication was determined by titrating the amount of PCV2 in the lymph node 
biopsies. In non-treated control pigs and rIFN-γ inoculated animals, PCV2 could be 
detected starting from 15 days post inoculation (dpi). No significant differences in the 
level of PCV2-replication between pigs from these different groups were found. In 
gnotobiotic pigs treated with ConA, PCV2 could already be isolated from inguinal 
lymph nodes starting from 10 dpi. At 15 dpi, the level of PCV2-replication was 
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significantly higher in ConA-treated pigs compared to the non-treated group. 
Although ConA treatment significantly increased PCV2-replication, no signs of 
disease were observed in any of the inoculated or non-inoculated animals. These 
experiments indicate that ConA-treatment enhances the replication of PCV2 in vivo, 
however data from the rIFN-γ treated pigs were not conclusive to show that the 
ConA-mediated enhancement of PCV2-replication was IFN-γ mediated. 
 
In chapter 5, the immune response of pigs against PCV2 was explored. Chapter 
5.1 describes the findings that were made in a study in which the cellular and humoral 
immune response were monitored in individual gnotobiotic pigs and correlated with 
the evolution of the replication of the virus. Twelve gnotobiotic pigs were inoculated 
with PCV2. Four of these pigs were treated with Cyclosporin A (CysA) to monitor the 
effect of the adaptive immunity on the development of the PCV2-infection. Through 
lymph node biopsies at 10, 15 and 21 days post inoculation (dpi), PCV2-replication in 
lymphoid tissues was monitored. The production of total PCV2-specific and PCV2-
neutralizing antibodies was followed, together with interferon-gamma (IFN-γ) mRNA 
expression levels in peripheral blood monocytes as a marker for cellular immunity. 
Generally, the CysA-treated pigs showed the highest PCV2-titres, indicating that the 
adaptive immunity is necessary to restrain PCV2-replication. Three different PCV2-
replication patterns were observed in non-CysA-treated pigs. Pattern 1: in two pigs, 
PCV2 was not detected. They had the highest neutralizing antibody titres, appearing 
from 15 dpi. In these pigs a good cellular response was indicated by a peak in IFN-γ 
mRNA at 15 dpi. Pattern 2: five pigs contained low to moderate PCV2 titres at 15 dpi, 
remaining constant or decreasing towards 21 dpi. Lower neutralizing antibody titres 
were observed and no rise in IFN-γ was detected. Pattern 3: in one pig, a low PCV2-
titre at 15 dpi dramatically increased towards 21 dpi. Although an antibody-response 
against PCV2 was mounted, no PCV2-neutralizing antibodies were detected. This pig 
also showed no rise in IFN-γ mRNA. The study indicates that variation in the onset of 
the adaptive immunity may account for variation in PCV2-replication between pigs. 
Absence of PCV2-neutralizing antibodies may be an important factor in the 
development of an increased virus replication. However, this study was performed in 
gnotobiotic pigs and it has been shown that the immune response of these pigs may 
deviate from the response of conventional animals. Therefore, in chapter 5.2 it was 
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investigated if similar observations could be made in experimentally or naturally 
PCV2-infected conventional animals. In the study presented in this chapter, it was 
shown that the correlation between the absence of PCV2-neutralizing antibodies and a 
high replication of the virus could also be found in SPF pigs in which PMWS was 
experimentally reproduced and in naturally PMWS-affected pigs. When looking at the 
total anti-PCV2 antibodies, PMWS-affected and healthy animals seroconverted at the 
same time but titres were slightly lower in PMWS-affected animals. In healthy 
animals the evolution of PCV2-neutralizing antibodies followed that of the total anti-
PCV2 antibodies whereas in PMWS-affected animals seroconversion in neutralizing 
antibodies was not observed (field studies) or they were detected only in low 
concentrations for a period of 1 week after which they disappeared (experimentally 
inoculated SPF pigs). Differences were found between the evolution of specific 
antibody isotypes against PCV2 in PMWS-affected and healthy pigs. In healthy pigs, 
IgM antibodies persisted until the end of the study whereas in PMWS-affected pigs 
they quickly decreased or remained at low titres. Furthermore, the mean titres of all 
other antibody isotypes tested (IgG1, IgG2 and IgA), were slightly lower in PMWS-
affected pigs compared to their healthy group mates at the end of each study. These 
differences were not always significant. 
 
A general conclusion of this thesis is that the level of PCV2-replication in a pig 
can be influenced by many host specific and external factors. It was demonstrated that 
in several experimental and field studies a small proportion of the pigs were not able 
to initiate an efficient immune response against the virus since they did not produce 
PCV2-neutralizing antibodies. This resulted in an increased level of PCV2-replication 
in these pigs and the development of PMWS in some studies. This inability of a 
proportion of the pigs to produce PCV2-neutralizing antibodies might be the clue to 
understand the genetical background of the susceptibility of pigs to PMWS. In this 
thesis another factor of possible importance was identified. It was demonstrated that 
IFN-γ and in more specific conditions also IFN-α were able to increase the 
susceptibility of porcine cell lines to PCV2-infection. A similar mechanism in vivo 
may explain the enhancement of PCV2-replication that has been observed in pigs 
when an immune response is induced in the pigs. Further work based on this thesis 
might supply pig producers with strategies to select towards a breed of pigs that is 
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resistant to high PCV2-replication or to implement sanitary measures to minimize the 
risk of inducing high PCV2-replication in the present pig population. 
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Samenvatting 
 
Het porcien circovirus type 2 (PCV2) is een zeer klein en vrij eenvoudig virus 
met een enkelstrengig, circulair DNA. Het wordt geassocieerd met een syndroom bij 
biggen dat gekend is als het infectieus groeistopsyndroom. Dit syndroom is echter 
beter bekend onder zijn Engelstalige naam: postweaning multisystemic wasting 
syndrome (PMWS). Na experimentele inoculatie van het virus bij biggen of na een 
natuurlijke infectie, vertoont de vermeerdering van het virus een uitzonderlijk hoge 
variatie. Deze hoge variatie toont aan dat de vermeerdering van het virus in het big 
beïnvloed wordt door bepaalde co-factoren die totnogtoe onvoldoende gekend zijn. In 
de wetenschappelijke literatuur kunnen indicaties gevonden worden dat deze factoren 
verband houden met het immuunsysteem van de dieren. Er werd namelijk aangetoond 
dat het induceren van een immuunrespons in dieren die reeds geïnfecteerd zijn met 
PCV2, aanleiding gaf tot een verhoogde vermeerdering van PCV2. In het verleden 
werd deze immuunrespons geïnduceerd door de dieren te inoculeren met bijkomende 
virussen of bacteriën, door ze te vaccineren of door een sterk immunogene stof te 
injecteren. De doelstellingen van deze thesis waren om zowel gastheerspecifieke als 
externe factoren te identificeren die in staat zijn om de vermeerdering van PCV2 te 
verhogen in het big. 
 
In de inleiding in hoofdstuk 1 wordt de classificatie en de organisatie van de 
circovirussen besproken. Verder wordt een overzicht gegeven van de bestaande 
kennis over de pathogenese van een PCV2-infectie en van de verschillende 
syndromen waarmee het virus reeds geassocieerd wordt. 
 
Hoofdstuk 2 geeft de doelstellingen van de thesis weer. De eerste doelstelling 
was om de vermeerderingskinetiek van PCV2 in continue cellen en in zijn 
belangrijkste doelwitcellen te onderzoeken. Nadien werd uitgezocht of bepaalde 
cytokines deze vermeerderingskinetiek konden beïnvloeden. De invloed van deze 
cytokines werd zowel in vitro als in vivo onderzocht. Een andere belangrijke 
doelstelling in deze thesis was om de specifieke immuunrespons tegenover PCV2 in 
geïnfecteerde biggen te onderzoeken en na te gaan in hoeverre deze immuunrespons 
verantwoordelijk was voor het verdere verloop van de infectie en eventueel een rol 
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speelde in de gevoeligheid van de dieren voor ziekten die met PCV2 geassocieerd 
worden. 
 
Hoofdstuk 3 geeft de resultaten van een studie weer waarin de kinetiek van de 
vermeerdering van verschillende PCV2 stammen werd vergeleken in de continue 
varkensniercellijn PK-15 en in twee primaire cellijnen waarvan gekend is dat ze bij 
het big belangrijke doelwitcellen zijn: porciene alveolaire marcofagen (PAM) en 
foetale cardiomyocyten (FCM). De doelstelling van deze studie was enerzijds om de 
vermeerderingskinetiek van twee referentiestammen te vergelijken in de verschillende 
cellijnen om te onderzoeken of er een verschil in gevoeligheid tussen de cellijnen was, 
anderzijds om te onderzoeken of er biologische verschillen optraden tussen PCV2 
stammen die geïsoleerd werden uit varkens aangetast door verschillende syndromen. 
In een eerste studie werden PK-15 cellen, PAM of FCM geïnoculeerd met de PMWS-
geassocieerde stam Stoon-1010 of met de abortus-geasocieerde stam 1121. Op 
verschillende tijdstippen na de inoculatie werden de cellen gefixeerd en geanalyseerd. 
Virale eiwitten werden gevisualiseerd door middel van een immunofluorescentie 
kleuring en de virusproductie werd bepaald door het virus in het supernatans van de 
celculturen te titreren in porcien circovirus-negatieve PK-15 cellen. Het kapsied eiwit 
werd in PK-15 cellen tot expressie gebracht in het cytoplasma vanaf 6 tot 12 uur na de 
inoculatie. Het eiwit verplaatste zich naar de kern van de cellen vanaf 12 tot 24 hpi. 
Vanaf 24 uur na inoculatie werd ook het replicatie-geassocieerde Rep eiwit 
gedetecteerd in de kern van de cellen. Het Rep eiwit werd tijdens de vroegste stadia 
van de infectie nooit opgemerkt in het cytoplasma van de geïnfecteerde cellen. Enkel 
in PK-15 cellen die afstierven ten gevolge van de infectie (te herkennen aan de 
gecondenseerde en gefragmenteerde kern) werd het Rep eiwit in lichte mate 
teruggevonden in het cytoplasma. Dit was waarschijnlijk het gevolg van lekkage 
vanuit de gedesorganiseerde kern. Een gelijkaardige opeenvolging van gebeurtenissen 
werd ook teruggevonden in de primaire cellijnen PAM en FCM. Bij deze cellen 
werden pas vanaf 48 uur na inoculatie virale eiwitten teruggevonden in de kern van de 
geïnfecteerde cel. In PAM werd bijkomend een belangrijke observatie gedaan. Er 
traden namelijk duidelijke verschillen op in gevoeligheid tegenover de PCV2-infectie 
tussen PAM afkomstig van verschillende biggen. In PAM van twee van de vijf geteste 
biggen konden nooit virale eiwitten in de kern van de geïnfecteerde cellen aangetoond 
worden, terwijl in PAM van de drie andere biggen tot 30% van de geïnfecteerde 
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cellen ook virale antigenen in de kern bevatten. Productie van nieuw virus kon in PK-
15 cellen waargenomen worden vanaf 36 uur na inoculatie maar kon niet worden 
aangetoond in PAM of FCM culturen. In het tweede deel van de studie werd de 
vermeerderingskinetiek van zeven verschillende PCV2 stammen onderzocht in PK-15 
cellen en onderling vergeleken. Er kon worden aangetoond dat twee abortus-
geassocieerde stammen een afwijkende vermeerderingskinetiek vertoonden ten 
opzichte van de PMWS en PDNS-geassocieerde stammen. Na inoculatie van deze 
abortus-geassocieerde stammen werd een hoger aantal geïnfecteerde cellen 
geobserveerd op 24 uur na inoculatie. Het percentage van deze geïnfecteerde cellen 
dat virale eiwitten in de kern vertoonde, was echter kleiner in vergelijking met de 
andere stammen. Uit deze studie kon besloten worden dat de vermeerderingskinetiek 
van PCV2 in PAM en FCM gelijkaardig was maar trager verliep dan in de PK-15 
cellen. Verder werd opgemerkt dat PAM afkomstig van verschillende varkens niet 
altijd even gevoelig waren voor infectie met PCV2. Dit kan erop wijzen dat de 
gevoeligheid van de macrofagen voor PCV2-infectie bepalend kan zijn voor de 
gevoeligheid van de gastheer zelf. Factoren die de status van de macrofaag zouden 
kunnen beïnvloeden, zouden op deze manier ook de gevoeligheid van het dier voor de 
PCV2-infectie kunnen beïnvloeden. De verschillen in vermeerderingskinetiek die 
waargenomen werden tussen de verschillende PCV2 stammen tonen aan dat ondanks 
de hoge genetische gelijkheid, mogelijk toch biologische verschillen tussen PCV2 
stammen kunnen voorkomen. 
 
Stimulatie van het immuunstelsel van het varken kan aanleiding geven tot een 
verhoogde vermeerdering van PCV2 in dat varken. De stimulatie van het 
immuunsysteem gaat altijd gepaard met de productie van een hele reeks van 
cytokines. Van een aantal van deze cytokines is geweten dat ze de vermeerdering van 
vele virale infecties kunnen tegengaan. Het lijkt dus contradictorisch dat PCV2 beter 
zou kunnen vermeerderen in een gastheer die deze antivirale cytokines produceert. 
Daarom werd een studie uitgevoerd die de invloed van een aantal cytokines op de 
vermeerdering van PCV2 naging. In hoofdstuk 4 wordt vooral de invloed van de 
verschillende interferonen toegelicht zowel in vitro als in vivo. In hoofdstuk 4.1 werd 
onderzocht of een reeks van recombinante porciene cytokines (interleukine-1 (IL-1), 
interleukine-6 (IL-6), interleukine-10 (IL-10), tumour necrosis factor-alpha (TNF-α), 
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interferon-alpha (IFN-α) en interferon-gamma (IFN-γ)) het verloop van een PCV2-
infectie in vitro konden beïnvloeden. Hiervoor werden twee verschillende cellijnen 
gebruikt: de PK-15 cellijn en de 3D4/31 cellijn die van oorsprong een prociene 
monocytaire cellijn is. Wanneer celculturen behandeld werden met IL-1, IL-6, TNF-α 
of IL-10, werd geen invloed op het verloop van de PCV2-infectie vastgesteld. 
Daarentegen werd wel een effect vastgesteld wanneer de cellen behandeld werden 
met IFN-α of IFN-γ. Wanneer IFN-γ aan het medium van de cellen werd toegevoegd 
voor, tijdens of na de inoculatie, werd een verhoging van het aantal geïnfecteerde 
cellen opgemerkt tot respectievelijk 418, 171 en 691% in PK-15 en tot 706, 114 en 
423% in 3D4/31 cellen. Een voorbehandeling van PK-15 cellen met IFN-α 
resulteerde in een daling van het aantal geïnfecteerde cellen. Maar wanneer het werd 
toegevoegd bij de cellen na de inoculatie steeg het aantal geïnfecteerde cellen tot 
529% in PK-15 cellen en tot 308% in 3D4/31 cellen. Het effect van beide interferonen 
kon geneutraliseerd worden door hun respectievelijk neutraliserend monoklonaal 
antistof. Door middel van concanavalin A (ConA) stimulatie van perifere bloed 
mononucleaire cellen (PBMCs) werd supernatans verkregen dat natuurlijk porcien 
IFN-γ bevatte. Wanneer dit supernatans gebruikt werd om PK-15 cellen te behandelen 
dan werd een gelijkaardig effect bekomen als met het recombinante IFN-γ. Het effect 
geïnduceerd door het supernatans van de ConA-gestimuleerde PBMCs kon eveneens 
geneutraliseerd worden door IFN-γ neutraliserende monoklonale antistoffen. 
Behandeling van PK-15 cellen met IFN-γ leidde tot een 20 maal verhoogde productie 
van nieuw virus. Door middel van confocale microscopie en aan de hand van 
recombinant kapsied eiwitten die “virion like particles” (VLPs) vormen, kon 
vastgesteld worden dat het effect van IFN-γ op de PCV2-infectie vooral te wijten was 
aan een verhoogde internalisatie van de membraan-gebonden VLPs door de cellen. Er 
kon geen verandering vastgesteld worden ter hoogte van de binding van de VLPs aan 
de cel of ter hoogte van de productie van virale eiwitten na infectie met infectieus 
virus. Deze studie rapporteerde voor de eerste maal dat een behandeling met IFN-α en 
IFN-γ de vermeerdering van een virus verbetert. 
In hoofdstuk 4.2 wordt een studie beschreven waarin gepoogd werd om de 
bevindingen die gedaan werden in hoofdstuk 4.1 te reproduceren in vivo. 
Gnotobiotische biggen werden intramusculair en subcutaan geïnoculeerd met ConA 
of recombinant IFN-γ (rIFN-γ) 12 uur voor de PCV2-inoculatie en gedurende 9 dagen 
180  Chapter 7 
___________________________________________________________________________________________________________________________________________ 
om de 3 dagen tijdens het verloop van de infectie. De vermeerdering van het virus 
werd gevolgd op drie verschillende tijdstippen door chirurgische biopsiename van de 
inguinale lymfeknopen op 10 en 15 dagen na de inoculatie (dpi) en bij de euthanasie 
op 21 dpi. In elk staal werd de hoeveelheid PCV2 bepaald door titratie van een 10% 
weefselsuspensie op PK-15 cellen. In de niet behandelde controlebiggen en in de 
biggen behandeld met rIFN-γ kon het virus pas worden teruggevonden in de inguinale 
lymfeknopen vanaf 15 dpi. Tussen deze groepen konden geen significante verschillen 
aangetoond worden. In biggen die behandeld werden met ConA kon het virus reeds 
vanaf 10 dpi teruggevonden worden. Op 15 dpi was de PCV2-vermeerdering hoger in 
deze biggen dan in de controlegroep. Ondanks de sterke verhoging van de 
virusvermeerdering onder invloed van ConA, konden in deze biggen geen klinische 
symptomen opgemerkt worden. Deze experimenten tonen aan dat een ConA-
behandeling de vermeerdering van PCV2 in vivo kan stimuleren maar er kon niet 
uitgemaakt worden of deze stimulatie al dan niet afhankelijk was van de inductie van 
IFN-γ productie. 
 
In hoofdstuk 5 werd de immuunrespons van het varken tegenover een PCV2-
infectie onderzocht. Hoofdstuk 5.1 beschrijft de bevindingen die gedaan werden 
tijdens een studie waarin de cellulaire en humorale immuunrespons van individuele 
gnotobiotische biggen tegenover PCV2 werd onderzocht en gecorreleerd met de 
evolutie van de vermeerdering van het virus in het big. Twaalf gnotobiotische biggen 
werden geïnoculeerd met PCV2 waarvan 4 behandeld werden met cyclosporine A 
(CysA). CysA is een schimmeltoxine dat de stimulatie van T-cellen tegengaat en op 
die manier de cellulaire en thymus-afhankelijke humorale immuunrespons inhibeert. 
De CysA-behandelde dieren werden ingesloten om het effect van de specifieke 
immuniteit op het verloop van de PCV2-vermeerdering te onderzoeken. Door middel 
van inguinale lymfeknoop biopten kon de PCV2-vermeerdering opgevolgd worden op 
drie tijdstippen: 10, 15 en 21 dpi. De evolutie van de totale anti-PCV2 antistoffentiter 
(IPMA) en de neutraliserende antistoffentiter werd opgevolgd alsook de expressie van 
IFN-γ mRNA in PBMCs als een merker voor de cellulaire immuniteit. De CysA-
behandelde biggen vertoonden de hoogste PCV2-vermeerdering, hetgeen aantoont dat 
de specifieke immuniteit zeer belangrijk is in het inperken van de virusvermeerdering. 
In de PCV2-geïnoculeerde dieren die niet behandeld werden met CysA, werden drie 
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verschillende vermeerderingspatronen opgemerkt. Patroon 1: PCV2 kon nooit 
geïsoleerd worden uit de lymfeknopen van 2 van de 8 biggen. Deze biggen werden 
wel geïnfecteerd met het virus vermits ze een duidelijke seroconversie vertoonden. Ze 
vertoonden zelfs de hoogste titers neutraliserende antistoffen tegenover PCV2 vanaf 
15 dpi. Bij deze biggen werd een duidelijke piek in IFN-γ mRNA expressie 
aangetoond vanaf 15 dpi hetgeen een duidelijke indicatie geeft voor een goede 
cellulaire respons. Patroon 2: vijf biggen vertoonden lage tot matige PCV2-titers op 
15 dpi die constant bleven of daalden naar 21 dpi toe. Deze biggen vertoonden 
duidelijke neutraliserende antistoffen maar de titers waren lager dan de titers bij de 
vorige biggen. Bij deze vijf dieren kon geen verhoging van de IFN-γ mRNA expressie 
aangetoond worden. Patroon 3: bij het laatste big werd een relatief lage PCV2 titer 
aangetroffen op 15 dpi. Deze titer vertoonde echter een sterke verhoging naar 21 dpi 
toe. Hoewel dit big duidelijk antistoffen tegenover PCV2 vertoonde (IPMA), kon er 
toch geen neutraliserende activiteit uitgaande van deze antistoffen aangetoond 
worden. Ook dit big vertoonde geen stijging in de expressie van IFN-γ mRNA. Deze 
studie toonde aan dat de aanvang van de specifieke immuunrespons tegenover PCV2 
mogelijk verantwoordelijk is voor de variatie in het verloop van de vermeerdering van 
het virus in de gastheer. De afwezigheid van PCV2-neutraliserende antistoffen is 
mogelijk een zeer belangrijke factor in de pathogenese van de verhoogde PCV2-
vermeerdering in een beperkt percentage van de biggen. Deze studie werd uitgevoerd 
in gnotobiotische biggen en er werd in het verleden reeds aangetoond dat de 
immuunrespons van dergelijke biggen erg kan afwijken van die van conventionele 
dieren. Daarom werd in hoofdstuk 5.2 onderzocht of gelijkaardige observaties konden 
gemaakt worden in conventionele dieren die natuurlijk of experimenteel geïnfecteerd 
werden met PCV2. In de studie die besproken wordt in dit hoofdstuk, werd 
aangetoond dat de correlatie tussen de afwezigheid van PCV2-neutraliserende 
antistoffen en het optreden van een verhoogde PCV2-vermeerdering in biggen ook 
terug te vinden was in conventionele dieren. In deze studie kon bijkomend een 
verband aangetoond worden tussen het afwezig zijn van de neutraliserende antistoffen 
en het optreden van PMWS in de biggen. De evolutie van de totale antistoffentiters 
verliep gelijkaardig bij subklinisch geïnfecteerde dieren en dieren die PMWS 
vertoonden. Beide groepen vertoonden seroconversie op hetzelfde tijdstip maar de 
titers bij de dieren met PMWS bleven iets lager. Bij de subklinisch geïnfecteerde 
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dieren liep de evolutie van de neutraliserende antistoffen samen met die van de totale 
antistoffen. Bij de dieren die PMWS vertoonden werd geen seroconversie in 
neutraliserende antistoffen aangetroffen of konden ze enkel gedurende een korte tijd 
gedetecteerd worden. Wanneer de verschillende antistof isotypes onderzocht werden, 
kwamen duidelijke verschillen naar voren. Bij subklinisch geïnfecteerde dieren bleven 
de IgM antistoffen tegenover PCV2 aanwezig tot aan het einde van elke studie. Bij de 
dieren met PMWS werden ook IgM antistoffen gedetecteerd maar deze verdwenen 
snel of bleven aanwezig in zeer lage titers. Verder werd ook duidelijk dat de 
gemiddelde titers van de andere onderzochte antistof isotypes lager lagen bij de dieren 
die PMWS vertoonden dan bij de subklinisch geïnfecteerde dieren. Deze verschillen 
waren echter maar in enkele gevallen significant. 
 
De algemene conclusie van deze thesis is dat de vermeerdering van PCV2 in zijn 
gastheer sterk beïnvloed wordt door verscheidene gastheer-specifieke en externe 
factoren. Er werd aangetoond dat in verschillende experimentele en veldstudies een 
deel van de biggen niet in staat was om een efficiënte immuunrespons tegenover 
PCV2 op te starten vermits ze geen neutraliserende antistoffen konden aanmaken. Dit 
resulteerde bij deze biggen in een sterk verhoogde vermeerdering van PCV2 en leidde 
in enkele studies tot het optreden van PMWS. Dit verschil in capaciteit om PCV2-
neutraliserende antistoffen aan te maken kan mogelijk de basis leggen voor het 
identificeren van de genetische invloed op de gevoeligheid van varkens voor PMWS. 
Verder werd in dit proefschrift ook aangetoond dat IFN-γ en in meer specifieke 
condities ook IFN-α de gevoeligheid van twee continue varkenscellijnen tegenover 
PCV2 konden verhogen. Er werden ook indicaties gevonden dat een gelijkaardig 
mechanisme in vivo een rol zou kunnen spelen. Toekomstig werk gebaseerd op de 
bevindingen die gemaakt werden tijdens dit werk, zou kunnen leiden tot de kennis om 
strategieën uit te werken om een varkenslijn te selecteren die resistent zou zijn aan 
een verhoogde PCV2-vermeerdering en dus aan PMWS. Verder kunnen op basis van 
deze bevindingen ook sanitaire maatregelen aanbevolen worden die kunnen leiden tot 
een lagere prevalentie van PMWS in de huidige varkensstapel. 
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Dankwoord 
 
Het einde van een doctoraat is het ideale moment om terug te kijken op een 
belangrijke periode. Hoewel deze periode vooral extra vragen heeft voortgebracht is 
ze toch zeer verrijkend geweest zowel op professioneel als op persoonlijk vlak. Het is 
de periode geweest waarin ik mocht, kon of moest samenwerken met mensen van 
verschillende pluimage en dat maakte het werk enorm boeiend. Dit is dan ook het 
ideale moment om deze mensen te danken voor hun aandeel in dit werk. 
Niet enkel uit beleefdheid of traditie, maar oprecht wil ik eerst Hans bedanken. Ik 
herinner mij nog levendig hoe mijn eerste gesprek met mijn promotor verliep: een 
stortvloed van ideeën, een vurig pleidooi voor de virologie, maar bovenal een passie 
voor het onderzoek en een gedrevenheid om PCV2 op de knieën te krijgen. Die passie 
en gedrevenheid zijn nooit verdwenen. Zelfs op momenten toen de resultaten veel te 
lang uitbleven en mijn motivatie onder het vriespunt zakte, was één gesprek genoeg 
om een nieuwe weg in te slaan. Natuurlijk kan een samenwerking gedurende vier jaar 
maar succesvol zijn wanneer er af en toe eens onenigheden zijn. Zo kon het wel eens 
gebeuren dat we tegenover elkaar in plaats van naast elkaar stonden, maar wanneer ik 
terugkijk op hetgeen we behaald hebben gedurende de voorbije vier jaar, dan denk ik 
toch dat ik mag besluiten dat we ons doel bereikt hebben.  
Toen ik aan het PCV2-vraagstuk begon, kon ik dit nog doen onder het kritisch 
oog van Prof. Pensaert. Ik heb het geluk gehad om de eerste twee jaar van mijn 
termijn aan het labo voor Prof. Pensaert te werken, hetgeen zoals mijn voorgangers 
weten, een unieke ervaring is. De verwezenlijkingen tijdens zijn carrière en zijn 
internationale faam kunnen ons enkel maar doen beseffen dat Prof. Pensaert een ware 
pionier was in de varkensvirologie. 
Verder wil ik ook Kristien en Herman bedanken voor de expertise die ze steeds 
ter beschikking stelden op het labo. Nooit heb ik enig moment ervaren waarop ik 
ongelegen kwam met een vraag. Herman kan je een beetje aanzien als de Eddy 
Merckx van de virologie. Iemand die overloopt van de capaciteiten maar zich nooit te 
goed voelt om anderen te helpen en steeds bescheiden blijft. Herman, nu nog vijf keer 
den tour winnen … 
A PhD work can only reach an acceptable level when its observations are being 
discussed with external experts. I was proud to find Professor Segalés willing to judge 
my work. I have always admired his critical way of dealing with the immensely 
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complex matter of PMWS and I acknowledge him as one of the most important 
researchers in the PCV2-PMWS community. Gelukkig kon ik ook dichterbij huis 
beroep doen op de hulp van experts. Zo speelde een groot deel van mijn werk zich af 
in de immunologie en dan kon ik steeds rekenen op Professor Cox. Onze 
samenwerking is steeds zeer vlot verlopen, zodanig zelfs dat ik niet enkel zijn PCR 
maar ook zijn laborante ter beschikking kreeg. Voor deze samenwerking wil ik zowel 
Prof. Cox als Griet bedanken. 
Het grote voordeel te werken aan deze faculteit was de aanwezigheid en 
beschikbaarheid van mensen met enorme kennis in uiteenlopende vakgebieden. 
Tijdens mijn tijd in de faculteit heb ik daar meermaals gebruik van kunnen maken. Ik 
dank prof. Ducatelle, prof. Maes, Prof. Van Ham, Prof. Deprez dan ook voor de hulp 
die ik kreeg voor het bekomen, analyseren of situeren van bepaalde resultaten. Ook in 
het eindstadium van mijn doctoraatswerk kon ik rekenen op mijn 
begeleidingscommissie (Prof. Cox, Prof. Ducatelle, Prof. Maes en Prof. Segalés) om 
deze thesis bij te sturen en “expert opinions” te leveren die gelukkig steeds mild 
genoeg waren. Bijkomend zetelden Prof. Pensaert, Prof. Haesebroeck, Prof Deprez, 
Prof Verdonck en Dr. Vyt in de examencommissie. Ik wil ze bedanken omdat ze de 
moed hadden om deze 180 bladzijden durende virologische beschouwing over het 
meest obscure der varkensvirussen tot zich te nemen.   
In de ogen van dierenartsen zoals ikzelf is onderzoek des te interessanter om uit 
te voeren wanneer het verband met de praktijk niet te ver te zoeken is. Dit was dan 
ook één van de belangrijkste aspecten van het project van het FOD volksgezondheid 
waaraan ik mocht werken. Ik heb de jaarlijkse werkvergaderingen met zowel mensen 
uit de academische wereld als uit de praktijk steeds als zeer interessant en sturend 
ervaren. De bevindingen van geroutineerde dierenartsen zoals Martin Fockedey zijn 
van onschatbare waarde voor onderzoekers zoals ikzelf. Ook de samenwerking met de 
mensen van DGZ en dan vooral met Katrien Desmet en Filip Vyt was een hulp om 
onze resultaten in het juiste perspectief te brengen. Ik wil hen en alle andere 
dierenartsen waarmee ik de voorbije jaren contact had (lees: lastig gevallen heb), 
hiervoor bedanken. Ook de andere leden van de begeleidingscommissie van het 
project wil ik danken voor hun wakend oog en sturende opmerkingen tijdens onze 
weg door het PCV2-kluwen, zeker ook Dr. Vanhuffel die de zaak steeds van op 
voldoende afstand bekeek. Het is altijd mijn doel geweest om u te overtuigen van het 
unieke van dit miniscule virus. Ik hoop dat ik daar minstens gedeeltelijk in geslaagd 
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ben. Natuurlijk dank ik het ministerie van landbouw (later het ministerie van 
volksgezondheid) om mij de kans te geven om gedurende al die jaren dit onderzoek 
uit te voeren.  
The research that I was able to perform and the results that came out of it are 
certainly not the result of my project alone. The observations that led to the golden 
hypothesis, were made by Dr. Romeo Sanchez. Romeo, together we went through a 
few tough years of PCV2 research. I’m sure you still remember them. I have always 
appreciated the fact that, although you were more than busy with getting your own 
publications, you still had time to give me the proper training I needed to get started 
myself. For this I cannot thank you enough. Know that this thesis would not have 
existed if you wouldn’t have done the basic research before. 
I am reassured to know that the PCV2 work will not be abandoned. In fact it will 
be continued by two guys with whome I had a lot of fun the last few years. Misinzo, 
although you look a bit darker compared to the rest of us, you really lightened up the 
lab. Countless times you were the real centre of the lab with jour stories about Africa. 
Whenever I get caught by a Boa Constrictor, I’ll be able to survive only thanks to 
your good advice. You had the amazing ability to blend into the lab the minute you 
arrived. I still remember the first dutch words you learned... and I will never forget the 
meaning of mbusi katoloki. Besides being a very good collegue, you are also a good 
scientist. I admired the way you were able to produce such high quality results once 
you had set your mind to it. David is degene die echt de fakkel overneemt. In het 
begin vroeg ik mij sterk af of de serieuze wetenschap wel te combineren viel met zo’n 
bedenkelijk gevoel voor humor. Blijkbaar wel. Tijdens de periode dat ik geen tijd 
meer had om nog veel in het labo rond te lopen, zag ik wel dat je je weg snel zelf zou 
vinden. Ook zag ik dat je snel charmanter gezelschap opzocht om mee te “werken”. Ik 
wens je veel succes, geluk (en sterkte) in het verdere PCV2-onderzoek. 
In mijn wetenschappelijke hindernissenkoers kon ik steeds rekenen op de hulp 
van drie van mijn mede-doctoraatsstudenten. Wanneer ik eraan terugdenk dan moet 
Steven wel dikwijls gedacht hebben: “Is hij daar nu wéér met zijn gezaag over dat 
onnozel virus?”. De gesprekken over onzer beider problemen op het labo hebben mij 
dikwijls geholpen om oplossingen te vinden, of toch tenminste om de moed terug te 
vinden om ernaar te zoeken. Mensen zoals jij waren onontbeerlijk om mijn doctoraat 
af te werken. Mijn andere trouwe toeverlaat was steeds Putti alias Peter D. Telkens als 
ik mij durfde (of moest) in het moleculaire doolhof wagen, was hij er het eerste 
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slachtoffer van. Ik verbaasde mij steeds weer over het enthousiasme en geduld 
waarmee hij mij de finesse van de moleculaire technieken trachtte bij te brengen. En 
dat terwijl een dierenarts daar toch niet echt voor gemaakt is… Ik troost mij met de 
gedachte dat het bloed trekken bij u net zo goed ging als het western blotten bij mij. 
Het ging wel maar ik was toch niet graag dat varken geweest… Aan wie ik natuurlijk 
niets meer moest vertellen in verband met de praktische kant van het onderzoek, was 
Geoffrey. Hoewel hij de bescheidenheid zelve was, moet hij één van de meeste 
precieze onderzoekers geweest zijn die op het labo rondliepen. Verder was zijn 
specialiteit het opsporen van typfouten en spellingsfouten waarvan we nadien deden 
alsof het typfouten waren. Geoffrey, ik hoop dat je mijn thesis niet te nauwkeurig 
naleest.  
Diergeneeskundig onderzoek kan natuurlijk niet zonder een hoop praktisch werk. 
Hiervoor kon ik steeds rekenen op de hulp van twee zeer geroutineerde en ronduit 
fantastische dierenverzorgers. Hoewel Fernand zijn specialiteit vooral lag in het 
zachtaardig omgaan met katten, had hij toch ook een zeer brede kennis over de sociale 
omgang met varkens. Hij was dan ook de geknipte (niet letterlijk te nemen) persoon 
om mij, na mijn theoretische studies, de praktische zaken bij te leren. Zoals zo vaak 
bleek de theorie weer niet op te wegen tegen jarenlange ervaring. Geert Surété had 
ook zo’n ervaring in de omgang met dieren, maar dan vooral met de dode versie 
ervan. Het was altijd een hilarische ervaring om samen met hem den boer op te gaan. 
Samen hebben we er ook altijd voor gezorgd dat de mensen die niet in contact 
kwamen met varkens, regelmatig met de neus op de feiten werden gedrukt. Fernand 
en Geert vormden samen de “Laurel en Hardy” (zelf in te vullen wie wie is) van de 
virologie. Als het urenlange schijven mij teveel werd, kon ik altijd eens wat tipkes 
gaan vullen en voor ik het wist waren we een uur en verscheidene breuken van het 
lachen verder. 
Het favoriete slachtoffer van ons neus-op-de-feiten-gedruk, was Carine. De 
massa’s werk die zij voor het PCV2-project heeft verzet is niet te overzien. De laatste 
6 maanden alleen al kwamen we aan meer dan tweehonderd PK-15 platen. Zij stond 
er ook steeds wanneer ik er moest aan herinnerd worden dat er nog platen voor mij in 
de broedstoof stonden. Dit werk zou onmogelijk geweest zijn zonder haar hulp. Dit 
geldt natuurlijk ook voor Chris. We hebben er samen wel een paar liter 2985 
doorgedraaid en hebben een nieuwe gestalte gegeven aan het werkwoord IPMAen. 
Onze samenwerking was zo goed dat we dikwijls gezegd hebben: “Wijle zijn nogal ne 
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keer een team hé zeg”. PRRSV en macrofagen waren de specialiteit van Chantal; 
bioassay’s, cytokines en augustijn die van Lieve. Met z’n allen vormden ze een team 
waarop iedereen steeds beroep kon doen. Het was dan ook met gemengde gevoelens 
dat ik dat team achterliet omdat ik besef dat zo’n samenwerking niet evident is. Ook 
de nieuwste kracht, Nele, heeft al aangetoond dat ze een waardevolle aanwinst is. 
Met mijn administratieve problemen kon ik altijd terecht bij Mieke en Gert. Gert 
was gelukkig beter met cijfers dan met de Koppenberg. Door met Mieke samen te 
werken werd alles een stuk eenvoudiger. Als je iets vroeg deed ze altijd het dubbele 
van datgene waarom je gevraagd had. Hetgeen gemakkelijk was wanneer je maar aan 
de helft had gedacht. Beiden waren ze enorm snel in het correct afhandelen van de 
zaken die hen toevertrouwd werden (behalve wanneer de melige vogelaars 
langskwamen). 
Over Dirk kan ik bladzijden lang doorvertellen. Zijn grote probleem was dat hij, 
net zoals ieder van ons, veroordeeld was tot het werken met Macintosh. Zijn beste 
eigenschap was dan weer dat hij daar nooit iets van liet merken en met de glimlach 
bleef proberen om een degelijk netwerk op poten te zetten en te houden, en dat lukte 
hem nog ook. Iedereen weet dat de IT onontbeerlijk geworden is in de huidige 
wetenschap en daarom is ook het werk van Dirk van zeer grote waarde geweest.  
Het comfort in het labo werd ook voor een groot deel verzekerd door Marijke. Zij 
zorgde ervoor dat de rommel op mijn bureau binnen de perken bleef waardoor ze 
zeker haar plaats verdiend heeft in dit dankwoord. 
Alle andere mensen in het labo droegen elk op hun manier bij aan het tot stand 
komen van dit werk. Tijdens mijn eerste jaren had ik het genoegen om naast Kristin te 
zitten. Samen hebben we een hoop afgelachen (ik toch). Kristin, er was maar één ding 
dat ik iets minder fantastisch vond zoals je wel al weet, maar echt kwalijk kan ik het 
je niet nemen. Tijdens mijn recente lange uren in de trein heb ik geleerd dat vrouwen 
en GSM’s nooit echt samengaan.  
Ook de mensen waarmee ik niet zo vaak samengewerkt heb: Karen, Filip, Sarah 
en Sarake, Nick, Hannah en Els, Ann, the shrimp guys, Kalina en Constantinos wil ik 
bedanken, alsook de mensen die in de loop der jaren van het labo vertrokken: Geert, 
Nathalie, Gerlinde, Dieter, Liliane, Veerle, Trees en Inge. Het is enkel uit gebrek aan 
plaats dat ik ze hier zo snel opsom. Bilbo in “The lord of the rings” gaf de perfecte 
onschrijving: “I don’t know half of you half as well as I should like …”. 
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I owe special thanks to my Danish collegues and not only for the nice week I 
spent at Lindholm. The work that they performed on PCV2 was another key to come 
to the golden hypothesis. I believe this is well illustrated in this thesis since I have 
referred 24 times to the publication of Ann-Sofie.  
Tenslotte wil ik ook mijn familie bedanken die er steeds voor gezorgd heeft dat ik 
mij in de beste omstandigheden kon verdiepen in dit werk. Zonder de steun van Els 
zou er van dit werk geen sprake zijn. Zonder de onbeduidende maar onvergetelijke 
momenten met Anaïs, zou het voorbije jaar er waarschijnlijk een stuk grijzer uitgezien 
hebben. We weten nog niet wat de toekomst ons zal brengen, maar ik ben er wel zeker 
van dat het iets goed zal zijn. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
De wetenschap mag weten,  
het wonder blijft bestaan. 
Ik weet maar één ding zeker,  
de rest mag je vergeten. 
Eén waarheid blijft bestaan:  
we komen en we gaan. 
 
Stef Bos, Vuur 
